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DNA double strand breaks (DSBs) pose a major threat to the maintenance of 
genetic integrity. Cells have evolved response pathways to detect, signal and 
repair those lesions. Alterations in the factors involved in these pathways may 
lead to disease development, such as cancer. Several histone modifiers have 
previously been shown to be recruited to the sites of DSBs, but their role in the 
repair process still remains unclear. It has been proposed that the cellular 
response to DSBs leads to changes in phosphorylation, methylation, acetylation 
and ubiquitination and other post-translational modifications (PTMs) of histones 
at the site of damage. Some of these modifications are known epigenetic 
markers involved in maintaining cellular identity. It has been proposed that 
DSB-induced alterations to the epigenetic code introduce a potential window of 
opportunity for pathological changes to occur.  
Here, I have developed a chromatin immunoprecipitation followed by mass 
spectrometry (ChIP-MS) method to enrich for mono-nucleosomes containing 
Ser139-phosphorylated H2AX (H2AX). I utilise targeted mass spectrometry to 
quantify histone PTMs associated with H2AX formed after ionising radiation (IR) 
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damage of HEK293 cells, as well as wild type and ATM deficient 1BR 
fibroblasts. Surprisingly, few local changes in histone PTMs associated with 
H2AX containing mono-nucleosomes were found. A damage-dependent 
increase in H2A(X) lysine15 ubiquitination (H2A(X) K15Ub) was detected and I 
gained insight into the dynamics of this important PTM. We found that H2AX 
levels are maximal within 30 min of IR exposure after 3 Gy whilst H2A(X) 
K15Ub reaches maximal level at 4-8 h. A dose-response analysis revealed that 
whilst H2AX levels increase linearly with dose, the level of H2A(X) K15Ub 
peaks at ~3 Gy and is substantially diminished after 40 Gy, demonstrating that 
the response is not linear with dose and becomes saturated at higher doses. 
Furthermore, our preliminary data suggests that contrary to previous reports 
ATM-dependent late repairing DSBs are not enriched in constitutive 
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53BP1  p53 binding protein 1    
Ac   Acetylation 
ADD   ATRX, DNMT3 and DNMT3L domain 
AEBSF  4-(2-aminoethyl) benzenesulfonyl fluoride hydrochloride 
Alt-NHEJ  Alternative NHEJ 
AP   Apurinic/Apyrimidinic 
APLF   Aprataxin and PNK-like factor 
APTX   Aprataxin 
ARR   Access-Repair-Restore model 
A-T   Ataxia telangiectasia disorder 
ATM   Ataxia telangiectasia mutated 
ATP   Adenosine tri-phosphate 
ATR   Ataxia telangiectasia and Rad3 related 
BAH   Bromo adjacent homology domain 
Bax   Bcl-2 associated X protein 
Bcl-2   B-cell lymphoma 2 
BER   Base excision repair 
BRCT   BRCA1 C-terminal domain 
BrD   Bromo-domain 
c-Abl   Cellular Abelson tyrosine-protein kinase 1 
CHK1/2  Checkpoint kinase 1/2 
ChIP   Chromatin immunoprecipitation 
CK2   Casein kinase 2 
CPT   Camptothecin 
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CtIP   CtBP-interacting protein 
DDA   Data-dependent acquisition 
DDR   DNA damage response 
DNA   Deoxyribonucleic acid 
DNA-PK  DNA-dependent protein kinase 
DNA-PKcs  DNA-dependent protein kinase catalytic subunit 
DSB   Double-strand break 
DUB   De-ubiquitinating enzyme 
EXO1   Exonuclease 1 
FA   Formic acid 
FAT   Focal adhesion kinase 
FAT-C  Focal adhesion kinase C-terminal 
FEN1   Flap endonuclease 1 
FHA   Forkhead-associated domain 
γH2AX  Histone H2AX pSer139 
GFP   Green fluorescent protein  
HDAC   Histone deacetylase 
HEAT Huntington, elongation factor 3 (EF3), the 65 kDa alpha 
regulatory subunit of protein phosphatase 2A (PP2A) and 
the yeast PI3-kinase TOR1 
HP1   Heterochromatin protein 1 
HR   Homologous recombination 
hTERT  Human telomerase reverse transcriptase 
IP   Immunoprecipitation 
IR   Ionising radiation 
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KAP-1   Kruppel associated box domain protein 1 
LC-MS/MS  Liquid chromatography tandem mass spectrometry 
LET   Linear energy transfer  
LIG3   DNA Ligase 3 
LTQ   Linear trap quadrupole 
MBT   Malignant brain tumour repeat  
MDC1   Mediator of DNA damage checkpoint protein 1 
Me1/2/3  Mono-/di-/tri-methylation 
MEF   Mouse embryonic fibroblast 
MNase  Micrococcal nuclease 
MMEJ   Microhomology-mediated end joining 
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NCS   Neocarzinostatin  
NER   Nucleotide excision repair 
NHEJ   Non-homologous end joining 
PAXX   Paralog of XRCC4 and XLF 
PAR   Poly(ADP-ribose) 
PARG   Poly(ADP-ribose) glycohydrolase 
PARP   Poly(ADP-ribose) polymerase  
PHD    Plant homeodomain 
PHF8   PHD finger protein 8 
PI3K   Phosphatidylinositol 3-kinase-related kinase 
PMSF   Phenylmethylsulfonyl fluoride 
PNKP   Polynucleotide kinase/phosphatase 
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PRC1   Polycomb repressive complex 1 
PTIP   PAX-interacting protein 1  
PTM   Post-translational modification 
PUMA   p53 upregulated modulator of apoptosis 
PWWP  ‘Proline-Tryptophan- Tryptophan- Proline’ domain 
RAD51  Radiation sensitive protein 51 
RAG1/2  Recombination activating gene 1/2 
RFP   Red fluorescent protein 
RIF1   Rap1-interacting factor 1 homolog 
RNA   Ribonucleic acid 
RNF168  Ring finger protein 168 
RNF8   Ring finger protein 8 
RPA   Replication protein A 
RT   Radiation therapy 
SDS   Sodium dodecyl sulphate 
SCID   Severe combined immunodefiency 
SRM   Selective reaction monitoring 
SSA   Single-strand annealing 
SRM   Selected reaction monitoring 
SSB   Single-strand break 
SSBR   Single-strand break repair 
SUMO  Small ubiquitin-like modifier 
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TDP1   Tyrosyl-DNA phosphodiesterase 1 
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TDP2   Tyrosyl-DNA phosphodiesterase 2 
TEAB   Triethylammonium bicarbonate 
TFA   Trifluoroacetic acid 
TIP60   60 kDa Tat-interactive protein  
TOP1   DNA topoisomerase 1 
TOP2   DNA topoisomerase 2 
TOP3   DNA topoisomerase 3 
Ub   Ubiquitination 
UV   Ultraviolet 
WD40   ‘Tryptophan-Asparagine’ dipeptide 40 motif  
XLF   XRCC4-like factor  
XRCC4  X-ray cross complementing group 4   
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1.1 DNA DAMAGE AND ITS CONSEQUENCES  
 
The genetic information of a eukaryotic cell is packaged into chromatin, which is 
a highly condensed structure composed of DNA, histones and other associated 
proteins. Besides being encoded by the DNA sequence, the information 
required for the proper functioning of the organism is also determined by the 
pattern of DNA and histone modifications known as epigenetic marks. 
Every day we are exposed to a range of genotoxic agents, which pose a major 
threat to the integrity of genetic information. It has been shown that a variety of 
exogenous and endogenous toxins or exposures, such as ultra violet (UV) light, 
ionizing radiation (IR) or replication stress to name a few, can induce DNA 
lesions.  
DNA double-strand breaks (DSBs) are particularly dangerous. If not repaired 
correctly, these lesions can have profound consequences to the health of the 
affected cell, tissue or even the whole organism. For instance, mutations to the 
genetic code can impact on crucial cellular pathways involved in the regulation 
of cell cycle, DNA repair and apoptosis, which are important for prevention and 
accumulation of chromosomal aberrations and consequently contribute to the 
development of a disease state, such as cancer, neurodegeneration, 
immunodeficiency and premature ageing (Jackson and Bartek, 2009). 
Therefore, faithful repair of DSBs is crucial for human health. 
In order to prevent the formation and propagation of those pathogenic changes, 
the cell has evolved DNA damage response (DDR) pathways that allow the 
recognition of DNA damage and signal it to the cell.  This signaling triggers the 
activation of a cell cycle arrest, which allows time for the repair of the break. 
Depending on the stage of the cell cycle and the type of lesion, different repair 
pathways may be preferred. The choice of repair pathway can be also 
influenced by the chromatin state, as well as by existing histone post-
translational modifications (PTMs) (Aymard et al., 2014). The signaling of 
damage and the repair process itself also require modification of the chromatin 
structure. 
Specific histone PTMs act to signal damage to the regions flanking the break, 
recruit factors that protect naked DNA ends or relax chromatin to allow access 
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of the repair machinery (Lukas, Lukas and Bartek, 2011). Additionally, some 
histones might be exchanged with their variants or even whole nucleosomes 
might be removed from the site of damage (Mehrotra et al., 2011; Xu et al., 
2012; Adam, Polo and Almouzni, 2013). Once the repair has occurred, the 
chromatin must be restored to its previous state.  
A range of histone PTMs have been reported to play a role in the cellular 
response to DNA damage. Also, several histone modifiers, which are often 
mutated in cancer, have been reported to be recruited to the sites of breaks. 
However, in most cases the exact role or consequence of the PTM in the 
subsequent DNA repair process is still to be elucidated. This thesis focuses on 
the impact of DNA DSBs on the surrounding chromatin environment. 
 
1.2 SOURCES OF DNA DSBS 
 
DNA DSBs are the most dangerous cytotoxic lesions. If they are not repaired 
correctly, they may lead to pathogenic changes, which in turn may contribute to 
development of disease states, such as cancer. If they are not repaired at all, 
they may lead to cell death. Enhanced cell death can cause stem cell depletion 
and is particularly dangerous if a given cell is for example a post-mitotic neuron, 
as this may contribute to neurodegeneration (Espada and Ermolaeva, 2016; 
McKinnon, 2017). DSBs arise, when the sugar-phosphate backbone of both 
strands of DNA are broken in close proximity to each other. This may lead to 
physical dissociation and separation of damaged DNA ends, and potentially to 
chromosomal rearrangements. Chromosomal translocations are known to 
cause loss-of-function in tumour suppressor genes or gain-of-function in proto-
oncogenes, further contributing to cancer development  (Haber and Fearon, 
1998). It has been estimated that on average ~10 DSBs per cell may arise 
spontaneously every day, induced by both internal and external factors sources 





1.2.1 Endogenous sources of DSBs 
 
1.2.1.1 Topoisomerases 
DSBs can be induced during normal physiological processes, such as 
transcription and DNA replication, which can produce superhelical tension in 
DNA. This torsional stress needs to be relieved and it may be lifted by a family 
of enzymes known as topoisomerases, of which there are three types: 1A 
(TOP3α/β), 1B (TOP1) and 2 (TOP2α/β) (Pommier et al., 2016). Although the 
TOP1 family is known to introduce a cleavage in a single strand of DNA, there 
are several instances where this lesion may be converted to a DSB. Some 
drugs used in cancer therapy, such as Camptothecin, function to trap TOP1 
complexes on DNA (Pommier et al., 2006). It has been proposed that if the 
DNA replication or transcription machinery encounters and collides with poised 
TOP1 complexes, it may lead to DSB formation (Cristini et al., 2016). Another 
possibility is that if two poised TOP1 complex-induced SSBs are positioned in 
close proximity on DNA, this may lead to the separation of DNA ends and 
conversion to a DSB. In addition, a multitude of exogenous and endogenous 
DNA lesions, as well as drugs can lead to TOP1 cleavage complex (TOP1cc) 
trapping, consequently leading to DSB formation and activation of DDR 
signalling (Pommier et al., 2006). 
On the other hand, TOP2 family enzymes alleviate transcriptionally induced 
torsional stress by introducing a transient cleavage to both of the strands of the 
DNA phosphodiester backbone, followed by rapid re-ligation of the ends (John L 
Nitiss, 2009). This process does not usually activate the DDR response. 
However in some cases, for instance in the presence of TOP2 poisons, the 
TOP2 cleavage complex (TOP2cc) is stabilised onto DNA preventing the re-
ligation step, subsequently leading to the formation of a cytotoxic lesion and 
activation of DDR signalling (John L. Nitiss, 2009). In non-replicating cells, 
TOP2-induced breaks have been shown to be a frequent cause of 
translocations in the regions of highly transcribed genes (Schwer et al., 2016; 
Wei et al., 2016). Consistently, inhibition of transcription reduces the rate of 
translocation, while depletion of TDP2 (5’-tyrosyl DNA phosphodiesterase), 
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which is involved in the removal of TOP2 prior to DNA ends re-ligation, 
increases in the translocation occurrence (Gómez-Herreros et al., 2017).  
1.2.1.2 R-loops 
Another potential source of endogenous DSBs are R-loops, which are 
RNA:DNA hybrids associated with ssDNA forming during transcription. Although 
for the most part these structures are resolved by RNA processing factors, high 
levels of transcription may lead to their accumulation. Exposed ssDNA can 
serve as a substrate for cytosine deamination by the APOBEC enzyme, which 
can then activate the BER (base excision repair) pathway, consequently leading 
to DSB formation (Stork et al., 2016). Alternatively, R-loops may lead to 
activation of the transcription-coupled nucleotide excision repair (TC-NER) 
machinery, which can remove the hybrid, generating a DSB upon encounter 
with the replication fork (Stork et al., 2016). R-loops can be also resolved by 
removing RNA itself through the action of RNase H nuclease or through RNA 
displacement by the Senataxin (SETX) helicase (Mischo et al., 2011; Skourti-
Stathaki, Proudfoot and Gromak, 2011; Sollier et al., 2014).  
Interestingly, we have recently demonstrated that depletion of SETX leads to 
increased misprocessing of R-loops in the proximity of DSBs, which may lead to 
large deletions and subsequently increased genomic instability (Brustel et al., 
2018) (the publication is attached to this thesis). Furthermore, SETX deficiency 
has been linked to the development of neurological diseases, highlighting it is 
important in the process of resolving R-loops (Yüce and West, 2013; Groh et al., 
2017). 
 
1.2.1.3 Antibody diversification 
In higher eukaryotes programmed DSBs can also be introduced during the 
development of the immune system. The adaptive immune response requires 
the generation of a repertoire of immunoglobulins (Ig) that can recognise and 
neutralise a plethora of antigens. This can be generated via pathways known as 
V(D)J recombination and class switch recombination (CSR) (Jung and Alt, 2004; 
Hwang, Alt and Yeap, 2015). Diversity is achieved via distinctive processes 
involving breakage and re-joining of DNA segments. This is achieved via action 
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of recombination activating enzymes, RAG1 and RAG2, whose expression is 
restricted to immature lymphocytes. Importantly, the DSBs introduced through 
the action of RAG proteins have to be repaired through a specific pathway, 
known as DNA non-homologous end joining (NHEJ) (Dudley et al., 2005). 
NHEJ has been shown to be required for the development of B and T cells and 
consequently, patients deficient in the components of this pathway display 
immunodeficiency, as well as increased radiosensitivity (Woodbine, Gennery 
and Jeggo, 2014).  
 
1.2.2 Exogenous sources of DSBs 
 
DNA damage can also arise due to external agents, such as ionising radiation 
(IR) and radiomimetic drugs. IR is a type of high-energy radiation that is able to 
release electrons from atoms and molecules, thereby ionising them. IR can be 
categorised into α- and β-particles, neutrons, and X- and -rays. The units of 
radiation are commonly expressed in gray (Gy), which is the measure of the 
amount of radiation absorbed by 1 kg of animal tissue (Dunne-Daly, 1999).  
DNA is highly susceptible to IR. IR is able to induce several types of DNA 
breaks, particularly DSBs. Charged particles may ionise DNA directly or may 
ionise water, consequently producing highly reactive hydroxyl (-OH) species, 
which can then react with DNA.  Additionally, reactive oxygen species (ROS) 
generated by IR can also induce several other types of DNA breaks, such as 
abasic sites and single strand breaks (SSBs).  
Importantly, IR-induced breaks can be very complex, containing multiple type of 
lesions in close proximity, posing an additional challenge for the repair 
machinery.  Collectively, these lesions contribute to cell death and mitotic failure, 
and these detrimental consequences are often exploited for radiation therapy 






1.2.3 The importance of DNA damaging agents in the cancer therapy 
treatments 
 
Cancer cells are particularly susceptible to DNA damage, hence IR and 
radiomimetic drugs are frequently used during treatment of cancer patients. 
This sensitivity arises as a consequence of the greater cycling capacity of 
tumour cells caused by inactivated checkpoint responses, resulting in 
uncontrolled proliferation and increase in genomic instability. In addition to that, 
downregulation of DDR pathways, for which synthetic lethality can be exploited, 
further sensitises tumour cells to DNA damage (Pearl et al., 2015; Jeggo, Pearl 
and Carr, 2016). Treatment with DNA damaging agents aims to reduce the 
tumour size or to eliminate residual tumour cells.  
Radiation therapy (RT) is the most commonly prescribed cancer treatment. The 
optimum IR dose depends on the type of cancer. The goal of RT is to deliver 
maximal IR dose to the tumour, while sparing normal tissue. A typical RT 
regime delivers daily doses of 1.5-3 Gy over several weeks and the limit of RT 
is decided based on the response of normal tissue that also receives some IR 
(Hickey et al., 2016; Yarnold, 2018). IR dose size and dose fractionation are 
important concepts in radiotherapy. Numerous studies have shown that 
reducing of the dose per fraction delays normal tissue toxicity and allows 
delivery of higher total doses to tumours, while improving patient survival 
(Bernier, Hall and Giaccia, 2004). However the molecular basis of this 
phenomenon are still not completely understood. 
Nonetheless, one of the downsides of RT is that IR unavoidably reaches normal 
tissue, as well as tumour. Subsequently, this may contribute to the formation of 
chromosomal abnormalities and increased risk of new malignancies. High RT 
doses are known to produce toxicity, which may contribute to poor patient’s 
prognosis (Brown, Mutter and Halyard, 2015). Additionally, some patients (5-
10%) appear to respond abnormally to RT, with severe cases of radiation 
induced toxicity leading to patients death (Rogers et al., 2000; Pollard and Gatti, 
2009). Therefore, RT regimens based on the individual patient/tumour capability 
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to repair IR-induced breaks could improve the decision for the most suitable 
treatment for cancer patients, as well as treatment safety. 
1.3 DNA REPAIR OCCURS IN THE CONTEXT OF CHROMATIN 
 
Nucleosomes are thought to provide a repressive background to cellular 
processes that require direct access to DNA, sterically hindering recognition 
sequences of DNA binding factors, such as RNA polymerases (Orphanides and 
Reinberg, 2000). Therefore, the processes that entail DNA substrates, such as 
transcription, replication and repair, require mechanisms which alleviate this 
repression. Indeed, a plethora of chromatin modifying enzymes has been 
shown to be involved in processes capable of modulating chromatin 
accessibility through covalent histone PTMs and nucleosomal remodelling.  
These processes have been widely studied in the background of transcription 
and replication, and more recently in the context of DDR and repair.  
In recent years, a model for the chromatin response to DNA damage has been 
proposed, and is referred to as the “access-repair-restore” (ARR) model 
(Smerdon and Conconi, 1999; Green and Almouzni, 2003; Polo and Almouzni, 
2015). In this model, recognition of a DNA break is followed by transient 
opening of the chromatin achieved via nucleosome mobilisation, chromatin 
remodelling and histone PTMs, which then allows the access of the repair 
machineries to the DNA lesion. Once the damage has been repaired, chromatin 
must be restored to its original state, to ensure preservation of the genetic and 
epigenetic integrity of the genome. In the past years, several examples of 
compliance with the ARR model have been demonstrated for the repair of DNA 
lesions during the nucleotide excision repair (NER) and DSB repair pathways.  
Several covalent modifications of histone tails have currently been reported to 
change in response to DNA DSBs. These include, but are not limited to, 
phosphorylation of serine and threonine residues, as well as acetylation, 
ubiquitination and methylation of lysine residues. These alterations have the 
potential to impact the chromatin structure, as well as to act as a binding 
platforms for the recruitment of the DNA damage repair machinery.  
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In this section, I will introduce the concept of the chromatin and discuss our 
current knowledge regarding its structure and regulation in the context of the 
DNA damage response. 
1.3.1 Chromatin structure  
 
Genetic information of a eukaryotic cell is packaged into chromatin, which is a 
complex between DNA and associated proteins, of which the most abundant 
are histones. The repeating unit of chromatin, the nucleosome, consists of 145-
147 base pairs (bp) of DNA wrapping 1.65 superhelical turns around an 
octamer of histone proteins, two of each: H2A, H2B, H3 and H4 (Figure 1.1) 
(Luger et al., 1997). Additionally, the linker histone H1 wraps another 20 bp, 
resulting in two full turns around the nucleosome. The structure of the histones, 
canonical nucleosome core and the many alternatives containing variant 
histones and post-translationally modified residues have been determined, 
allowing us to gain an insight into the mechanism of chromatin regulation 
(Koyama and Kurumizaka, 2018).  
1.3.1.1 Nucleosome structure 
Each nucleosome is composed of the ‘core’, linker DNA and in most cases, a 
linker histone, together forming the elementary repeating unit of chromatin. The 
core is composed of four pairs of histones, which are small (11-15 kDa), basic 
proteins that are very highly conserved between species. Each of the histones 
contain a dimerising central histone-fold domain, composed of four α-helices 
and two loops, spanned by N- and C-terminal unstructured regions known as 
histone tails. The histone core is involved in mediating stable histone-histone 
contacts through “handshake” interactions to form the core octamer, as well as 
forming numerous histone-DNA interactions serving to compact DNA into the 
nucleus (Mariño-Ramírez et al., 2005). 
H3/H4 and H2A/H2B dimers associate with each other through α-helical 
dimerization domains. H3/H4 dimers interact via the H3/H3 interface, forming 
stable tetramers in solutions. On the other hand, H2A/H2B dimers associate 
with H3/H4: H3/H4 tetramers via interactions between H2B:H4, forming a 









Figure 1.1 Structure of the nucleosome. Nucleoprotein complex consisting 
of 147 bp of DNA wrapped around a histone octamer composed of two 
copies of each: H2A, H2B, H3 and H4. Flexible, unstructured regions 
protruding from the nucleosome are histone tails. Adapted from: Ordu, 
Lusser and Dekker, 2016. 
31 
 
and the entire octamer only forms when wrapped by DNA (McGinty and Tan, 
2015). 
Flexible histone tails protrude from the nucleosome core and are easily 
accessible to the enzymes that deposit post-translational modifications (PTM), 
which play an important role in the regulation of the nucleosomal structure and 
dynamics, as well as contribute to the epigenetic regulation of cell fate 
(Bannister and Kouzarides, 2011). The tails adopt random coil conformations 
when not associated with DNA or when free in solution. They contain an 
abundance of lysine and arginine residues, as well as glycine, alanine and 
threonine, which greatly contribute to their unstructured conformation.   
PTMs of histone tails may alter condensed chromatin structure, thereby playing 
a role in access to genes; serve as a binding platform for cellular machinery or 
signal specific cellular events (Kouzarides, 2007). Specific genomic regions 
may contain different patterns of histone PTMs and the combinatorial effect of 
these modifications has been termed the “histone code” (Strahl and Allis, 2000). 
 
1.3.1.2 Core and variants histones 
The majority of core histones are synthesised during S phase of the cell cycle to 
allow rapid compaction of the DNA behind the replication fork. However, 
replication-independent histone variants may also be incorporated into the 
chromatin in other stages of the cell cycle. 
Incorporation of histone variants into the nucleosome may lead to profound 
changes in chromatin properties and in this way impact upon DNA compaction, 
replication, transcription and repair. Proteins which facilitate exchange of 
components of the nucleosome, histone chaperones, may recognise both 
canonical and variant histones, while some have evolved to recognise specific 
histones. 
Out of the four core histones, H2B shows very little functional diversification, 
while H4 is the only histone that has a single isoform. However, several 
paralogues of H2A and H3, as well as linker histone H1 are known (Figure 1.2). 









Figure 1.2 Variants of core histones. Black lines represent 
unstructured N-terminal tails. Key differences in amino acids amongst 
the H2A, H2B and H3 variants are depicted. Amino acids in the variants 
of H1 are not shown due to the high sequence divergence. Figure 
adapted from: Maze et al., 2014. 
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CENP-A, is incorporated into specialised nucleosomes, which play a role in 
kinetochore assembly, while CenH3 is found at the centromeres. CenH3 has 
been revealed to assemble into centromeric nucleosomes independently of 
DNA sequence, signifying an example of epigenetic inheritance. Another 
example is histone H3.3, which is expressed in all cell cycle stages, is 
incorporated into the nucleosome in a replication-independent manner and is 
known to be enriched in transcriptionally active genes. Interestingly, H3.3 has 
been shown to be important for the maintenance of genomic stability following 
DNA damage. 
It has been revealed that following UV-C irradiation and prior to repair, the 
histone chaperone HIRA deposits new histone H3.3, leading to its accumulation 
at the sites of DNA damage in active genes. There H3.3 variant replaces core 
H3 and primes chromatin for later reactivation of transcription (Adam, Polo and 
Almouzni, 2013). To further underscore the importance of this variant in 
maintaining genomic stability and in the response to DNA damage, mutations in 
the N-terminal tail of this variant have been associated with increased UV 
sensitivity, and linked to several paediatric cancers, such as glioblastomas, 
chondroblastomas and giant cell tumours of the bone (Schwartzentruber et al., 
2012; Wu et al., 2012; Behjati et al., 2013).  
Similarly, some H2A variants have been linked to the DDR. Like H3.3, the H2AZ 
variant was also shown to be rapidly incorporated into the chromatin flanking 
DNA breaks, with the loss of the specific histone chaperones that facilitate 
H2AZ exchange lead to inefficient RAD51 foci formation, and subsequently to 
defects in homologous recombination (HR) (Alatwi and Downs, 2015).  
Another DNA damage related histone variant, macroH2A.1, has been recently 
demonstrated to promote DSB repair. The recruitment and incorporation of this 
variant has been shown to induce chromatin condensation, which facilitates 
accumulation of BRCA1 and DSB repair via HR (Khurana et al., 2014). One of 
the best described DNA damage-associated histone variants is H2AX. It is now 
well established that in response to DNA damage, H2AX is phosphorylated on 
serine 139 (generating what is commonly referred to as H2AX), where it serves 
as a signalling molecule and a binding platform for the recruitment of the cellular 
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machinery that enables timely and efficient DNA repair (Rogakou et al., 1998a). 
This will be discussed in detail later. 
 
1.3.2 Regulation of chromatin structure and function through histone 
PTMs 
 
Histone tails are the substrate for a range of cellular enzymes catalysing 
covalent modifications (Figure 1.3). The structure and function of chromatin can 
be regulated via multiple PTMs. These serve to modulate interactions between 
histones and DNA, and subsequently allow or restrict the access of the cellular 
machinery to genes, signal specific cellular events or provide binding platforms 
for the proteins involved in the regulation of DNA related processes. The most 
common histone modifications include acetylation, methylation and 
ubiquitination of lysine residues, and phosphorylation of serine and threonine 
residues (Figure 1.4); however, a plethora of other post-translationally modified 
residues have also been reported (Bannister and Kouzarides, 2011; Lawrence, 
Daujat and Schneider, 2016).  
Importantly, several of these modifications, as well as histone variants have 
been implicated in the response to DNA DSBs (Tables 1.1 and 1.2). 
 
1.3.2.1 Acetylation  
Histones are covalently modified by the addition of an acetyl moiety to the ε-
amino group of lysine residues (Figure 1.4) by the class of enzymes known as 
histone acetyltransferases (HATs), and this modification can be reversed by the 
action of histone deacetylases (HDACs). HATs utilise acetyl-CoA as a cofactor 
to catalyse the transfer of the acetyl group to the lysine residue, the addition of 
which neutralises the positive charge on a lysine and consequently opens the 
chromatin structure by weakening of the interactions between the histones tails 
and DNA. 
There are two major classes of HATs: type-A and type-B. Type-A HATs are 
present in the cell nucleus and are often found within large multiprotein 
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complexes involved in the regulation of transcription through modifications of 
nucleosomal histones. On the other hand, type-B HATs are cytoplasmic and 
only capable of modifying free, newly synthesised histone H4 at lysine 5 and 12. 
This pattern of acetylation plays a role in the deposition of the histones into 
chromatin, after which the marks are apparently removed (Parthun, 2007). The 
positive charge on lysine residues may be restored by the action of HDACs. 
Their action is thought to stabilise local chromatin architecture, leading to the 
repression of transcription.  
Apart from its ability to neutralise the lysine charge, the acetyl group may also 
serve as a binding platform for the recruitment of proteins containing 
bromodomains (BrD), which are the readers of this modification. Interestingly, 
several DDR proteins contain BrDs, suggesting a role for acetylation of histones 




Figure 1.3 Major histone PTMs and histone modifiers. Enzymes in green and red are associated with transcriptional 





Figure 1.4 Chemical structures of common histone modifications. 


















K5  Increase by WB and MS after IR 
(Xie et al., 2010; Ikura et al., 2015) 
K36 No change after IR (Jiang, Xu and 
Price, 2010) 
Increase by MS after IR (Jiang, Xu 
and Price, 2010) 
H3 
 
K9 Decrease by WB and IF after 
Phleo, IR and laser micro-
irradiation (Tjeertes, Miller and 
Jackson, 2009; Meyer et al., 2016a) 
K14 No change by WB after Phleo 
(Tjeertes, Miller and Jackson, 2009) 
K18 Increase with ChIP-qPCR after I-
SceI (Ogiwara et al., 2011) 
No change by WB after Phleo 
(Tjeertes, Miller and Jackson, 2009) 
K23 No change by WB after Phleo 
(Tjeertes, Miller and Jackson, 2009) 
K56 Decrease by WB after Phleo 
(Tjeertes, Miller and Jackson, 2009) 
Not changed by ChIP-qPCR after 
AsiSI (Clouaire et al., 2018) 
H4 K16 Increase with WB and IF after IR 
(Gupta et al., 2005; Sharma et al., 
2010) 
Decrease by WB and IF after 
Bleocin; and by ChIP-qPCR after I-
SceI (K. Hsiao and Mizzen, 2013) 
No change by ChIP-qPCR after 






H2AX S139 Increase by WB, IF, ChIP, MS 
(Rogakou et al., 1999a; Savic et al., 
2009a; Hatimy et al., 2015) 
H4 S1 Increase by ChIP-qPCR after AsiSI 






H3 K4me2/3 No change by ChIP-qPCR after 
AsiSI or by WB after Phleo 
(Clouaire et al., 2018; Tjeertes, Miller 
and Jackson, 2009) 
Decrease with IF and ChIP-qPCR 
after laser micro-irradiation and 
AsiSI (Mosammaparast et al., 2013; 
Gong et al., 2017) 
H3 K9me2/3 No change by ChIP-qPCR after 
AsiSI (Clouaire et al., 2018; Tjeertes, 
Miller and Jackson, 2009) 
Increase with ChIP-qPCR after I-
SceI or p84-ZFN (S. Fnu et al., 
2011; Ayrapetov et al., 2014a) 
H3 K36me2 No change by ChIP-qPCR after 
AsiSI (Clouaire et al., 2018) 
Increase by WB after IR, increase 
by ChIP-qPCR after I-SceI (Sheema 
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Fnu et al., 2011) 
H3 H36me3 No change by ChIP-qPCR after 
AsiSI (Clouaire et al., 2018) 
Constitutive K36me3 increased at 
HR-dependent breaks (Pfister et al., 
2014; Clouaire et al., 2018) 
H3 K79me2 Decreased by ChIP-qPCR after 
AsiSI (Clouaire et al., 2018) 
No change by WB after Phleo 
(Tjeertes, Miller and Jackson, 2009) 
No change by WB after IR (Huyen 
et al., 2004) 
H4 K20me1 Increased by ChIP-qPCR after 
AsiSI and I-SceI (Pei et al., 2011; 
Tuzon et al., 2014; Clouaire et al., 
2018) 




H2A(X) K15 Increase by FK2 antibody and MS; 
mutational studies show defect in 
DDR (Stewart et al., 2009; Gatti et 
al., 2012; Mattiroli, J. H. a Vissers, et 
al., 2012) 
H2B K120 Decreased by ChIP-qPCR after 
AsiSI (Clouaire et al., 2018) 
H4 K91 Increased by WB (Yan, Dutt, Xu, 
Graves, Juszczynski, John P Manis, 
et al., 2009) 
 
Table 1.1 An overview of selected mammalian DDR/repair histone PTMs 
implicated in DDR and repair. WB = western blot; IF = immunofluorescence; 
ChIP = chromatin immunoprecipitation; p84-ZFN, AsiSI and I-SceI = DSB-









Change following damage induction 
 H2AZ Decreased by ChIP-qPCR after AsiSI (Clouaire 
et al., 2018) 
Rapidly incorporated and removed from 
chromatin, shown by laser micro-irradiation 
(Alatwi and Downs, 2015; Gursoy-Yuzugullu, 
Ayrapetov and Price, 2015) 
macroH2A1.1 Increase by ChIP-qPCR after AsiSI and I-SceI 




H3.1 No change with ChIP-qPCR after I-SceI 
(Ogiwara et al., 2011) 
Decreased by ChIP-qPCR after AsiSI (Clouaire 
et al., 2018) 
H3.3 Increase by IF after UV (Adam, Polo and 
Almouzni, 2013) 
 





Chromatin function can also be regulated through methylation of histone basic 
residues. In contrast to acetylation, methylation does not change the charge of 
the amino acids; and therefore it is considered that the function of this mark is 
exerted by effector molecules that are able to bind it. Location and degree of the 
methylation status has been linked to regulation of transcription, both activation 
and suppression; maintenance of genomic integrity, and propagation of 
epigenetic memory. Lysine, as well as arginine residues can be modified by 
addition of a methyl moiety in several ways. Lysines can be mono (me1), di- 
(me2) or tri-methylated (me3), while arginine residues can be mono-methylated 
and symmetrically or asymmetrically di-methylated (Figure 1.4) (Zhang and 
Reinberg, 2001; Bedford and Clarke, 2009).  
Three families of methyltransferases are able to catalyse the addition of the 
methyl group from S-adenosylmethionine to histone residues. SET-domain-
containing and DOT1-like proteins methylate lysines, while arginine residues 
are modified by protein arginine N-methyltransferases (PRMTs) (Greer and Shi, 
2012). Some methyltransferases can be recruited directly to specific DNA 
sequences (Woo et al., 2010) or their targeting to specific genomic loci can be 
facilitated by long and small non-coding RNAs (Verdel, 2004; Rinn et al., 2007; 
Ogawa, Sun and Lee, 2008; Gupta et al., 2010; Woo et al., 2010). Additionally, 
interplay between DNA methylation and histone deacetylation has been shown 
to play a role in orchestrating histone methylation (Fuks, 2005).  
Interestingly, methylation of histones can also be regulated by co-occurring 
histone marks. For example, a combinatorial pattern of histone modifications 
can influence the binding properties of the methyltransferases promoting co-
occurrence of certain marks, such as H2B ubiquitination and H3K4 methylation 
(Krogan et al., 2003; Kim et al., 2009). Conversely, some combinations of 
histone marks may mutually exclude others, for example H3K4me3 recruits an 
enzyme, PHF8, which then removes a methyl group from H3K9me2  (Horton et 
al., 2010).  
Methyl marks can be recognised by ‘reader’ proteins containing methyl-binding 
motifs, such as PHD, chromo, tudor, PWWP, WD40, BAH, ADD, ankyrin repeat, 
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MBT and Zn-CW domains (Hyun et al., 2017). Depending on the histone 
residue, binding of the methyl ‘reader’ proteins can regulate multiple complex 
cellular metabolic pathways, impact on chromatin structure, influence 
transcription, induce cell cycle arrest, senescence, apoptosis, autophagy and 
more (Hyun et al., 2017). Interestingly, several DDR factors contain methyl 
binding domains, which suggests possibly a role for methylation during DNA 
repair (Wei et al., 2018).  
Importantly, several methylated histone residues, as well as histone methyl 
transferases have been implicated in the DDR and the choice of repair 
pathways. For instance, pre-existing H3K36me2 has been shown to promote 
non-homologous end joining (NHEJ) pathway, while H3K36me3  has been 
shown to be required for the repair of DSBs by HR, and consequently a 
reduction in H3K36 methylation levels was shown to lead to repair defects and 
increased genomic instability (Fnu et al., 2011; Aymard et al., 2014; Pfister et al., 
2014).  
Histone H3K9 residue methylation has also been shown to be an important 
player during the DDR and repair. However, studies reporting methylation 
changes in this mark are often conflicting. For instance, di- and trimethylation of 
histone lysine9 (H3K9me2/3) has been reported to increase, decrease and 
remain unchanged at the sites of DNA DSBs (Falk et al., 2007; Young, 
McDonald and Hendzel, 2013; Ayrapetov et al., 2014a; Jiang et al., 2015; Wu et 
al., 2015).  
 
Another interesting histone residue involved in the DDR is H4K20. H4K20me2 
serves as a binding platform for the DDR mediator protein, 53BP1 (Botuyan et 
al., 2006a; Wilson et al., 2016), which has been shown to be important for the 
regulation of the choice between HR and NHEJ pathways (Kakarougkas et al., 
2013).  This modification is deposited progressively into newly synthesised 
nucleosomes throughout the G2, M and G1 phases of the cell cycle. It is very 
abundant, and has been shown to constitute over 80% of all H4K20 
modifications (Pesavento et al., 2008). It has been proposed that 53BP1 binding 
to the damaged chromatin behind the replication fork is weakened as the 
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dilution of H4K20me2 between ‘new’ and ‘old’ chromatin reduces its ability to 
bind nucleosomes, and subsequently cells are more likely to repair DSBs using 
homology directed repair (Pellegrino et al., 2017).  
  
1.3.2.3 Phosphorylation  
Protein phosphorylation involves the transfer of the -phosphate group from 
ATP to serine (S) (Figure 1.4), threonine (T) or tyrosine (Y) of the target protein. 
This modification is deposited by multiple protein kinases and it is reversible by 
protein phosphatases. The phospho-moiety adds negative charge to proteins, 
which can change their structure and functional activity. In addition, the 
phosphate-moiety can serve as a binding platform for the recruitment and 
retention of other protein factors. 
Phosphorylation is a key cellular regulatory mechanism activated in response to 
multiple extra- and intra-cellular stimuli, including DNA damage. Several 
kinases have been implicated in DDR to DSBs, most importantly ataxia-
telangiectasia mutated (ATM), ataxia-telangiectasia and Rad3-related (ATR) 
and DNA protein kinase (DNA-PK), all of which are members of the 
phosphoinositide 3-kinase (PIKK) family. They are all crucial in the early stages 
of DDR signalling, where amongst other targets, they phosphorylate the histone 
variant H2AX on S139 (Rogakou et al., 1998b; Stiff et al., 2004). Their role will 
be discussed in more detail later.  
DNA damage-induced phosphorylation of S/T residues serves to recruit proteins 
containing phospho-binding motifs, such as 14-3-3, Polo-box domains, WD40 
repeats, BRCA1 carboxy-terminal (BRCT) and Forkhead-associated (FHA) 
domains (Reinhardt and Yaffe, 2013). These proteins are involved in the 

































Figure 1.5 Schematic representation of the ubiquitination reaction. A) 
The ubiquitination reaction occurs in three steps, catalysed by specialised 
enzymes: an ubiquitin activating enzyme (E1), an ubiquitin conjugating 
enzyme (E2) and an ubiquitin ligating enzyme (E3). B) Additional ubiquitin 
molecules can be ligated to the lysine chains of previously attached 
ubiquitin molecules resulting in different molecular outcomes. Figure 
adapted from: Dikic, Wakatsuki and Walters, 2009. 
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1.3.2.4 Ubiquitination  
In addition to acetylation and methylation, lysine residues of histones can be 
also ubiquitinated. This modification involves addition of a single or multiple 
ubiquitin residues to specific lysine residues linked via an isopeptide bond. 
Ubiquitin is a 76-residue polypeptide that is attached to target proteins in a 
three-step process catalysed by E1, E2 and E3 ubiquitin ligases (Figure 1.5 A). 
A range of outcomes in ubiquitin signalling cascades can be achieved through 
different E3 ligases. Additionally, ubiquitin is rich in lysine residues that can be 
further modified with additional ubiquitin molecules, forming varied poly-ubiquitin 
chains and branches adding another layer of complexity to ubiquitin signalling 
(Figure 1.5 B).  
Protein ubiquitination has been shown to play a role in the regulation of cellular 
processes, such as stem cell maintenance and differentiation, cell cycle 
regulation, protein degradation, transcription and DNA repair (Cao and Yan, 
2012). Ubiquitination of the histones H1, H2A and H2B and H4 have been 
described in the literature to play a role in the response to DNA DSBs, 
specifically to promote the local relaxation of the chromatin fibre and recruitment 
of DDR factors to the sites of breaks (Doil et al., 2009a; Pinato et al., 2009; Yan, 
Dutt, Xu, Graves, Juszczynski, John P. Manis, et al., 2009; Yan et al., 2013; 
Thorslund et al., 2015a).  
The importance of ubiquitin signalling during DDR is further emphasised by the 
link between the defects in this response and human diseases (Stewart et al., 
2009; Tessadori et al., 2017). 
 
 
1.3.3 The effect of chromatin compaction on DSB repair 
 
Nucleosomal DNA complexes commonly referred to as “beads-on-a-string” 
structure, constitute the first level of chromatin condensation. However, in order 
to fit an average eukaryotic genome into the nucleus, additional levels of 
condensation must also be achieved. It has been proposed that chromatin 
becomes arranged into higher order structures in a hierarchical manner to 
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ultimately form mitotic chromosomes (Woodcock and Ghosh, 2010) (Figure 
1.6). In the interphase nucleus, chromatin is broadly categorised into two major 
states according to its condensation level. Compacted chromatin, or 
heterochromatin, is transcriptionally inactive, whereas open regions are known 
as euchromatin and are transcriptionally active (Babu and Verma, 1987).  
Heterochromatin consists of two distinct forms, facultative and constitutive, 
which are distinguished by their pattern of histone PTMs. Facultative 
heterochromatin is enriched in H3K27me2/3 and H2AK119Ub, two gene 
silencing histone marks. Facultative heterochromatin is  known to contain genes, 
and can adopt open and transcriptionally active conformations, depending on 
the cell type and developmental stage (Trojer and Reinberg, 2007). Constitutive 
heterochromatin is enriched in H3K9me2/3 and H4K20me3 histone marks, 
which denote gene-poor, repetitive and late replicating DNA sequences 
(Saksouk, Simboeck and Déjardin, 2015).  
Transcriptional repression and compaction of constitutive heterochromatin is 
achieved through the action of several factors. DNA methylation by DNA methyl 
transferases leads to gene silencing, while H3K9 methylation promotes local 
compaction of chromatin; at the same time, marks promoting transcription (e.g. 
H3K4me3) are removed (Katan-Khaykovich and Struhl, 2005; Saksouk, 
Simboeck and Déjardin, 2015). This condensation is achieved via action of 
several proteins. Notably, H3K9me2/3 promotes the recruitment of the 
heterochromatin binding protein HP1 (heterochromatin protein 1), which 
subsequently recruits KAP1 (KRAB (Kruppel-associated box) domain-
associated protein 1) which then promotes heterochromatin assembly (Kwon 
and Workman, 2011; Jang et al., 2018). Additionally, HP1 serves as scaffold for 
recruitment of chromatin modifiers, such as H3K9 methyltransferases and 
histone deacetylases, the combined action of which leads to heterochromatin 




Figure 1.6 Schematic representation of the hierarchical model 
of chromatin compaction. The model assumes sequential 
condensation of the primary DNA structure into nucleosomes, the 30 





Interestingly, it has been demonstrated that the rate of repair of DSBs is not the 
same in eu- and hetero-chromatin. Based on that information a model has been 
proposed, which postulates that biphasic repair kinetics (which has been 
observed in many studies) consists of a fast component that repairs the majority 
(>80%) of the breaks within the first few hours following break induction, while 
the remaining breaks are repaired by a slow component and is dependent on 
ATM signalling, as well as the DNA damage mediator proteins MDC1, RNF8, 
RNF168 and 53BP1 (Figure 1.7 A)  (Goodarzi et al., 2008a; Noon et al., 2010). 
Consequently, cells lacking functional ATM show a specific defect in the repair 
of slow component breaks. It has been suggested that chromatin provides a 
barrier for the DNA repair process and that the local compaction state of the 
chromatin may impact on repair efficiency (Goodarzi, Noon and Jeggo, 2009). 
In accordance with that, immunofluorescence (IF) studies have shown that 
H2AX foci co-localise with heterochromatin markers, such as H3K9me3 or 
DAPI dense chromocenters in mouse cells (Figure 1.7 B), at late time points 
(24h) following damage induction. ATM has been shown to be required for the 
relaxation of heterochromatin via phosphorylation of KAP1 S824. Furthermore, 
relaxation of the heterochromatin structure through the knock-down of KAP1, 
HP1 or HDAC1/2 has been shown to alleviate the requirement for ATM activity, 
consistent with the idea that the condensed chromatin provides a barrier to 
repair processes (Goodarzi et al., 2008a). 
Interestingly, H3K9 methyltransferases, as well as HP1 and KAP1 compacting 
factors have also been shown to be rapidly recruited to the sites of DSBs, 
suggesting a role for chromatin compaction during DDR (Ayoub et al., 2008; 
Sun et al., 2009). Indeed, de novo H3K9 tri-methylation at the site of DSBs has 
been also demonstrated using chromatin-immunoprecipitation (ChIP) studies 
(Ayrapetov et al., 2014a).  This raises the question whether the defect 
associated with late repairing, ATM-dependent DSB repair represents the repair 
of DSBs within pre-existing heterochromatin or in regions that become 






























Figure 1.7 Heterochromatic breaks repair with slower kinetics. A) Model 
for the repair of fast and slow component. The Majority of X-ray induced 
DSBs breaks are repaired with fast kinetics and are associated with low 
complexity chromatin. Repair of DSBs in high complexity chromatin is 
associated with slower kinetics. Figure adapted from: Goodarzi, Jeggo and 
Lobrich, 2010. B) Inhibition of ATM kinase leads to persistent H2AX foci (red) 
associated with periphery of chromocenters (green) in murine cells. Figure 




Another protein that has been previously implicated in the repair of slow 
repairing breaks is Artemis endonuclease (Woodbine et al., 2010). More 
recently it has been proposed that in the G0/1 stage of the cell cycle c-NHEJ 
repairs breaks with biphasic kinetics, which depend on a need for resection 
prior to end ligation (Löbrich and Jeggo, 2017). It has been demonstrated that 
Artemis–mediated repair of slow component DSBs in G1 requires resection and 
microhomology-mediated end joining in order to repair those breaks. The 
majority of the breaks repaired using this process have been shown to result in 
deletions and half of the translocations that arise following the damage repair 
depends on this pathway (Biehs et al., 2017). This suggests the possibility that 
these late repairing breaks are highly complex, and therefore, require extended 
periods of time to be resolved, rather than the delay in repair being due to 
increased chromatin compaction. 
1.4 ACTIVATION OF THE DDR IN RESPONSE TO DSBS 
1.4.1 Phosphatidylinositol-3-kinase (PIKK) family 
 
DDR signalling is initiated and regulated by the PIKK family of three related 
kinases: ataxia telangiectasia mutated (ATM), ATM- and Rad3-related (ATR), 
and DNA-dependent protein kinase (DNA-PK). All PIKK family members have a 
similar domain organisation and common structural features containing N-
terminal HEAT (huntington, elongation factor 3, protein phosphatase 2 and 
TOR1) repeats, the FAT (FRAP-ATM-TRRAP) domain, the catalytic kinase 
domain, PIKK regulatory and FAT motif (FAT-C) at the C-terminus (Figure 1.8) 
(Blackford and Jackson, 2017). 
All three kinases have been shown to have a preference for phosphorylation of 
serine or threonine residues followed by glutamine (S/T-Q) (Chen et al., 1991; 
Kim et al., 1999). Although, all three kinases can be activated in response to 
DNA damage, ATM and DNA-PK primarily respond to DSBs, while ATR is 
activated by single strand regions of DNA and is the major player during 





























Figure 1.8 Structural organisation of PIKK family members: ATM, ATR 
and DNA-PK. Coloured boxes denote specific protein domains, while 
numbers represent specific amino acids. An encircled letter P indicates 




The sensing of DNA damage is crucial for human health and consequently cells 
deficient in any of the PIKK kinases show repair defects and increased genomic 
instability, which may lead to cancer or other diseases. ATR is essential for 
survival and its absence in mice leads to chromosome fragmentation and 
embryonic lethality (Brown and Baltimore, 2000). Hypomorphic mutations in 
ATR lead to Seckel syndrome which is characterised by intrauterine growth 
retardation, dwarfism, microcephaly and mental retardation (O’Driscoll et al., 
2003; Ogi et al., 2012). 
Although ATM-/- patients are viable, they display several abnormalities. 
Hypomorphic mutations in DNA-PK result in aberrant V(D)J recombination and 
consequently severe combined immunodeficiency (SCID), as well as profound 
neurological defects (Beamish et al., 2000; van der Burg et al., 2009; Woodbine 
et al., 2013). ATM deficiency results in the disorder, A-T (ataxia telangiectasia) 
characterised by dilated blood vessels (telangiectasia) and progressive 
neurological deterioration, leading to a lack of movement coordination, as well 
as gait abnormality (ataxia). A-T patients also present with immunodeficiency 
and susceptibility to malignancies, particularly lymphoid tumors (McKinnon, 
2004; Tubbs and Sleckman, 2014). Cells lacking both ATM and DNA-PK, are 
severely radiosensitive and show increased genomic instability further 
underscoring their importance in response to DSB-inducing insults. 
1.4.1.1 Detection of DSBs and activation of ATM kinase 
DNA DSBs are potentially one of the most deleterious genotoxic lesions, 
therefore they must be rapidly detected and repaired to ensure cell survival. 
ATM is a central DDR kinase, important for the maintenance of genomic 
integrity. In the absence of genotoxic stress, ATM exists in the form of inactive 
dimers , and requires a DSB for activation. 
In response to genotoxic stress, DSBs are thought to be initially recognised by 
the MRN (Mre11-Rad50-Nbs1) complex, which binds to lesion and tethers the 
DNA ends, providing a platform for ATM binding. It is believed that Nbs1 
recruits inactive ATM kinase dimers, resulting in auto-phosphorylation at 






Figure 1.9 DNA DSB-dependent activation of ATM signalling cascade. 
MRN complex binds to DNA at DSB and subsequently recruits and activates 
ATM kinase. This initiates a cascade of phosphorylation and acetylation 
events, which sustain ATM signalling. c-Abl and TIP60 acetylate ATM, which 
than phosphorylates H2AX and MDC1. This subsequently leads to 
activation of a phosphorylation-ubiquitination cascade mediated by ubiquitin 
ligases RNF8 and RNF168 and consequently results in recruitment and 
spreading of 53BP1. ATM phosphorylates 53BP1, which then recruits its 
effectors, RIF1 and PTIP, which promote repair via NHEJ. NHEJ is 
counteracted by BRCA1 and CtIP, also ATM substrates, to promote repair 
via HR. P = phosphorylation, Ac = acetylation, Me = methylation, Ub = 
ubiquitination.  Figure adapted from Blackford and Jackson, 2017. 
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(Falck, Coates and Jackson, 2005). However, other phosphorylation sites on 
ATM have been also proposed to play a role in its activation, including S367 
and S1893 (Kozlov et al., 2006). Once activated, ATM phosphorylates a 
plethora of other DDR proteins, resulting in activation of the DNA damage 
signalling cascade.   
ATM-dependent signalling in response to DSBs has been shown to influence a 
multitude of signal transduction pathways affecting the repair of damage, cell-
cycle arrest and apoptosis, as well as metabolism, bioenergetics, transcription 
and protein turnover (Shiloh, 2006). 
 
1.4.2 Phosphorylation of the H2AX variant in response to DSB and 
amplification of the DDR 
 
As already mentioned, one of the best described histone modifications 
occurring in response to DSBs is phosphorylation of the histone variant H2AX 
on serine 139 (H2A serine 129 in yeast). This residue is embedded within an 
SQE motif at the C-terminal tail of H2AX, which is a consensus sequence for 
phosphorylation by the PIKK kinases: ATM, ATR and DNA-PK.  
Immunofluorescence studies demonstrated that H2AX can be rapidly detected 
within a few minutes following DSB induction. Via an orchestrated assembly 
process, H2AX recruits DDR proteins, which can then influence the nature of 
DSB repair and DDR signalling. It has been demonstrated that following H2AX 
phosphorylation, mediator of DNA damage checkpoint protein 1 (MDC1) gets 
recruited to DSBs and binds H2AX directly via its C-terminal BRCT domain 
(Stucki et al., 2005). 
Direct interaction of MDC1 with H2AX and ATM tethers it to the site of damage.  
This leads to the accumulation of ATM via a positive feedback loop facilitating 
further phosphorylation of H2AX along the broken chromosome, thus allowing 
the assembly of additional DDR factors on the chromatin (Lou et al., 2006). 
Chromatin immunoprecipitation (ChIP) based studies have demonstrated that 
H2AX phosphorylation can spread up to 1 Mbp away from each end of the 
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break. However it is depleted across 1-2 Kbp regions flanking the break (Shroff 
et al., 2004a; Savic et al., 2009b; Iacovoni et al., 2010b). H2AX domains form 
distinct nuclear foci, which are visible using immunofluorescence microscopy 
and are thought to represent DSB repair factories (Rogakou et al., 1999a). They 
have been shown to co-localise with a plethora of other factors necessary for 
the repair of the break. As a result, H2AX foci are one of the most common 
markers used for the detection of DSBs and immunofluorescence-based studies 
often use co-localisation with H2AX, as a proof of protein recruitment to the site 
of a DSB.  
It is worth mentioning at this point that H2AX-deficient cells show only a minor 
repair defect, with around 85% of the breaks being repaired following damage 
induction (Riballo et al., 2004). However it is currently unknown whether 
accuracy of DNA repair under these circumstances is affected. Nonetheless, 
numerous studies have demonstrated H2AX phosphorylation aids recruitment 
and retention of several important DDR players. Consequently, cells deficient in 
the histone variant H2AX show radiosensitivity, increased genomic stability and 
cancer predisposition, mainly to leukaemia (Bassing et al., 2003; Celeste et al., 
2003; Turinetto and Giachino, 2015). 
 
1.4.3 RNF8/RNF168 signalling and ubiquitination of H2A(X)  
 
Upon recruitment to DSBs, ATM phosphorylates MDC1 on a TQxF motif, which 
then serves as a binding platform for the recruitment of the E3 ubiquitin ligase, 
RING finger protein 8 (RNF8) via its forkhead-associated domain (FHA) (Kolas 
et al., 2007). At the site of damage, RNF8 co-operates with UBC13, which is the 
E2 conjugating enzyme known to specifically catalyse the formation of K63 
linked ubiquitin chains (Hofmann and Pickart, 1999; Kolas et al., 2007; Mailand 
et al., 2007; Michael S.Y. Huen et al., 2007). It has been recently demonstrated 
that the major substrate for K63 ubiquitination at the site of DSBs is the linker 
histone H1. RNF8-dependent ubiquitination of H1 in response to DSBs is a 
critical priming step, which provides a high affinity binding platform for 
recruitment of another E3 ubiquitin ligase, RNF168. Accordingly, 
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downregulation of histone H1 or RNF8, leads to impaired RNF168 recruitment 
and a repair defect (Thorslund et al., 2015b). 
Ubiquitination of histone H2A variants on lysine 13/15 by RNF168 has been 
previously reported to be induced in response to DNA DSBs (Doil et al., 2009b; 
Gatti et al., 2012; Mattiroli, J. H. A. Vissers, et al., 2012; Hu et al., 2017).  
Deposition of this mark on the nucleosomes local to DSBs creates an essential 
platform for the recruitment, binding and retention of repair proteins, most 
prominently 53BP1 (Figure 1.10) (Doil et al., 2009b; Fradet-Turcotte et al., 
2013; Hu et al., 2017). Consequently, cells lacking RNF168 fail to recruit 53BP1 
to the sites of breaks and display significant radiosensitivity (Doil et al., 2009b; 
Stewart et al., 2009; Devgan et al., 2011; Bohgaki et al., 2013; Pietrucha et al., 
2017).The protein turnover of RNF168 and the extent of RNF168-induced 
chromatin ubiquitination are tightly regulated in response to DNA damage by 
two E3 ubiquitin ligases, TRIP12 and UBR5. Consistently, if those are depleted, 
RNF168 hyper-accumulates at DSBs, leading to massive spreading of 53BP1 
and BRCA1. It has been reported that RNF168 becomes a limiting factor in 
response to increasing amounts of IR, becoming saturated at ~20-40 DSBs, 
consequently leading to impaired formation of 53BP1 at higher IR doses 
(Gudjonsson et al., 2012b). Recently, it has been demonstrated that efficient 
formation of 53BP1 foci is required for RAD51 recruitment and HR, and failure 
to do so, leads to hyper resection of DNA around the break and in G2 phase 
repair via the highly mutagenic RAD52-mediated single-strand annealing 
pathway (Ochs et al., 2016). 
 
1.4.4 Activation of cell cycle checkpoint control 
 
In response to DNA damaging agents, such as IR, specific signalling pathways 
are activated in order to halt cell cycle progression. Arrest of the cell cycle is an 
important component of the DDR. By allowing additional time for DNA repair, 
the process serves to maintain genome stability and helps prevent cancer 
development. The main regulators of checkpoint arrest are activated by the 





























Figure 1.10 RNF168 ubiquitination-dependent recruitment of 
53BP1.  A) Model for the ubiquitin-dependent recognition of nucleosome 
by 53BP1. B) The amino acid sequence of 53BP1 ubiquitin recognition 






its stabilisation and accumulation in the nucleus (Haupt et al., 1997; Caspari, 
2000).  
The actions of p53 are achieved via transcriptional reprogramming (Figure 
1.11), which leads to the activation of various genes involved in growth proteins, 
checkpoint kinase 1 and 2 (CHK1 and CHK2) respectively, and together with 
ATM they phosphorylate several residues on the tumour suppressor p53, which 
results in its dissociation from MDM2 (mouse double minute 2 homolog), 
inhibition, most prominently, the cyclin-dependent kinase inhibitor p21, which 
halts replication and promotes G1 phase checkpoint activation (Giono and 
Manfredi, 2006). Furthermore, p53 can also promote G2/M arrest through 
repression of CDC25C, a phosphatase that promotes mitosis (Clair and 
Manfredi, 2006).  
In some circumstances, p53 may induce senescence, which is a permanent cell 
cycle arrest via transcriptional activation of the retinoblastoma (RB) tumour 
suppressor (Campisi and d’Adda di Fagagna, 2007). Additionally, p53 may also 
promote death via activation of pro-apoptotic genes, such as Bax, PUMA or Bcl-
2 (Haupt et al., 2003; Bieging, Mello and Attardi, 2014).  
The p53-mediated stress response is exerted by the activation and repression 
of gene transcription, therefore is not surprising that p53 has also been shown 
to associate with chromatin remodelling complexes, suggesting p53-mediated 
DDR also leads to DNA damage-induced changes (Murphy et al., 1999; Juan et 

































Figure 1.11 DNA damage induced activation of p53 signalling. Following 
acute DNA damage ATR/ATM and CHK1/2 phosphorylate p53 on serine 
residues 15 and 20, respectively. These phosphorylation events prevent p53 
interaction with MDM2/4, and leading to its stabilisation. Additionally, these 
phosphorylation events allow for interaction with several transcriptional 
cofactors essential for activation of DNA damage-dependent cellular 
responses, such as cell cycle arrest, DNA repair, apoptosis and 





1.5 REPAIR OF DNA DSBS 
 
Failure to accurately repair DNA DSBs leads to increased genomic instability, 
and therefore contributes to the development of cancer, neurodegeneration, 
accelerated aging and immunodeficiency (Hoeijmakers, 2009; O’Driscoll, 2012; 
Madabhushi, Pan and Tsai, 2014). Cells have evolved several pathways to 
repair DSBs, depending on the cell cycle phase and the availability of the 
cellular repair components. 
 
 
1.5.1 Homologous recombination (HR) 
 
In late S phase or G2, when a sister chromatid is available, cells may choose to 
repair some of the breaks via homology directed pathways (Figure 1.12). 
During this process, a 3’ overhang single stranded DNA generated by 5’-3’ 
resection of the ends of DSBs provides a substrate for assembly of RAD51 
filaments. The 5’-3’ resection is initiated by the MRN complex and CtIP, and 
serves as a critical step for the choice of the repair pathway (Symington and 
Gautier, 2011). Resection is a critical step in HR, and consequently failure to 
regulate this step leads to increased DNA damage sensitivity, genomic 
instability and cancer predisposition (Stracker et al., 2004; Wu and Lee, 2006; 
Sartori et al., 2007; Huertas and Jackson, 2009).  In the following step, 
nucleoprotein filament formation enables invasion of single stranded DNA into 
the sister chromatid, which serves as a primer for repair synthesis by DNA 
polymerases using the intact sister homologue as a template, which is followed 
by ligation by DNA ligase I. This repair process leads to the formation of DNA 
crossovers, also referred to as Holliday junctions, which are than resolved to 





























































Figure 1.12 Major protein factors involved in HR. During HR repair, DSBs 
are recognised by the MRN complex, which activates ATM kinase leading to 
initiation of DSB repair. CtIP and EXO1 nucleases resect DNA from 5’ to 3’, 
resulting in the formation of ssDNA that is subsequently coated with RPA 
protein. Next, BRCA1/2 and PALB2 protein complex facilitates loading of 
RAD51, which then replaces RPA coated ssDNA. RAD51 nucleoprotein 
performs homology mediated search and mediates strand invasion. 
Damaged DNA is restored by branched migration, DNA synthesis, resolution 
and ligation. Alternatively, the repair may occur via the SSA pathway. Here, 
extensive regions of DNA are resected, revealing homologous repeats that 
are then annealed together. ssDNA flaps are removed by FEN1, leading to 




1.5.2 Classical NHEJ (c-NHEJ) 
 
In all of the stages of the cell cycle, but particularly in G0/1 phase, when a sister 
homologue is not available, the majority of DSBs will be repaired via the 
classical NHEJ pathway, which essentially leads to ligation of the broken ends. 
Repair by c-NHEJ can be divided into four major steps (Figure 1.13). Following 
break induction, broken DNA ends are recognised by the Ku70/80 heterodimer, 
which loads onto double-stranded DNA forming a ring-like structure around 
naked ends (Walker, Corpina and Goldberg, 2001). This complex protects DNA 
naked ends and acts as a scaffold to recruit the PI3K kinase, DNA-PKcs, which 
then forms a complex with Ku, creating a bridge between the DNA ends 
(DeFazio et al., 2002). Recruitment of DNA-PK leads to phosphorylation of 
several substrates in proximity of the DSBs, including itself, which is necessary 
for the subsequent recruitment of NHEJ factors. Although in vitro and in vivo 
studies have identified several substrates for DNA-PK phosphorylation, such as 
H2AX, Ku70/80, XRCC4, XLF, Artemis and DNA ligase IV, these 
phosphorylation sites do not appear to be strictly required for NHEJ (Lee et al., 
2004; Wang et al., 2004; Douglas et al., 2005; Drouet et al., 2005; Goodarzi et 
al., 2006; YU et al., 2008; Sharma et al., 2016).  
Genotoxins, such as IR,  induce chemical modifications  in the proximity or at  
the termini of DSBs, which often need processing to produce 3’-hydroxyl and 5’-
phosphate groups at the opposing ends that are required for direct ligation of 
broken DNA (Povirk, 2012). 
Several factors, for example Artemis, polynucleotide kinase 3’-phosphatase 
protein (PNKP), AP-endonuclease 1 (APE1) and tyrosyl-DNA 
phosphodiesterase (TDP1), which have a range of enzymatic activities, have 
been shown to be required for this end-processing. This procedure may 
however result in the formation of gaps that then need to be repaired by 
































Figure 1.13 Major steps and protein factors involved in c-NHEJ. Classical 
NHEJ is initiated by loading of Ku70/80 heterodimer (blue and red circles) on the 
broken DNA ends, forming a cradle that harbours DNA molecules, aligns the 
ends and prevents degradation Once in place, Ku recruits the catalytic subunit of 
DNA-PK (green) to form the holoenzyme capable of phosphorylating several 
downstream NHEJ factors and regulating their interactions with Ku. Since NHEJ 
requires two blunt ends to join together, some terminal processing (magenta) 
may be required. For example, overhanging ends may be trimmed via action of 
nucleases, such as Artemis or/and correct 5’ end chemistry may be restored by 
PNKP. Finally, once compatible ends are in place, XRCC4/XLF/LIG4 ligation 
complex is recruited to seal DNA ends together (yellow/red/black). For more 
detail description see the main text. 
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The retention of NHEJ factors depends on adaptor proteins, such as Aprataxin 
and PNK-like factor (APLF), paralog of XRCC4 and XLF (PAXX), and modulator 
of retroviral infection (MRI), whose function is redundant for NHEJ. They were 
proposed to form large multimeric, filament-like complexes around the break to 
promote the retention of NHEJ factors. Cells lacking one or more of these 
factors show mild defects in the repair of DSBs and radiosensitivity and 
increased genomic instability (Fenton et al., 2013; Liu et al., 2017; Hung et al., 
2018). 
Once end-processing is complete, ligation is carried out by a complex 
composed of LigIV, XRCC4 and XRCC4-like factor (XLF), which are recruited to 
the break via interaction with the Ku70/80 heterodimer. This complex has been 
shown to be critical for NHEJ and consequently, cells lacking either LigIV or 
XRCC4 display embryonic lethality. Although cells lacking XLF can still recruit 
XRCC4 and LigIV to the break, XLF-/- patients display immunodeficiency and 
microcephaly. The core components of c-NHEJ are Ku70/80, DNA-PKcs, 
XRCC4, LigIV and XLF are essential for the efficient and timely repair of DSBs, 
and alterations  in this pathway lead to a range of pathogenic phenotypes in 
humans (Pierce and Jasin, 2001).  
 
1.5.3 Auxiliary pathways 
 
Under certain circumstances, alternative pathways to NHEJ are used in the cell. 
Typically, these involve extensive resection of the DNA ends to expose regions 
of sequence homology, leading to their annealing and thus stabilisation of the 
broken ends (Ceccaldi, Rondinelli and D’Andrea, 2016).  
Two main auxiliary pathways capable of resolving DSBs are alternative NHEJ 
(alt-NHEJ) and single strand annealing (SSA), and both require micro-homology 
usage to facilitate repair. SSA annealing is mediated by RAD52 rather than 
RAD51 and is used alternatively to HR during late S and G2 phases. On the 
other hand, alt-NHEJ can be potentially used throughout the cell cycle, at least 
in mouse cells (Simsek et al., 2011; Iliakis, Murmann and Soni, 2015). 
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Interestingly, it has been recently demonstrated that exposure to high doses of 
IR (that lead to induction of more than 40-60 DSBs), may result in the depletion 
of some of the DDR factors and consequently a switch from the accurate to the 
more mutagenic repair pathways. In particular, RNF168 protein levels and 
turnover have been shown to be highly regulated throughout the cell cycle and 
at the site of DSBs. Consequently, at increasing amounts of DSBs, RNF168 
gets diluted between more and more breaks. Since RNF168 is required for the 
recruitment of 53BP1 to DSBs, 53BP1 foci do not form efficiently at high IR 
doses (Gudjonsson et al., 2012b; Ochs et al., 2016).  
Recently it has been demonstrated that 53BP1 is required for the formation of 
RAD51 filaments and subsequent repair via HR. Failure to recruit sufficient 
amount of 53BP1 to DSBs has been shown to result in extensive resection of 
DNA ends and repair via RAD52-directed SSA, consequently leading to large 
deletions (Figure 1.12) (Ochs et al., 2016). 
RNF168 is known to deposit the ubiquitin mark on lysine 15 of histone H2A 
variants, and this ubiquitination has been shown to be important for the 
recruitment of 53BP1 to DSBs. However, due to the lack of a specific and 
commercially available antibody, it is still to be confirmed whether it is limited 
ubiquitination of H2A variants by RNF168 or its other function that leads to the 










1.6 THE CURRENT METHODS TO STUDY DNA DAMAGE-ASSOCIATED 
HISTONE PTMS 
 
1.6.1 Introduction  
 
The two most common approaches used to investigate protein levels involve 
antibody-based and mass spectrometry-based (MS-based) proteomic 
approaches. Antibody-based proteomics relies on the specific binding affinity of 
antibody and its target to detect and quantify proteins of interest.  Antibodies are 
used in applications such as chromatin immunoprecipitation (ChIP), 
immunofluorescence (IF) and immunoblotting (IB). However, specificity and 
reproducibility of antibodies is a common and well recognised issue that 
challenges the quality and the strength of experimental results (Bordeaux et al., 
2010; Bock et al., 2011; Bradbury and Plückthun, 2015; Bradbury and 
Plückthun, 2015; Buck, 2015). Indeed, recent initiatives to address the quality of 
commercially available antibodies to histone PTMs revealed that at least 25% of 
those failed to specifically recognise their intended target (Egelhofer et al., 
2011). Furthermore, the recognition of histone PTMs by antibodies can be also 
influenced by batch-to-batch variations, as well as pattern of the neighbouring 
PTMs, which may introduce a specific bias to the study (Figure 1.14) (Fuchs et 
al., 2011; Rothbart et al., 2015). Therefore, the quality and specificity of anti-
histone PTMs antibodies should be carefully assessed prior to experimental 
application, which may result in high cost and additional workload.  
Once specific antibody has been found and validated, additional difficulties may 
arise in regards to the specific application they are used in. For instance, IF 
approaches identify DSB-associated changes based on the direct co-
localisation of specific histone marks with damage foci, such as H2AX or 
53BP1 (Facchino et al., 2010; Miller et al., 2010a; Liu et al., 2013; Gong et al., 
2017). While spatial co-localisation can reveal valuable information about size, 
number and sub-nuclear localisation of the damage focus, this method is very 




























Figure 1.14 Examples of the basis for epitope steric hindrance during 
the antibody recognition. Cartoon representing an antibody 
A) recognition of the epitope without the interference, (B) cross-reacting 
with non-intended epitope, (C) not-recognising the epitope in the context of 
neighbouring PTM, and (D) not recognising the epitope due to obstruction 
by distantly located PTM. Figure adapted from: Önder et al., 2015 
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Furthermore, the concept of co-localisation is also limited by the resolution 
power of the microscope used for the particular experiment, which means that 
often co-localisation may be concluded, while there may in fact be separation 
that is too small to be detected, consequently, making this approach vulnerable 
to human bias (Dunn, Kamocka and McDonald, 2011).  
This problem also applies to ChIP-based approaches, since they also rely on 
the specificity of the antibodies. Another issue with ChIP-based approaches is 
the fact that they require a prior knowledge of the genomic locus containing the 
DNA break. To achieve that, restriction nucleases, such as I-SceI, HO and 
AsiSI are transfected into cells to induce the break in a sequence specific 
manner, resulting in a cycle of cutting and repair events.  Since, the genomic 
region containing the DSB is known, they allow direct analysis of chromatin 
surrounding it, using chromatin immunoprecipitation (ChIP) based techniques. 
Due to the accessibility issues, most of these nucleases are known to cut 
mainly in the open chromatin regions. However, it is currently unknown, whether 
this process of continuous DNA cutting may affect the surrounding chromatin 
structure. 
Although antibodies can be very sensitive in detecting histone PTMs, they are 
not ideal for discovery-type experiments, since they require prior knowledge of 
the type and location of modification. In addition to that, antibody-based studies 
can typically analyse only one PTM at a time, making this method low 
throughput and not suitable for the study of the combinatorial effects of PTMs.  
In recent years MS-based proteomics has become the tool of choice for 
analysis of histone PTMs (Plazas-Mayorcaet al., 2010; Qi et al., 2010; Sweet et 
al., 2010; Martinez-Garcia et al., 2011; Wu et al., 2011; Zheng et al., 2012, 2014; 
Maile et al., 2015). Several MS-based assays have been developed for 
simultaneous monitoring of multiple histone PTMs in single experiments, 
therefore making this approach high throughput, as well as allowing for the 
examination of the combinatorial effects of multiple PTMs (Karch et al., 2013). 
Since previous knowledge of the modification is not a requirement, MS-based 
analysis can also allow discovery of previously unknown marks, however the 
sensitivity of the detection of low abundance marks will be limited.  
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In this thesis I have combined the antibody-based and MS-based proteomic 
strategies to quantify histone PTMs associated with the nucleosomes containing 
histone H2AX. 
 
1.6.2 Overview of biological mass spectrometry workflow 
 
Mass spectrometry proteomics is an analytical technique used to identify 
peptides and proteins within a mixture by measuring the mass-to-charge ratio 
(m/z) of ionised particles generated from this mixture. Commonly in MS-based 
proteomics, proteins are digested enzymatically to smaller fragments with 
proteases, such as trypsin or Arg-C (Figure 1.15 A). The peptides from 
complex mixtures are typically separated by liquid chromatography prior to the 
introduction into the mass spectrometer, where they get further fragmented into 
smaller pieces, known as ‘fragment ions’.  
The basic components of a mass spectrometer include an ion source, a mass 
analyser and a detector (Figure 1.15 B). After the samples are loaded onto a 
mass spectrometer they are vaporised and ionised by the ion source, where 
they acquire a charge that allows these molecules to accelerate them through 
the remaining parts of the system. In the mass analyser ions are subjected to 
the electric or magnetic field, which deflects the path of individual ions based on 
their m/z, leading to their separation. Additionally, mass analysers can be also 
used to perform a more targeted type of analysis, where only specific ions of 
interests are selected for further analysis. Once successfully selected by the 
mass analyser, ions reach the detector. For an electron multiplier detector, once 
ions hit the detector plate, a cascade of electrons is emitted leading to 
amplification of the signal, greatly improving sensitivity of detection. The whole 
























Figure 1.15. Basic principles of protein ‘bottom-up’ liquid chromatography 
(LC)-coupled mass spectrometry workflow. A) Protein mixture is 
enzymatically digested and peptides are separated on the LC column prior to 
MS analysis. B) Basic components of a mass spectrometer. LC-separated 
peptides enter the source to become ionised prior the entry to a mass analyser, 
where they become separated according to their m/z. Ionised peptides are 
detected in an ion detector and the intensities of the ions are recorded in the 
data system. C) Hypothetical mass spectrometry output from a hybrid mass 
spectrometry instrument. Relative intensities of ‘PEPTIDE’ parent and fragment 
ions (‘b’ and ‘y’) recorded on the spectrum. 
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study incorporates two detectors: a linear ion trap and an Orbitrap. In this setup 
specific ions can be selected and fragmented in the ion trap analyser and 
passed A variety of mass analysers has been developed that apply different 
principles and have different characteristics. The LTQ-Orbitrap-XL instrument 
used in this  
to the Orbitrap, where their m/z ratio is determined at high resolution. In this 
study, collision induced dissociation (CID) was used to fragment the ions. This 
type of fragmentation induces fragmentation along the peptide bond in between 
carboxyl and amino groups of neighbouring amino acids, producing mainly ‘b’ 
(extend from amino-terminus of peptide) and ‘y’ (extend from carboxy-terminus) 
ions. The readout from a mass spectrometer of m/z values and their intensities 
is referred to as a ‘mass spectrum’ (Figure 1.15 C). 
MS-proteomic technology can be utilised for data dependent acquisition (DDA) 
to perform discovery-based experiments (shotgun proteomics). In a typical 
shotgun-type of experiment the MS instrument generates a full scan mass 
spectra of precursor ions (MS1) to determine their mass to charge ratio (m/z), 
and then acquires MS/MS (MS2) spectra of the most intense peptides. Since in 
the DDA mode only the most abundant proteins/peptides are fragmented, this 
method has limited sensitivity. 
MS-proteomic experiments can also be hypothesis driven (targeted proteomics). 
In contrast to shotgun-type of experiment, the MS instrument is programmed to 
analyse pre-defined set of peptides. Essentially, in targeted analysis, precursor 
ions of the peptides of interest are filtered based on their m/z, which are then 
fragmented to generate specific fragment/product ions that can be detected and 
quantified. Each specific precursor/product ion pair is referred to as a 
“transition”. This method allows for the characterisation of lower abundance 
peptides. 
Targeted MS technologies, such as selected reaction monitoring (SRM), parallel 
reaction monitoring (PRM) and pseudo SRM (pSRM), allow highly reproducible 
detection and quantification of the specific set of peptides. These approaches 
differ depending on the instrument used. SRM experiments are conducted on a 
triple quadrupole MS, PRM analysis is conducted typically on Q Exactive 
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instruments, while pSRM assays are conducted exclusively on LTQ linear ion 
trap or LTQ-Orbitrap. pSRM records all the products of selected precursor ions, 
while in SRM only selected transitions are measured. Targeted MS approaches 
can be used for absolute and relative quantification of peptides of interest.  
Furthermore, these methods may involve the use of labelling (chemical or 
metabolic stable isotope labelling) or may be performed label-free (e.g. using 
internal peptides for standardisation). 
Next I will describe the particular steps of an MS-based proteomic workflow in 
more detail. 
 
1.6.3 Enzymatic digestion of proteins  
 
Enzymatic digestion of proteins involves cleavage of the peptide bonds at 
specific amino acid residues along a polypeptide chain, yielding a range of 
smaller peptides that can be analysed by mass spectrometry. Multiple 
proteases are available for this purpose (Table 1.3). It is a very common 
technique and it is utilised in a variety of applications, such as determination of 
the peptide/protein sequence or PTM analysis. 
Trypsin is the most widely used in bottom-up MS approaches and is considered 
the gold standard in proteomics (Switzar, Giera and Niessen, 2013). It cleaves 
peptide bonds C-terminal to basic residues lysine and arginine (K and R), 
unless they post-translationally modified by more than one methylation (K, R), 
acetylation and ubiquitination (K), or followed by proline residue (Olsen, Ong 
and Mann, 2004; Ong, Mittler and Mann, 2004; Baeza et al., 2014). On average, 
trypsin digest creates ~14 residues long peptides that carry at least two positive 
charges, making it highly suitable for MS analysis (Switzar, Giera and Niessen, 
2013). 
Multiple protocols have been developed for trypsin digestion of samples in-
solution and in-gel. They usually involve protein denaturation, reduction of di-
sulphide bridges and subsequent alkylation of cysteine residues, with the 
inclusion of several steps that aid unfolding of the proteins and allow trypsin 
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access to K and R residues. The process is terminated by acidification of the 















































Protease Family Cleavage site 
ArgC Cysteine protease C-terminal of R 
AspN Metalloprotease N-terminal of D 
Chymotrypsin Serine protease C-terminal of F, Y, L, W and M 
GluC Serine protease C-terminal of D 
LysargiNase Metalloprotease N-terminal of R and K 
LysC Serine protease C-terminal of K 
LysN Metalloprotease N-terminal of K 
Pepsin Aspartic protease C-terminal of Y, F and W 
Trypsin Serine protease C-terminal of R and K 
WaLP and MaLP Serine protease C-terminal of aliphatic amino acids 
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1.6.4 High performance liquid chromatography coupled to MS (HPLC-MS) 
 
One of the ways by which MS samples can be introduced to the instrument is 
via direct infusion. This method however has several limitations, since the 
majority of MS instruments cannot perform separation of the components of the 
complex mixture and multiple peptides may have the same molecular mass and 
fragmentation pattern, potentially leading to increased experimental error. 
Therefore, combining MS with another separation technique is commonly used 
to achieve higher accuracy and reduced experimental error. Liquid 
chromatography is an analytical technique that leads to separation of the 
individual components of complex mixture based on their chemical properties 
(Figure 1.16) and it is an important step in proteomic workflow for achieving 
high signal to noise data and subsequently increased quantitative capabilities.   
Reverse phase HPLC column packed with C18 material, which was used in this 
thesis, separates peptides in a biological mixture based on their properties. 
Depending on the properties of the peptides, the time of elution from the column 
will vary, with hydrophilic peptides eluting at earlier times and the more 
hydrophobic peptides being retained on a column for longer. The elution of 
peptides is experimentally manipulated by applying a concentration gradient of 
an organic solvent over time (from low to high concentration). 
Attempts to simultaneously quantify large amounts of transitions in a single 
targeted MS run may lead to extended duty cycle of experiment and adversely 
affect quantitative performance of the assay. Therefore, only a limited number 
of peptides can be measured at one time. Retention time (RT) scheduling is 
often used to overcome this issue. In this approach, the retention times on the 
column for the peptides of interest are usually established empirically or with the 
use of bioinformatics prediction tools (Escher et al., 2012; Gallien et al., 2012). 
However, several variables may affect the stability of the RTs, preventing the 














Figure 1.16. General LC-MS workflow. Following proteolytic digestion, 
proteins from complex biological samples are converted into peptides, which 
are then injected onto LC-column, where they are separated according to their 
chemical properties. As the samples are eluted from the LC column they are 








1.6.5 Electrospray ionisation (ESI) 
 
In order to measure m/z, the analyte must first be ionised. Broadly, ionisation 
techniques are divided into ‘hard’ and ‘soft’ ionisation methods. ‘Hard’ ionisation 
leads to extensive fragmentation of the molecule, producing multiple fragment 
ions, while ‘soft’ ionisation methods produce molecular ions, which are derived 
from neutral molecules by loss or gain of electrons. The two soft ionisation 
techniques most commonly used in proteomics are matrix-assisted laser 
desorption ionisation (MALDI) and electrospray ionisation (ESI), the latter was 
used in this thesis. 
In ESI, a strong electric field is applied to the liquid sample passing through a 
capillary tube. This leads to the accumulation of charged molecular species at 
the end of the capillary tube, causing formation of highly charged droplets. A 
voltage applied to the capillary tube is causing the liquid analyte to leave the 
tube as a cone-shaped spray, with the ions accumulated on the surface of 
droplets (Figure 1.17). 
In the case of protein and peptide samples, ions mainly carry positive charge, 
due to additives such as formic acid that are added to the solvents as proton 
donors. Passing through heated capillary before entering mass analyser 
desorbs the solutes. The differential pressure between the ionisation step, 
which occurs under atmospheric pressure, and downstream steps, which occur 
under the vacuum, facilitates the entry of the ions into the mass analyser.  
Due to its ability to produce multiply charged ions, ESI is well suited for the 
study of biological molecules, such as proteins/peptides. Commonly, peptides 
carry single (+1), double (+2) or triple (+3) charge, depending on the size and 
the number of basic residues. As the most commonly protease used in MS-
based proteomics is trypsin, which leaves basic lysine or arginine residue at the 













Figure 1.17 Schematic representation of ESI. Within ESI source, a 
continuous stream of solubilised sample is passed through spraying nozzle. 
Electrical energy is used to transfer the ions from solution into gaseous phase, 
which occurs in three steps. Firstly, charged parental droplets are dispersed via 
fine spray, which is followed by solvent evaporation. The droplets shrink until it 
reaches the point, when surface tension can no longer sustain the charge (the 
Rayleigh limit), resulting in “Coulombic explosion”, splitting the droplets apart, to 
produce smaller charged progeny droplets that can repeat the process, as well 








1.6.6 Tandem mass spectrometry (MS/MS) 
 
Mass analysers typically used in proteomic studies are time-of-flight, 
quadrupole, ion trap and Orbitrap (Table 1.4). The performance of those 
analysers is assessed by three criteria: 1) upper mass limit, 2) transmission and 
3) resolution.  The upper mass limit refers to the maximum m/z ratio that can be 
measured. Transmission is a ratio between the number of ions reaching the 
detector to the number of ions produced in the ion source. The resolution refers 
to the instruments ability to produce distinguishable signals from ions with small 
mass differences. Additional important aspects are dynamic range, analysis 
speed and fragmentation capabilities. 
LTQ-Orbitrap XL mass spectrometer used in this study contains two mass 
analysers: linear ion trap and Orbitrap. A key advantage of this instrument is its 
ability to perform multiple stages of MS/MS fragmentation, allowing the yield of 
large amounts of structural information. The linear ion trap mass analyser is 
capable of isolating, storing and fragmenting ions. It works by confining ions 
radially with the use of quadrupole rods, while a static electrical potential on the 
ends of the electrodes serves to confine the ions axially. The combination of 
axial and radial trapping results in the ions arranging themselves in a linear 
string. The application of a dynamic field to the trapped ions leads to specific 
m/z values being isolated or activated for fragmentation. The advantages of 
linear ion traps are high sensitivity and high sequencing speed. However, in 
comparison to high resolution mass analysers, such as Orbitrap, their mass 
accuracy, mass resolution and linear dynamic range are relatively low. In hybrid 
MS instruments, linear ion traps are most frequently used for fragmentation due 
to their fast cycle times, resulting in the smaller number of ions required for 
MS/MS in that device. 
Orbitrap mass analysers employ electrostatic fields to trap and measure ions. 
The Orbitrap cell is composed of a central spindle-like shaped electrode within 
an outer barrel-like shaped electrode insulated by a ceramic ring, which allows it 
to act as both, analyser and detector. The electrostatic field applied on ions 
inside the Orbitrap causes them to orbit around the central electrode with axial 










Table 1.4. Comparison of the features and specifications of the mass 


















MS scan rate 
Time-of-flight 15000 <5 ppm Attomole Low Fast 
Quadruple 2000 100 ppm Attomole High Moderate 
Ion trap 4000 100 - 300 
ppm 
Femtomole Low Moderate to 
fast 


















Figure 1.18 Schematic layout of the LTQ Orbitrap XL mass spectrometer. 
Ions created in the ESI source are trapped in the LTQ XL, axially ejected and 
collected in a C-shaped ion trap (C-Trap), then passed into the Orbitrap mass 
analyser, where they are captured by rapidly increasing voltage on the centre 
electrode of the Orbitrap. Trapped ions undertake circular trajectories around 
centre electrode and their axial oscillations. Depending on their m/z values, ions 












Ions with different m/z values oscillate at different frequencies, allowing their 
separation. The mass spectra of the ions are acquired using image current 
detection by measuring the oscillation frequencies induced by ions on the outer 
electrode. Due to their superior high mass accuracies (1-2 parts per million 
(ppm)) and high resolution (150000 resolution units) Orbitrap analysers are 
commonly used when high resolution measurements are required. In addition, 
sub-fentomole sensitivity, large dynamic and m/z ranges make it particularly 
suitable for the studies of highly complex biological samples. 
 
1.6.7 Mass spectrometry (MS) for the study of histone PTMs 
 
Although antibodies can be very sensitive in detecting histone PTMs, they are 
not ideal for discovery-type of experiments, since they require prior knowledge 
of the type and location of modification. In addition to that, antibody-based 
studies can typically analyse only one PTM at a time, making this method low 
throughput and not suitable for the study of the combinatorial effects of PTMs.  
In the recent years MS-based proteomics has become the tool of choice for 
analysis of histone PTMs (Plazas-Mayorca et al., 2010; Qi et al., 2010; Sweet et 
al., 2010; Martinez-Garcia et al., 2011; Wu et al., 2011; Zheng et al., 2012, 2014; 
Maile et al., 2015). Several MS-based assays have been developed for 
simultaneous monitoring of multiple histone PTMs in single experiments, 
therefore making this approach high throughput, as well as allowing for the 
examination of the combinatorial effects of multiple PTMs (Karch et al., 2013). 
Since previous knowledge of the modification is not a requirement, MS-based 
analysis can also allow discovery of previously unknown marks, however the 
sensitivity of the detection of low abundance marks may be limited. 
By convention, MS-based strategies are divided into three main groups known 
as top-down, middle-down and bottom-up (Figure 1.19). All of these 

























Figure 1.19 Summary of the key steps involved in bottom-up, middle-down 
and top-down MS strategies. Bottom panel figure is adapted from Switzar, 




and have several advantages and disadvantages depending on the application 
context. For instance, in top-down approach intact histone proteins are 
analysed, allowing investigation of combinatorial effects of PTMs. However, 
technically this approach is very challenging for several reasons: 1) MS/MS 
spectra are difficult to obtain due to poor ionisation efficiency of high molecular 
weight species, therefore require a large amount of starting material; 2) the 
separation of histones containing different combinations of the same number 
and type of PTMs is currently impossible; 3) the generated data is highly 
complex and computationally challenging to deconvolution.  
In contrast to top-down MS strategy, both bottom-up and middle down approach 
use enzymes to digest proteins to smaller fragments. Most commonly used 
proteases cleave after basic or acidic residues. An analysis of the histone PTMs 
using proteolytic digest is not straightforward, since their sequence is highly 
enriched in lysine and arginine residues; predominantly at the N-terminal tails, 
where the majority of known PTMs are deposited. For instance, trypsin cleaves 
after basic residues, resulting in the small peptides that are difficult to be 
retained on the reverse phase chromatography column, thus are challenging for 
MS analysis. In contrast, digestion with proteases which cleave after acidic 
residues, for instance Glu-C, produces large, multiply charged peptides that are 
notoriously difficult for interpretation.  
Several methods have been developed to overcome this issue. For example, 
Arg-C enzyme can be used to produce suitable length peptides, as it cuts 
principally after arginine residue (McKittrick et al., 2004). However, Arg-C 
digestion was found to lack reliability (Garcia et al., 2007). Alternatively, 
chemical derivatisation of unmodified lysines by adding a propionyl group prior 
to tryptic digestion can be used. This chemical derivatisation restricts action of 
trypsin to arginine residues and produces Arg-C-like peptides, but with 
increased reliability compared to Arg-C digest, making this method well suited 
for quantitative studies of histone PTMs (Garcia et al., 2007). Due to relatively 
short length of the peptides produced in this way, MS spectra are less complex, 
when compared with top-down and middle-up approaches, and therefore easier 
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to interpret. In addition to that, propionic group increases hydrophobicity of the 
peptides, thus improving their retention on the chromatography column, and 
therefore, MS detection. For these reasons, a bottom-up approach using Arg-C-
like tryptic digestion following propionylation of unmodified lysines, has  been 
selected as the most suitable for this study. 
However, several aspects needs to be considered, when using this method. 
Firstly, this derivatisation is not suitable in studies of naturally occurring histone 
propionylation (Sidoli et al., 2015). Additionally, propionic anhydride 
derivatisation was found to lead to partial alkylation of the hydroxyl groups on 
the serine, tyrosine and threonine residues, while ammonium bicarbonate, a 
buffering agent commonly used in proteomic workflows, was found to compete 
with hydroxyl groups for propionylation (Liao et al., 2013; Meert et al., 2015). 
These side reactions may therefore lead to several analytical issues, leading to 
reduced accuracy of results, reproducibility and sensitivity of MS analysis. 
More recently, it has been shown that some of these side reactions may be 
improved. For example, switching from ammonium bicarbonate to 
triethylammonium bicarbonate improves propionylation efficiency, but leads to 
increase in side reactions, due to reactivity of anhydride towards hydroxyl 
groups, which can be overcome by using an excess  of hydroxyl amine to 
quench the reaction, or even reverse overpropionylation of unwanted residues 
(Meert et al., 2016). 
 
1.7 THE IMPORTANCE OF RESEARCH INTO THE CHROMATIN RESPONSE 
TO DNA DAMAGE AND THE AIMS OF THE PROJECT 
 
The dramatic changes in histone PTMs associated with the repair of DNA 
lesions, as well as the loss of nucleosomes that potentially carry important 
epigenetic instructions, gives rise to the question of whether this information is 
re-established, and if so, how. It could be speculated that failure to faithfully 
recover from this kind of trauma can potentially lead to the loss or gain of the 
epigenetic memory, which, in turn, can have severe consequences for the 
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fitness of the organism. For instance, it was previously demonstrated that 
induction of DNA DSBs can lead to transcriptional silencing in the proximity of 
the break, which is usually reversible (Shanbhag et al., 2010). However, there is 
a possibility that at a subset of these breaks, marks that are associated with 
transcriptional silencing persist, leaving a message that is propagated through 
subsequent cell divisions (Cuozzo et al., 2007). This can be especially 
dangerous if the silenced region, for example, encodes a tumor suppressor 
gene. 
 
To further underscore the importance of chromatin structure and the associated 
marks, it is worth noting that the enzymes involved in chromatin remodeling 
complexes are often mutated in cancers (Kandoth et al., 2013), although their 
exact role is still to be elucidated. Therefore, insight into mechanisms involved 
in the dynamics of histone PTMs and histone exchange in response to 
genotoxic stress will be an important milestone in the understanding of the 
development of disease. Once acquired, this knowledge can be further used to 
screen and analyze cell lines from e.g. cancer patients. This knowledge could 
allow us to design therapies that specifically target pathways involved in 
disease states. 
 
The central aim of my thesis was to enhance our understanding of the role of 
chromatin in the response to DNA DSBs. My specific target was to unravel the 
landscape of histone PTMs involved in the DDR and DSB repair. I have 
established a novel chromatin immunoprecipitation coupled with mass 
spectrometry method (ChIP/MS) for recovery of the nucleosomes from the sites 
of DNA damage and quantification of associated histone PTMs. I have used this 
































2.1 CELL CULTURE AND STABLE ISOTOPE LABELLING WITH AMINO ACIDS 
IN CELL CULTURE (SILAC) 
 
The cell lines used in this thesis were grown in the media described in the 
Table 2.1 and were passaged every 3-4 days. For biotinylation experiments, the 
cell media was substituted with dialyzed serum (PAN Biotech). All of the cell 
lines were grown in 370C humidified atmosphere containing 5% CO2.   
For the biotinylation system, to induce damage cells were treated with the 
indicated concentration of Neocarzinostatin (NCS) (N9162, Sigma). Biotinylation 




Table 2.1 The cell lines and growth media used in the thesis. DMEM = 
Dulbecco’s Modified Eagle Medium; MEM = Minimum Essential Medium Eagle; 
SILAC = stable isotope labelling of amino acids in culture. 
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2.1.1 Plasmids and transfections 
 
Plasmids pcDNA3.1(+) BirA-6xHis-GFP and pcDNA3.1(+) BAP-6xHis-H3.1 
were previously described in (Kulyyassov et al., 2011). To PCR RNF168 and 




AGAAACATAATCGTGTTTATATT3’ respectively. To make BirA-6xHis-
RNF168/53BP1, the GFP in pcDNA3.1(+) BirA-6xHis-GFP was replaced with 
the wild type cDNA sequence of RNF168 and 53BP1 (kind gifts from C. Lukas 
and P. Jeggo respectively).  










GCAGAACCCTGTACGGCTTCGGCGGCTAACTCGAG-3’), synthesized by 
Eurofins Genomics, into the NheI/XhoI sites of the pcDNA3.1 vector.  All the 
plasmid sequences were confirmed by Sanger sequencing. Transfections into 
cell lines were performed with Jet-PEI reagent (PolyPlus) according to 
manufacturer recommendations. 
 
2.1.2 Generation of stable cell lines  
 
To generate stable cell lines expressing 3xFLAG-BAP-H4 or BAP-tagged H3.1 
plasmids were cut with BstZ17I and ScaI, respectively, and transfected into 
U2OS cells with Jet-PEI (PolyPlus) transfection reagent according to 
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manufacturer recommendations. After 48 h successfully transfected cells were 
selected with 0.6 mg/ml of G418. Cells expressing BAP-tagged H3.1 were kept 
as polyclonal culture, while in the case of cells expressing BAP-tagged H4 
monoclonal colonies were selected for further experiments. Positive 
transfectants were maintained thereafter in media containing 0.2 mg/ml of G418.  
2.2 INDUCTION OF DNA DAMAGE 
 
Where indicated in the results chapters, cells were damaged using X-rays. For 
this treatment, cells were grown to 90% confluence (HEK293) or G1-arrested by 
growing to confluence (1BR.3 hTERT and AT-1BR hTERT) and exposed to IR 
using an AGO HS X-Ray System at 250 kV potential and 500 mGy/min dose 
rate. Cells were collected at indicated time points by trypsinisation, washed in 
PBS, pelleted, snap-frozen in liquid nitrogen and stored at -800C.  
For IR dose-response experiments, HEK293 cells were trypsinised and pelleted 
at 780 rcf for 2 min and re-suspended in complete DMEM. Exposure to gamma-
rays was carried out using cesium-137 source (6 Gy/min). Cells were allowed to 
recover for 30 min, then pelleted, washed in PBS and snap-frozen in liquid 
nitrogen pellets were stored in -800C. 
2.3 PREPARATION OF SAMPLES FOR MASS SPECTROMETRY ANALYSIS 
Preparation of samples for MS involved several stages. These are described in 
detail in this section and include the following steps: 1) Isolation of nuclei; 2) 
Extraction of mono-nucleosomes; 3) Chemical derivatization (step used in the 
indicated experiments) and proteolytic digestion. The list of reagents and 




























Reagent name Manufacturer Product code 
Propionic anhydride Acros Organics #131522500 
Hydroxylamine Sigma #467804 
TEAB (triethylammonium) Sigma T7408 
Ammonium bicarbonate Sigma #09830 
Anhydrous methanol Acros Organics #364391000 
Trypsin Promega V511A 
H2AX antibody Abcam ab81299, LOT: 
GR297741-12 
Protein G Dynabeads Invitrogen #10004D 
Streptavidin Dynabeads Invitrogen #65001 
AEBSF  Thermo Scientific #78431 
Leupeptin  Thermo Scientific #78435 
Pepstatin A  Thermo Scientific #78436 
Sodium butyrate Acros Organics #263191000 
Sodium fluoride Sigma S7920 
N-Ethylmaleimide  Thermo Scientific #23030 
MNase Worthington LS004798 
2-Chloroacetamide Sigma C0267 




Table 2.3 Table of buffers and their components used in the Proteomic 
Methods section.  




0.5 mM AEBSF (Thermo Scientific, 
#78431) 
serine proteases inhibitor 
1 mM PMSF (Thermo Scientific, 
#36978) 
serine proteases inhibitor 
21 µM leupeptin (Thermo Scientific, 
#78435) 
serine and cysteine protease 
inhibitor 
2.9 µM pepstatin A (Thermo 
Scientific, #78436) 
aspartic acid protease inhibitor 
10 mM sodium butyrate HDAC inhibitor 
5 mM sodium fluoride phosphatase inhibitor 
20 mM N-ethylmaleimide (Thermo 
Scientific, #23030) 
DUB inhibitor 
NIB-250 15 mM Tris-HCl pH 7.5 
 
60 mM KCl 
 
5 mM MgCl2 
 




0.3 % NP-40 (IGEPAL CA-630 ) detergent added for nuclear 
isolation step, but not wash 
step 
Protease and epigenetic inhibitors added freshly 
MNase digestion 
buffer 
250 mM sucrose nuclei cushion 
50 mM Tris-HCl 
 






10 mM EDTA 
 
IP wash buffer 500 mM NaCl 
 
50 mM Tris-HCl 
 
1 % NP-40 
 
1 % Triton 
 
2xLaemlli buffer 4 % SDS  
 
20 % glycerol 
 
120 mM Tris-HCl pH 6.8 
 
0.02 % bromophenol blue 
 
5 % beta-mercaptoethanol  added freshly 
Running buffer 25 mM Tris base 
 
190 mM glycine 
 
0.1 % SDS 
 
Transfer buffer 25 mM Tris base 
 
190 mM glycine 
 





Step 1: Nuclear isolation 
Cell pellets were thawed on ice and re-suspended in 10 volumes of NIB-250 
(Nuclear Isolation Buffer) described in Table 2.3 containing 0.3% NP-40 and 
freshly added protease inhibitors (Table 2.3). Cells were incubated on ice for 5 
min and the nuclei were pelleted at 500 rcf, 40C for 5 min. Nuclear pellets were 
washed in NIB-250 (without NP-40 and N-Ethylmaleimide) and pelleted as 
above. 
 
Step 2: Chromatin extraction with Micrococcal nuclease digestion and - 
phosphatase treatment 
Nuclei were re-suspended in the MNase buffer supplemented with protease and 
epigenetic inhibitors at DNA concentration 2 g/l and equilibrated to 370C for 
10 mins. To follow, 1 U of Worthington MNase/70 g of DNA was added and 
nuclei were incubated for 10 min (unless indicated otherwise) at 370C, 800 rpm 
(ThermoShaker). The reaction was quenched with 10 mM EDTA final 
concentration, nuclei were pelleted for 10 min, 9300 x g in the table top 
centrifuge at 40C and the supernatant was collected. To test antibody specificity, 
where indicated, protein phosphorylation was removed prior to 
immunoprecipitation. To do that, MNase extracts were treated with -
Phosphatase (Table 2.2) according to manufacturer instructions.  
 
Step 3: Analysis of DNA sizes following MNase digestion 
Following MNase digest, the DNA size distribution was analysed with a 
Bioanalyzer (Agilent) DNA high-sensitive chip according to manufacturer 
instructions or by agarose gel electrophoresis. For the gel analysis samples 
were incubated with 2% SDS at 75oC for 30 minutes, vortexing occasionally. 
For MNase time-course experiment (Fig. 3.2 A), equal amounts of digest 
corresponding to each time-point were loaded, and for the time-course after 
DNA damage induction (Fig. 3.2 B), 1g of DNA per sample was loaded onto a 
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1.5% agarose gel. The DNA was resolved at 50 Volts, for 1 hour at 4oC, and 
stained with 0.5 µg/ml ethidium bromide.  
Step 4: H2AX IP  
H2AX-containing nucleosomes were immunoprecipitated with rabbit 
monoclonal antibody (ab81299, LOT: GR297741-12)). 0.5-1 mg of MNase 
digest was re-suspended to 0.5 mg/ml of final protein concentration. After 
addition of antibody (8 g of antibody per mg of MNase digest after 10 Gy of X-
rays; proportionally adjusted to different conditions), samples were incubated at 
40C overnight, with rotation. 200 g of Protein G Dynabeads (Invitrogen) per 1 
g of H2AX antibody were added and incubated for 1 h. The samples were 
placed on a magnetic rack and the unbound flow-through was removed. The 
beads were washed 3 x 5 min at room temperature with IP wash buffer (500mM 
NaCl, 50 mM Tris-HCl, 1% NP-40, 1% Triton) with gentle shaking. 
Immunoprecipitated proteins were eluted twice (10 min shaking at room 
temperature) with 100 ng/l synthetic phosphopeptide (ATQASphosQEY; 
synthetized by JPT) dissolved in double distilled water. Eluates were stored at -
200C. 
 
Step 5:  
1. In-solution Trypsin digestion for analysis of H2AX S139 
phosphorylation 
Samples were thawed on ice. 50% of the H2AX eluate (IP from 0.5 mg of 
MNase digest) and 5 g of input sample per condition were adjusted to 10 l 
volume and 50 mM ammonium bicarbonate. 0.25 g of trypsin (Promega) was 
added per sample and incubated over night at 37oC. On the following day, 
samples were speedvac concentrated and acidified to 0.1 % TFA final 
concentration and 20 l final volume. Samples were stored at -200C.  
 
2. In-solution Histone Derivatization and Trypsin digestion  
Samples were thawed on ice. 50% of the H2AX eluate (IP from 0.5 mg of 
MNase digest) and 2 g of input sample per condition were adjusted to 10 l 
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volume and 100 mM TEAB. 1 l of 1% propionic anhydride in acetonitrile was 
added to each sample and incubated for 2 min at room temperature. Reaction 
was quenched with 1 l of 80 mM hydroxylamine (Sigma) for 20 min. If 
necessary, pH was adjusted to around 8 and 0.25 g of trypsin (Promega) was 
added per sample and incubated over night at 37oC. On the following day, 
samples were subjected to a second round of derivatisation (as above), 
speedvac concentrated to 10 l volume, acidified to 0.1 % TFA final 
concentration and 20 l final volume. Samples were stored at -200C.  
 
2.3.2 Streptavidin pull-down of biotinylated nucleosomes 
 
Step 1: Nuclear isolation, Step 2: Chromatin extraction and Step 3: 
Analysis of DNA sizes following MNase digestion were performed as 
described in Section 2.3.1. 
 
Step 4: Streptavidin pull-down of nucleosomes containing biotinylated 
histone H4. 
Biotinylated nucleosomes were pulled-down using streptavidin coupled 
Dynabeads (Invitrogen). 100 µg of beads were used per 1 mg of MNase extract, 
incubated on the rotating wheel overnight at 40C. The beads were washed 3 x 5 
min at room temperature with IP wash buffer (500mM NaCl, 50 mM Tris-HCl, 1% 
NP-40, 1% Triton) with gentle shaking. Precipitated proteins were eluted with 4% 
SDS buffer for 5 min at 950C. Eluates were stored at -200C. 
Step 5: In-gel trypsin digestion for analysis of H2AX S139 phosphorylation 
and associated proteins 
Samples were run into resolving 15% SDS-PAGE gel, stained with coomassie 
and the bands were cut out. Samples were de-stained (50% acetonitrile, 50 mM 
ammonium bicarbonate) for 3 x 5 min shaking and speedvac dried for 5min; 
reduced (10 mM DTT, 50 mM ammonium bicarbonate) at 500C for 45 min and 
alkylated (50 mM chloroacetamide, 50 mM ammonium bicarbonate) at room 
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temperature, for 45 min, in the dark. Samples were washed twice (50% 
acetonitrile, 50 mM ammonium bicarbonate), speedvac dried for 5 min and re-
hydrated (12.5 ng/l trypsin, 50 mM ammonium bicarbonate) for 10 min on ice. 
Excess trypsin was removed, gels were covered with 50 mM ammonium 
bicarbonate and incubated over night at 370C. Gel pieces dehydrated with 100% 
acetonitrile, peptides were collected. Samples were speedvac concentrated to 
remove acetonitrile and re-suspended in 0.1% TFA final concentration 
 
2.3.3 Western Blotting 
 
Samples were boiled in 2x Laemmli buffer (Table 2.3) and separated in either 
homemade SDS-PAGE (5% stacking/15% resolving acrylamide gel) or 4-20% 
gradient gels (Bio-Rad). Samples were resolved with 150 V in running buffer 
(Table 2.3). Proteins were transferred to nitrocellulose in a pre-chilled wet buffer 
(Table 2.3) for 60 minutes at 400 mA. Membranes were blocked in 5% BSA in 
0.2% TBST buffer (20 mM Tris-HCl, 150 mM NaCl and 0.2 (v/v) Tween-20). 
Primary incubations were carried out at dilutions specified in the section 2.9, in 
5% BSA in 0.2% TBST at 4oC overnight. This was followed by three 10 minutes 
washes in 0.2% TBST at room temperature and 1 hour incubation in secondary 
HRP-linked antibody (dilutions in subchapter) and subsequently washed further 
three times in 0.2% TBST. Proteins were then detected with the 
chemiluminescent ECL western blotting reagent and exposed onto hyperfilm 
(Amersham Biosciences/GE Healthcare, Bucks, UK). 
2.3.4 Silver staining 
 
Following protein separation with SDS-PAGE as described above, gel 
membranes were incubated in fixing solution (50% ethanol and 10% acetic acid) 
for 30 min. Membranes were then hydrated for 15 min in 1:10 dilution of fixing 
solution (5% ethanol and 1% acetic acid and washed three times in water for 5 
min per cycle prior incubation with 200 mg/L solution of sodium thiosulphate for 
1 minute. Membranes were then rinsed three times with water and incubated for 
20 minutes in the staining solution (2 mg/mL AgNO3, 0.0277% formaldehyde). 
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After incubation membrane was rinsed in water three times. Finally, the 
membranes were placed in developing solution (60 mg/mL sodium carbonate, 
0.0185% formaldehyde and 4 pg/mL sodium thiosulphate) untill protein bands 
were visible. The reaction was quenched with 5% acetic acid. Targeted mass 
spectrometry analysis 
2.3.5 Nano-LC/MS 
Peptide samples were analysed by nano-LC–MS (ThermoFisher U3000 
nanoLC and Orbitrap XL mass spectrometer). Peptides were loaded onto a C18 
trapping cartridge (Pepmap100 C18; 0.3 × 5 mm i.d.; 5 μm particle size) for 
5 min at a flow-rate of 5 μL/min in 0.1% TFA loading buffer. Peptides were 
separated on an analytical column (PepMap100; 25 cm × 75 μm; 5 μm particle 
size) by a gradient from 1 to 45% ACN over 50 min, in the presence of 0.1% FA, 
at a flow rate of 0.3 μL/min. 
Nanospray was from a New Objective emitter with 10 μm tip (FS360-20-10-N-
20). Pseudo-SRM was carried out in the linear ion trap of an Orbitrap XL, with a 
precursor isolation window of 2 m/z, an ion-trap fill time of maximum 50 ms and 
an LTQ target ion count of 1E4. A high-resolution precursor scan was carried 
out in the Orbitrap (5E5 target). Total cycle time was <2 s, enabling at least 10 
points across eluting peptide peaks for quantitation. 
 
2.3.6 Pseudo-SRM creation and analysis 
 
Skyline v3.1 (MacCoss Lab, University of Washington) was used for both 
development of pseudo-SRM methods and for data analysis. Peptide 
sequences for proteins of interest were obtained from Uniprot and entered into 
Skyline. Predicted b and y ions were surveyed on the instrument. To distinguish 
between different isobaric masses at least three transitions were selected that 
were unique to each peptide. Integration boundaries for all the peaks were 
inspected manually and edited if necessary to fully integrate the peak. At least 
two peak widths of elution time (one on either side of the peak) outside the peak 
were allowed to understand the surrounding noise and potential interference. 
Due to change in the retention times during MS runs, occasionally the 
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quantitative peak area would be reduced, in which case, these peaks would be 
removed from further quantitation. Appendix Table 1 contains the list of 
targeted peptides, their m/z and transitions used for quantification. 
2.3.7 Statistical analysis 
 
LC-pseudoSRM raw mass spectra were imported to and processed using 
Skyline v.3.1. Statistical bioinformatics analysis was performed with Microsoft 
Excel 2013 and GraphPad Prism v.7.04 computing software. Relative 
abundance of each targeted peptide at a given time-point was calculated. For 
each peptide in a group, all transitions were summarized and the proportion of 
that peptide relative to all differentially modified peptides in the group was 
calculated and expressed as percentage value. All p-values are from two-tailed, 
paired t-tests. Error bars represent the standard error of the mean, unless 
indicated differently.  
2.3.8 Data dependent acquisition and sample analysis 
 
Database search was performed using Mascot Ver.2.3.2. Data were searched 
against the human Swiss-Prot database. Peptides were matched using trypsin 
as digestion enzyme. Peptide mass tolerance was set to 5 ppm and fragment 
mass tolerance was set to 0.5 Da. A maximum of two missed cleavages was 
allowed. Carbamidomethylation of cysteines was set as fixed modification. 
Oxidation of methionine, mono-, di- and trimethylation of lysine, as well as 
acetylation and Gly-Gly lysine were set as variable modifications. 
2.4 FLUORESCENCE-ACTIVATED CELL SORTING (FACS) ANALYSIS OF 
CELL CYCLE STAGES 
 
For cell cycle analysis, cells were fixed with cold ethanol 70%, washed with 
PBS and re-suspended in PBS containing propidium iodide (PI, Sigma, 5 ug/ml) 
and RNAse A (Sigma, 50 ug/ml) overnight at 4 °C. Samples were run on a 
FACS-accuri (Beckton Dickinson) and data analysed with the BD accuri 
software. Briefly, single cells were gated, first on their size (FLH) and their 
granularity (SSC) to exclude debris, and then on the linearity between FLH-H 
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and FLH-A signal to exclude doublets. PI signal (correlating with DNA content) 
was read on the FL2 detector. 
2.5 IMMUNO-FLUORESCENCE (IF) 
 
The cells were grown on 96-well plates (Corning CoStar) and treated as 
indicated. They were fixed with 4% formaldehyde for 15 min, permeabilised with 
0.3% Triton for 10 min, washed with PBS, incubated with primary antibodies for 
1h, washed 3 times with PBS (5 min), incubated with secondary antibodies for 
30 min and washed twice in PBS (5 min), then incubated in DAPI (1:20,000) for 
7 min and  replaced with PBS. Images were acquired with the ScanR system 
(Olympus). 
 
2.6 ANTIBODIES  
 
The antibodies and their dilutions employed in this study are listed in Table 2.4. 
For IF antibodies were diluted in 1% BSA in PBS, while for IB they were diluted 



























JBW301 Millipore  1:1000  1:500 
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H1029 Sigma  1:1000  1:3000 
Histone H3 rabbit 
polyclonal 
ab8898 Abcam  1:1000  1:1000 
Histone H4 rabbit 
polyclonal 
ab10158 Abcam NA  1:1000 
H3K9me3 rabbit 
polyclonal  
07-442 Millipore NA  1:1000 
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3 CHAPTER THREE: DEVELOPMENT OF 
A NOVEL MASS SPECTROMETRY METHOD 
FOR QUANTIFICATION OF HISTONE POST-
TRANSLATIONAL MODIFICATION AT THE 















In recent years several histone post-translational modifications (PTMs) have 
been shown to play an important role in regulating the DDR and repair 
processes in eukaryotic cells. Numerous histone PTMs have been reported to 
change, either increasing or decreasing, at the sites of DNA DSBs. Furthermore, 
several histone modifiers have been shown to be recruited to the sites of DNA 
DSBs, but for many of them their exact role in the process of repair still remains 
obscure.  
In order to understand the mechanism underlying the chromatin response to 
DNA damage and how failure in this process can lead to disease states, it is 
crucial to identify the spatio-temporal landscape of histone PTMs and histone 
turnover that is associated with the repair of the break. Methods traditionally 
adapted to study histone PTMs involve use of techniques, such as immuno-
fluorescence and chromatin immuno-precipitation. These techniques rely on the 
use of antibodies specifically raised to given modifications. Although these are 
very powerful methods, the downside is that they require knowledge of the 
modification of interest in advance. Moreover, some antibodies can have poor 
specificity resulting from cross-reactivity with similar modifications set in the 
same sequence context (Bock et al., 2014). Due to the nature of histones being 
heavily post-translationally modified, there is also the risk that specific 
modifications may not be detected as a result of epitope occlusion by the 
neighboring mark (Cheung, 2004).  
Recently, mass spectrometry (MS) based proteomics has emerged as a 
powerful tool to study protein PTMs. This method enables the discovery of 
novel histone modifications, as well as the sensitive detection and quantification 
of low abundance marks. We have developed a targeted mass spectrometry 
approach to quantify histone PTMs on the nucleosomes containing H2AX. This 
MS approach allows simultaneous quantification of numerous PTMs, including 
those for which specific antibodies are not available (e.g. H2AK15 
ubiquitination). In this study, we enrich chromatin close to DSBs using H2AX 
antibody, enabling sensitive detection of local changes in histone PTMs.   
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3.2 AIMS OF THIS CHAPTER 
 
To quantify dynamic changes in histone PTMs at the nucleosomes local to 
DSBs, I aimed to develop a mass spectrometry-based method for enrichment, 
detection and quantification of these marks. To achieve this, we designed and 
optimised chromatin immuno-precipitation of mono-nucleosomes containing 
histone H2AX, followed by targeted mass spectrometry (H2AX-ChIP/MS). 
This chapter describes the development and validation of a novel method for 
the enrichment and quantification of histone marks associated with DNA DSBs. 
3.3 EXPERIMENTAL DESIGN 
 
To sensitively detect and quantify histone PTMs associated with DNA DSBs, a 
H2AX-ChIP/MS method was designed. Briefly, cells were damaged IR and 
collected after the indicated recovery times (Fig.3.1 A). To enrich for nuclear 
proteins, the nuclei were isolated and chromatin solubilised using MNase 
treatment to yield mainly a mono-nucleosomal preparation (Fig.3.1 B). 
Nucleosomes from the sites of DNA damage were then recovered by H2AX 
chromatin immuno-precipitation (Fig.3.1 C).  
Since histone proteins are very rich in lysine and arginine residues, simple 
trypsin digestion would result in the production of multiple peptides too small to 
be retained on the chromatography column. To overcome this issue, H2AX 
precipitates, as well as the starting material, were derivatized with propionic 
anhydride in two rounds, separated by a trypsin digestion step (Fig.3.1 D). The 
first round of derivatization served to propionylate unmodified and mono-
methylated lysine residues, which consequently resulted in an Arg-C-like 
digestion by trypsin. The second round served to propionylate the N-termini of 
the peptides, for improved chromatographic retention of hydrophilic peptides. 
Since all of the lysine residues are thus blocked either by endogenous 
modifications or an added propionyl group, this approach generates a highly 
reproducible set of peptides of equal length. Furthermore, propionylation of the 
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F. Data analysis 
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a decrease in their hydrophilicity and consequent improved retention on the 
nanoLC column (Garcia et al., 2007b).  
The samples prepared in this way were then analysed with LC-MS/MS using a 
pseudo-SRM approach (Fig.3.1 E). The resulting data was then analysed using 
Skyline software (Fig.3.1 F). The relative abundance of a modified peptide was 
obtained by integrating the area under the specific peak and division by the total 
area of all modified and unmodified forms. 
 
3.4 VALIDATION OF THE H2AX-CHIP/MS APPROACH 
 
3.4.1 Micrococcal Nuclease treatment for mono-nucleosomal preparation 
of the chromatin 
 
Previously, our laboratory conducted a mass spectrometry analysis and 
quantification of the levels of histone H2A variants in three different cell lines 
(U2OS, HeLa and LCL), showing that H2AX constitutes between 2 and 5% of 
the thirteen H2A family members quantified (Hatimy et al., 2015b). Each 
nucleosome contains two H2A histones. Assuming a random distribution, this 
would suggest that on average only one in ten to twenty five nucleosomes 
would contain the H2AX variant. Therefore, in order to be able to maximise the 
ability of the H2AX antibody to specifically enrich for H2AX-containing 
nucleosomes, the chromatin must be extensively digested using micrococcal 
nuclease, which is known to digest DNA between nucleosomes, to yield a 
predominantly mono-nucleosomal preparation.  
To develop a method for the production of a mono-nucleosomal preparation, I 
have determined the time that is required for complete digestion of inter-
nucleosomal DNA. This revealed that after 9-12 minutes of MNase treatment 
most of the DNA fragments were between 100-200 base pairs, which is 
consistent with a mainly mono-nucleosomal preparation (Fig. 3.2 A). Longer 
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Figure 3.2 MNase treatment for extraction of mono-nucleosomes. A) 
MNase treatment time course. Nuclei of HEK293 cells were isolated and 
treated with MNase for the indicated times. Extracted DNA was run on a 
1.5% agarose gel and visualised with ethidium bromide. B) HEK293 cells 
were treated with 3 Gy x-rays and collected at the indicated time-points. 
Nuclei were isolated and the chromatin was extracted following 10 minutes of 
MNase treatment. The extent of digestion was verified by DNA gel 
electrophoresis (B) and Bioanalyzer analysis (C). Red stars indicate samples 
that were randomly selected for Bioanalyzer analysis. C) A representative 
Bioanylazer trace. Lower and upper markers peak at 35 bp and 10380 bp, 
respectively. FU = fluorescence units. D) MS analysis and quantification of 
histone H3 K9 modifications. MNase extracted (S1) and remaining pellet (S2) 
samples were run into SDS gel and prepared as in Methods section. H3 K9 
modifications were quantified relative to each other. Error bars represent 
standard error of the mean from 5 biological replicates. 
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To follow this, HEK293 cells were treated with 3 Gy of X-rays and collected at 
the indicated time-points (Fig. 3.2 B). The mono-nucleosomes were extracted 
using a 10 minute MNase treatment. The extent of DNA digestion was 
confirmed by agarose gel analysis (Fig. 3.2 B). Since some smearing 
suggestive of higher DNA molecular sizes was observed, a selection of 
randomly picked samples was further analysed (Fig. 3.2 B – denoted with red 
stars) using a Bioanalyzer microfluidic capillary separation spectrophotometer 
(Fig. 3.2 C). This was done to precisely quantify the average size of DNA 
fragments. It was calculated that MNase extracts consisted on average of 97% 
mono-nucleosomes (Appendix Table 2).  
In addition, I tested whether MNase digestion showed any bias towards specific 
types of chromatin. To this end, we quantified epigenetic marks on histone H3 
lysine9 (H3K9). H3 K9 di- and trimethylated are known markers of 
heterochromatin, while unmodified, monomethylated and acetylated versions 
are known to be present in more open and transcriptionally active chromatin 
(euchromatin) (Rea et al., 2000; Nakayama, 2001; Barski et al., 2007). This 
analysis confirmed that MNase digests both types of chromatin (Fig. 3.2 D). 
 
 
3.4.2 Antibody titration  
 
The specificity of the antibody used for the immunoprecipitation of H2AX-
containing nucleosomes was tested. Firstly, titration of the antibody was 
performed to determine the amount required to achieve complete depletion of 
H2AX (Fig. 3.3 A). To this end, a range of antibody concentrations linearly 
increasing from 1-8 g per mg of MNase extract were tested. This showed that 
between 4 and 8 g/mg of antibody was sufficient to deplete the majority of 
H2AX in HEK293 cells exposed to 10 Gy X-rays. Furthermore, increasing 
amounts of histone H4 were co-immunoprecipitated in a manner dependent 
upon the amount of H2AX. Moreover, H2AX-IP in a -phosphatase treated 
sample was also performed. -phosphatase treatment led to removal of the 
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majority of the histone H2AX S139 phospho-group, which consistently resulted 
in a low level of co-immunoprecipitated histone H4 (Fig.3.3 A). Collectively, 
these experiments suggested that co-immunoprecipitation of H4 using H2AX 
antibody, depends predominantly on the presence of H2AX.  
 
3.4.3 Phospho-peptide elution 
 
Immuno-precipitated samples are commonly eluted from the beads with SDS-
containing buffer, which is incompatible with mass-spectrometry analysis. 
Therefore, prior to mass spectrometry the samples are cleaned-up by 
electrophoresis through a SDS-PAGE gel to remove detergent. However, the 
extraction of the protein sample from the gel often leads to significant loss of the 
material. This is an even greater problem when attempting to immuno-
precipitate low abundance proteins, and consequently requires cell culture 
experiments to be conducted on a large scale, which is laborious and expensive. 
Furthermore, SDS-buffer also elutes the antibody chains, as well as other non-
specific factors that bind to the isolation matrix, which may also interfere with 
the mass spectrometry analysis. Therefore, to avoid the above, elution by 
competition was tested. To do that, we designed and purchased a synthetic 
peptide containing phosphorylated H2AX S139 and its surrounding amino acid 
residues (ATQA(pS)QEY, Peptide Protein Research Ltd.). This proved to be as 
effective in elution of H2AX as SDS buffer (Fig. 3.3 B), while avoiding the 
problem of contamination by antibody chains (Fig. 3.3 C). In addition, since 
there is no requirement for detergent removal via gel electrophoresis clean-up, 
this method leads to enhanced recovery of protein, as well as increased 





Figure 3.3 Optimisation of H2AX IP. A) Antibody titration. HEK293 cells 
were treated either with 10 Gy x-rays to induce H2AX S139 phosphorylation 
or PPase to remove phosphate group from proteins. Increasing amount of 
antibody was added to 200 µg of MNase extracts at the concentrations 
indicated on the figure. 10% of the input and flow through, and 20% of IP 
were loaded on the 15% SDS-PAGE gel. Input and Flow Through, and IP 
blots were acquired at different exposure times for both antibodies. B and C) 
Phospho-peptide elution. HEK293 cells were damaged with 10 Gy X-rays. 
H2AX IP was performed and the immuno-precipitates were eluted with 4% 
SDS buffer (SDS) or increasing concentrations of phospho-peptide (PP) 
(ATQA(pS)QEY). 5% of input and 8% of IP samples were run on 4-20% of 
SDS-PAGE gel and probed for H2AX (B) or silver stained (C). IP = 
immunoprecipitate; ST = input; M = protein marker; PP = phosphopeptide; 




3.4.4 Recovery of nucleosomes from the site of DNA damage 
 
Using an approach previously developed in our laboratory (Hatimy et al., 2015b), 
we quantified the abundance of H2AX relative to other H2A variants in the IP 
and input samples, comparing the H2AX-specific peptide GKTGGKAR with the 
major form of this peptide, GKQGGKAR, (present in 11 H2A variants) and 
GKQGGKVR (present in H2AJ) (Figure 3.4).  
Next, the ability to recover nucleosomes from the sites of DNA damage using 
this approach was tested. To achieve this, I first confirmed that IR treatment 
was able to prompt phosphorylation of histone H2AX. As expected, induction of 
H2AX was observed as quickly as 5 min following treatment with 3 Gy X-rays 
and returned close to its background levels by 24 hours (Fig. 3.5 A). 
We observed that in HEK293 cells, of all H2A variants measured, H2AX on 
average represents 4% of the total, while in the H2AX -IP samples around 50-
60% of total H2A was H2AX (Figure 3.5 B). Although we were able to detect 
the GKQGGKVR peptide, we removed it from further quantification due to its 
low abundance (< 0.5% - data not shown). Since the MNase digestion yields 
mainly mono-nucleosomes, this result suggests that the majority of histone 
H2AX is deposited in nucleosomes asymmetrically, being associated with 
another H2A variant.  
Moreover, I was able to detect and quantify the ratio of phosphorylated H2AX 
S139 to unmodified H2AX S139 in both IP and input samples. This showed that 
on average more than 80% of histone H2AX is phosphorylated on S139 (Fig. 
3.4 C and D). Collectively, this analysis shows that nucleosomes containing a 














Figure 3.4 Sequence alignment of the N-terminal portion of histone H2A variants using Clustal programme. H2A 




Figure 3.5 Recovery of nucleosomes from the sites of DNA damage. 
A) Western blot analysis of the time-dependent DNA damage induction in 
HEK293 cells following treatment with 3 Gy of X-rays. To monitor DNA 
damage response, H2AX marker was used; upper band represents 
mono-ubiquitinated histone H2AX (H2AX-Ub).  B) Quantification of the 
abundance of histone H2A variants in the input and H2AX IP samples. 
Error bars represent three biological replicates. C) MS/MS fragmentation 
of singly charged ATQASQEY S139phos precursor. D) Quantification of 
the ratio of phosphorylated to unphosphorylated H2AX S139. Error bars 
represent the average of six independent replicates.  
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3.5 SELECTION AND OPTIMISATION OF PSEUDO-SRM PARAMETERS OF 
TARGETED PEPTIDES 
 
Targeted proteomics assays are characterised and assessed based on 
several performance metrics and features. These include peptide stability 




Stability was assessed based on the ability to detect a given peptide over 
time. During the initial MS runs, we observed significant time- and 
concentration-dependent effects on the detection of some of the more 
hydrophobic, late eluting peptides (Fig. 3.6 – top panel). Since adsorption of 
the peptides to the solid surfaces is an acknowledged concern in quantitative 
proteomics (Hoofnagle et al., 2016), we considered that this issue may also 
be an underling problem responsible for run-to-run variation that we 
consistently observed. To overcome this problem, previous reports 
suggested that addition of carrier proteins, detergents (Lawless, Hopkins and 
Anwer, 1998; Song et al., 2002) or organic solvent (Stejskal, Potěšil and 
Zdráhal, 2013) to the samples could serve to minimise peptide loss. 
Furthermore, it was reported that the loss of peptide intensity by adsorption 
to the vial is more extensive for low-concentration samples due to limited 
binding capacity of the wetted solid surface area (John et al., 2004). Indeed, 
we found that increasing the concentration of the samples in combination 
with 24 hours pre-run incubation in the auto-sampler at 4OC significantly 
improved the recovery of troublesome peptides, yielding more reproducible 









Figure 3.6   The effect of the sample concentration on peptide 
quantification.  A single MNase extracted chromatin sample was diluted 
to a final concentration of 2.5 or 10 ng/l. The 10 ng/l sample was also 
incubated for 24h in the auto sampler pre-run. Each concentration was 
aliquoted into 10 vials and injected on the chromatography column at 
equal volumes. Figure was extracted from Skyline and shows calculated 
peak area for concentration of affected H3 K79me1 peptide 




3.5.2 Reproducibility  
 
Reproducibility refers to the observed run-to-run variation in quantification 
associated with a specific peptide. To measure that, digested input samples 
were diluted to a final concentration of 10 ng/l, while H2AX IP samples 
were diluted to 1% of IP sample/l. These were then incubated in the auto-
sampler at 4OC for 24 hours to reduce the time-dependent effect on the 
peptide quantification. Each sample was then analysed in 20 technical 
replicates and the coefficient of variation (%CV, the standard of deviation 
divided by the mean) was calculated for each peptide (19 replicates for IP 
samples, since one had to be discarded due to a technical issue). CV 
calculations allow estimates of the level of change we would have detected 
(above assay noise) (Appendix Table 2).  
The %CV for the majority of the peptides fell between 0.1-15%. As the H3 
K79me1 peptide was highly irreproducible (CV >69%), it was discarded from 
further analysis. The signal to noise ratio for H3 K9acK14un peptide was 
very low (below the limit of detection).  
 
3.5.3 Peptide linear dynamic range 
 
The linear dynamic range, the lower limits of detection and upper limit of 
quantification for the assayed peptides were determined. Since we expected 
that there may be differences in the complexity of the matrix between the 
input and IP samples, a response curve was generated for both, the input 
(linearly increasing from 0.8 – 100 ng) and IP (linearly increasing from 0.1 – 
12.5 % of IP) samples. The R2 and slope for each targeted peptide was 
determined and is indicated on the graph Fig. 3.7 (full data is available in 























Figure 3.7 Example of peptide response curve. A) The input samples 
linearly increasing from 0.8 – 100 ng and B) IP samples linearly increasing 
from 0.1 – 12.5 % of IP samples were injected into chromatography column 
and analysed by mass spectrometry. The raw intensities for each peptide 
were plotted on the double-Log10 scale. R2 and slope of the linear trendline 
for each peptide was displayed on the graph. 
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The response curve allowed us to determine the lowest amount of sample 
required for confident detection of all of the desired peptides (i.e. the signal 
was distinct from the noise). Based on that we observed that the majority of 
the peptides could be detected even at the lowest injection amounts used, 
however, to be able to detect and quantify all of the desired peptides in a 
single run, the lowest possible loading would be around 20 ng for input 
sample and 3% of IP (based on IP from starting amount of 0.5 mg of MNase 
extract after 3 Gy of IR).  
Furthermore, the upper limit of quantification for this study was determined. It 
has been observed that the majority of the targeted peptides displayed 
linearity across all tested concentrations. However, for a small subset of 
peptides the signal intensity departed from linearity at 60 ng of injection (Fig. 
3.8). Consequently, in future experiments we allowed some space for the 














Figure 3.8 Measurement of upper limit of quantification. H4 3Ac 
K5unK8AcK12AcK16Ac peptide becomes saturated at higher concentrations 
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Here I have presented the development and optimisation of a novel H2AX-
ChIP/MS approach for investigation of post-translational modifications on 
nucleosomes associated with histone H2AX phosphorylated on S139, a 
known marker for DNA damage. 
To this end, I have shown that this method enables the specific enrichment 
of H2AX-containing nucleosomes, as evidenced by the fact that at least 50% 
of the histone H2A forms in the H2AX-IP sample is H2AX (Fig. 3.5 B). If one 
assumes a random distribution of histone H2AX throughout the genome, this 
result is expected since MNase extraction of chromatin used as a starting 
material for this IP predominantly consists of mono-nucleosomes (Fig. 3.2 A-
C). In addition to that, at least 80% of H2AX in the IP samples is 
phosphorylated on S139 (Fig. 3.5 C and D), further confirming the specificity 
of the H2AX antibody used in this study.  
Additionally, I have demonstrated that competitive elution of the H2AX-
precipitate with the antigen-phosphopeptide used for production of this 
antibody, improves the stringency of this protocol. I have shown that 
phosphopeptide elution is as effective as SDS at recovering H2AX (Fig. 3.3 
B), while avoiding contamination with antibody chains (Fig. 3.3 C). Another 
advantage of this method of elution is the avoidance of the gel clean-up 
stage, which is a cause of significant loss of material.  
With the use of the targeted mass spectrometry method we were able to 
detect over 60 histone peptides in a single MS run. These included histone 
variants and differentially modified histone peptides. The ideal conditions for 
stability of majority of the peptides were determined and the coefficient of 
variation was measured for each peptide in the input and IP matrices (Fig. 
3.6., Appendix Figure 1 and Appendix Table 3). Moreover, the lower limit 
of detection, as well as upper limit of quantification have been measured for 
each peptide and based on that ideal loading, the amounts for input and IP 
samples were determined. 
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In a typical SRM experiment where one tries to measure the abundance of 
the protein, usually only a few of the best behaving peptides are measured 
(i.e. peptides with good stability, low %CV and large dynamic range). Since 
we are measuring specific PTM-containing peptides, we do not have the 
luxury of choosing the best behaving peptides. This leads to decreased 
sensitivity of the assay, specifically in the case of the peptides with 
larger %CV. Therefore; in other words, we cannot exclude the possibility that 
there may be some changes in peptide abundance that we were not able to 
detect.  
In conclusion, I have validated and optimised a novel high throughput and 
multiplex method for detection and quantification of histone post-translational 
modifications and histone variants associated with DNA damage. 
Subsequently, this method was used to measure both temporal and IR dose-
associated chromatin changes (Chapter 4). Furthermore, I have used this 
method to investigate the chromatin context associated with late repairing 






















4 CHAPTER FOUR: QUANTIFICATION OF 
HISTONE POST-TRANSLATIONAL 
















4.1 INTRODUCTION  
 
Phosphorylation of H2AX on serine 139 is the most commonly used marker 
of DNA DSBs (see introduction for more details). This modification has been 
shown to spread up to 1 Mbp away from the site of damage (Rogakou et al., 
1998a, 1999b; Savic et al., 2009b; Iacovoni et al., 2010b). It has been 
proposed that chromatin presents a barrier to repair of DSBs, and in the past 
years there have been multiple studies reporting DNA damage induced 
changes in histone acetylation, ubiquitination and methylation (see 
Introduction and Table 1.1).  
In the previous chapter, I have presented a method for enrichment of 
nucleosomes containing H2AX. Here I combined this method with a pulse-
chase strategy to quantify co-occurring histone modifications. Furthermore, I 
have used an IR-dose response approach to look for factors that might 
become limiting at high doses.  
 
4.2 H2A(X) K15 UBIQUITINATION MARKS NUCLEOSOMES 
SURROUNDING DNA DSBS 
4.2.1 Assay design for detection of H2A(X) K15 ubiquitination 
 
Dynamic spatiotemporal alterations in chromatin modifications local to DSBs 
have been reported to play a crucial role in the regulation of the cellular 
response associated with a repair process. As mentioned in the introduction, 
previous studies suggest a crucial role for RNF168 induced ubiquitination in 
the repair of DSBs. Due to lack of a specific assay to directly detect damage-
induced H2A(X) K15 ubiquitination, this modification has not previously been 
quantified and more indirect approaches have been used to investigate its 
role in response to genotoxic stress. These included mutational studies and 
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the use of the FK2 antibody, which is known to detect DSB induced ubiquitin 
foci (Huen et al., 2007; Doil et al., 2009b; Gatti et al., 2012; Mattiroli, Vissers, 
et al., 2012; Fradet-Turcotte et al., 2013).  
The N-terminal portion of H2A containing the K13/15 ubiquitination sites 
(amino acids 12-17) is largely conserved between all variants (Figure 4.1). 
We targeted the two most common variants of the peptide encompassing 
these sites: AKAKTR, present in five variants, and AKAKSR, the version 
present in eight variants including H2AX (from now on referred to as H2A 
and H2AX-like, respectively). Although, H2A(X) K13Ub was detectable and 
did not co-elute with K15Ub, the signal was low and close to the background. 
Therefore, for further study we focused on K15Ub. To develop a sensitive 
SRM assay for detection of H2A ubiquitination by MS, we employed 
synthetic peptides containing a K15 Gly-Gly modification, identical to that 
generated by trypsin digestion of ubiquitinated lysine residues. Following 
derivatization and digestion, the peptides were detected by the pseudo-SRM 
assay (Figure 4.2).  
 
4.2.2 Quantification of temporal changes in H2A K15 ubiquitination 
 
We combined H2AX-ChIP/MS with a time-course strategy to quantify 
temporal changes in H2A(X) K15 ubiquitination. In agreement with previously 
published studies, we detected an increase in K15 ubiquitination following 
damage induction (Figure 4.3). Globally, the rise in the K15Ub mark was 
observed by 5-15 minutes following 3 Gy X-rays, reaching a peak around 
0.5-1 hour, and staying relatively stable up to 4-8 hours, when it slowly 
decreased (Figure 4.3 A and B). At 24 hours following damage induction, 
K15 ubiquitination remained above the background level, suggesting that not 
all DSB have undergone repair. 
Consistent with RNF168 being recruited to damage foci, we observed a 
marked accumulation of this mark in H2AX-IP samples over input samples 
(Figure 4.3 C and D). Interestingly, the dynamics of the ubiquitin deposition 
on K15 differed between H2A and H2AX-like peptide. Both, globally and 
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locally, an increase in H2AX-like K15Ub was observed within 5 minutes after 
damage, whereas the same level of ubiquitination on the H2A peptide was 




Figure 4.1 Sequence alignment of the N-terminal portion of histone H2A variants using Clustal programme. K13/15 
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Figure 4.2 H2A(X) K15Ub synthetic peptide for the development of sensitive pSRM. 50 fmol of each of derivatized peptides 
were injected and analysed by pSRM assay. MS/MS fragmentation of doubly charged H2A K15ub (top panel) and H2AX-like 
K15ub (bottom panel) synthetic peptides. Extracted fragment ion mass spectra shown on left panel. Red and green bars 
represent y- and b-ions, respectively. Right panel shows extracted ion chromatograms with detected fragment ions displayed in 
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Figure 4.3 Ionising radiation induced ubiquitination of H2A(X) K15 is 
enriched at H2AX nucleosomes. A) HEK293 cells were damaged with 
3 Gy X-rays and collected at the indicated time points. H2A(X) peptide 
spanning amino acid residues 12-17 containing ubiquitinated or 
unmodified lysine 15 were targeted for MS analysis. Percentage of 
H2A(X) K15 ubiquitinated relative to unmodified was quantified for all time 
points, both in the H2AX-IP and input samples (A and B). Quantification 
of H2A K15 ubiquitination in the input samples was magnified in (C and 
D). E) Fold enrichment of K15 ubiquitination on the H2A- and H2AX-like 
peptide calculated relative to undamaged at 5 min post IR in IP and Input 
samples, showing the faster rate of ubiquitin deposition on H2AX-like K15 








15 minutes, suggesting that deposition of ubiquitin on H2AX-like peptide was 
nearly twice as fast as on the H2A peptide (Figure 4.3 E).  At the local level, 
we could detect several fold higher levels of H2A(X) K15 ubiquitination. Even 
in the undamaged sample, this mark was on average   11- and 6-fold higher 
compared with the undamaged input sample (Figure 4.3 A and B 
respectively). This result is not surprising, since these experiment were 
conducted in asynchronous cells, and it is well known that during S-phase, 
replication stress arises with activation of DNA repair pathways (Técher et al., 
2017). However, the local dynamics of K15Ub on the H2AX nucleosomes 
were different from the global dynamics. Whereas globally K15Ub peaked 
between 0.5-1 hours after damage, locally the peak was reached between 4-
8 hours following damage induction, where it was over 20-fold higher relative 
to the undamaged input sample. In contrast, H2AX peaked by 0.5-1 hour 
(Figure 3.5 A).  
 
4.2.3 H2A K15 ubiquitination decreases in response to increasing 
doses of IR 
 
As mentioned in the introduction, previous studies have shown that 53BP1 
foci are dependent on RNF168 and that they do not display a linear increase 
with dose, potentially due to limited RNF168. To examine whether this 
dependency might be due to an impaired ability to create H2A(X) K15 
ubiquitination at high doses, we exposed HEK293 cells to increasing doses 
of IR, allowed them to recover for 30 minutes and analysed the samples as 
previously. As expected, western blot analysis showed a linear increase in 
the H2AX damage mark with increasing IR dose (Fig. 4.4 A). In contrast, 
K15 ubiquitination per immunoprecipitated H2AX nucleosome increased up 








Figure 4.4 Histone H2A K15 ubiquitination is a limiting factor in 
response to DNA damage. A) Western blot analysis of H2AX response 
to increasing doses of ionizing radiation. HEK293 cell were damaged with 
the indicated dose, allowed to recover for 30 minutes and collected. 
MNase extracted chromatin was run on SDS-PAGE gel and probed for 
H2AX and histone H4. B) H2AX-containing nucleosomes were 
immunoprecipitated and H2A K15 ubiquitination was quantified. Each 
biological replicate was run in technical duplicate. Error bars represent 






4.3 HISTONE H3 MODIFICATIONS DO NOT CHANGE IN RESPONSE TO IR 
4.3.1 H3K9 and K14 modifications 
 
Modifications on histone H3 lysine 9 (H3K9) are involved in the epigenetic 
regulation of cellular identity. For instance, the acetylated form of H3 K9 is 
found at the transcription start sites of genes and is associated with the 
activation of gene expression (Karmodiya et al., 2012), while H3 K9me2/3 
are found in condensed, transcriptionally silenced chromatin regions 
(Jacobson et al., 2000; Lachner et al., 2001; Peters et al., 2002; Hathaway et 
al., 2012).  
As mentioned in the introduction H3K9me3-marked chromatin has been 
reported to be refractory to repair. It has been proposed that its condensed 
structure makes it more difficult for the repair machinery to access it, 
therefore a chromatin relaxation step is required prior to this process 
(Goodarzi et al., 2008). 
Furthermore, several studies have suggested that changes in H3K9 
acetylation and methylation also may be involved in the DDR. For instance, it 
has been shown that failure to down regulate H3K9 acetylation in response 
to DNA damage leads to increased radiosensitivity and impaired recruitment 
of ATM (Meyer et al., 2016b). However, somewhat contradictory 
observations have been reported in the literature regarding H3 K9me2/3, 
which were demonstrated to increase, decrease and remain unchanged at 
the sites of DNA DSBs (Falk et al., 2007; Young, McDonald and Hendzel, 
2013; Ayrapetov et al., 2014a; Jiang et al., 2015; Wu et al., 2015). 
We further explored the role of the modifications on this residue in the DDR. 
In our assay we were able to detect unmodified, mono-, di-, trimethylated 
and acetylated versions of an H3K9 peptide in combination with unmodified 
or acetylated K14, which gave us a total of 10 differentially modified peptides 
(Figure 4.5). We combined H2AX-ChIP/MS with a time-course strategy to 







Figure 4.5 Quantification of H3 K9K14 modifications. Chromatin was 
extracted with MNase from untreated HEK293 cells. The ratio of 10 
differentially modified H3 peptides containing lysine 9 and lysine 14 were 
quantified and expressed as a percentage of total (average of n = 20). 
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Figure 4.5 Quantification of H3 K9K14 modifications. Chromatin was 
extracted with MNase from untreated HEK293 cells. The ratio of 10 
differentially modified H3 peptides containing lysine 9 and lysine 14 were 
quantified a d expressed as a percentage of total (average of n = 20). 






We found that in H2AX nucleosomes none of the targeted methylations 
significantly changed (Figure 4.6). A slight decrease in K9 acetylation was 
observed, however a one-way ANOVA test did not show that change to be 
significant.  
H3 peptide encompassing K9 contains another lysine residue (K14), which is 
known to be either unmodified or acetylated. We also monitored this mark 
over 24 h after IR, but no significant changes in the acetylation state of this 
residue were observed (data not shown). 
Next, we considered the possibility that we were not able to detect new 
methylation at the site of the break due to low sensitivity of the method used. 
To test this hypothesis we combined H2AX-ChIP/MS method with heavy 
methyl SILAC labelling to analyse the turnover of methylation following 
damage induction. To do that HEK293 cells were cultured in media 
containing light methionine, then switched to the heavy methionine media 1 h 
prior to damage induction with 3Gy X-rays (Figure 4.7). The cells were 
collected at several time points and prepared as previously. H2AX IP and 
Input samples were then analysed using the pseudo-SRM method, targeting 
all of the potential combinations of H3K9 peptide.  
As the heavy label gets incorporated, peaks corresponding to new H3K9me3 
intermediate state precursor ions can be progressively observed on the 
spectrum. Analysis of the cells grown in the light media only, shows 
precursor ions that correspond to H3K9me3 containing three light, thus three 
“old” methyl groups (K9me3:0) (Figure 4.7 B – top panel). Upon the switch 
to the heavy media, new intermediates can be observed; for example 
K9me3:2, refers to H3K9 trimethylated, with two heavy or “new” methyl 
groups (Figure 4.7 B). Quantification of H3K9me3 turnover rate showed no 
large difference in the methylation between H2AX and Input samples 














Figure 4.6 Histone H3 K9 methylation is not significantly affected by 
ionising radiation. Quantification of histone H3K9 modifications following 
IR in H2AX (left panel) and Input (right panel) samples. HEK293 cells 
were treated with 3 Gy IR and collected at the indicated time points. 
Histone H3 peptides (R.KSTGGKAPR.K [amino acids 9 - 17]), either 
unmodified, mono-, di-, tri-methylated or acetylated on lysine 9, and 
unmodified or acetylated on lysine 14 were targeted for MS analysis. 
Relative abundance of each peptide was quantified for each time point. 
Each biological replicate was run in technical duplicate. Error bars 
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Figure 4.7 Heavy methyl SILAC labelling to study turnover of histone 
H3 K9 methylation in response to DNA damage. A) Strategy for using 
heavy methyl-SILAC labeling to study dynamics of histone methylation. 
HEK293 cells were switched from light to heavy methionine-labeled medium 
to allow for incorporation of the heavy methyl group on histones 1 h prior to 
3 Gy X-rays. B) Extracted mass spectrum, showing time-dependent 
incorporation of heavy label to histone H3K9me3. C) Quantification of 









4.3.2 Other histone H3 modifications 
 
Several modifications on histone H3 have been previously reported to be 
involved in the DDR (see Introduction). Using our H2AX-ChIP/MS approach 
we were able to monitor the dynamics of methylation and acetylation on the 
several H3 residues. These included: K4, K9, K14, K18, K23, K27, K36 and 
K79. We found no significant changes in the methylation and/or acetylation 
of any of these residues suggesting that majority of the epigenetic marks on 
this histone remain stable in response to DNA damage. 
 
4.4 QUANTIFICATION OF H4 N-TERMINAL MODIFICATIONS IN RESPONSE 
TO IR 
 
The amino acid sequence of histone H4 is the most conserved component of 
the core nucleosome. In human cells, there is a single histone H4 encoded 
by 14 genes. The N-terminal tail of histone H4 has been reported to be highly 
modified by acetylation, methylation and phosphorylation in order to regulate 
cellular processes, such as transcription, replication, checkpoint activation 
and DNA repair.  
The modification of several H4 N-terminal residues have been previously 
described to change in response to DSBs. Using our H2AX-ChIP/MS 
method we were able to detect and quantify modifications on peptides 
containing lysine residues 5, 8, 12 and 16 (amino acids 4-17) and lysine 20 
(amino acids 20-23). 
 
4.4.1 H4  K5, 8, 12 and 16 
 
Acetylation and deacetylation of the N-terminal lysine residues of H4 were 
previously implicated in the DDR (Bird et al., 2002; Tamburini and Tyler, 
142 
 
2005; Murr et al., 2006; Miller et al., 2010; Sharma et al., 2010b; Krishnan et 
al., 2011; Krishnan et al., 2011; Hsiao and Mizzen, 2013; Tang et al., 2013). 
Furthermore, HDAC inhibitors were shown to sensitise cells to DNA damage, 
suggesting an important role for the regulation of histone acetylation during 
the DDR (Groselj et al., 2013). 
Using our targeted mass spectrometry approach, we were able to detect and 
quantify the abundance of ten differentially modified H4 N-terminal peptides 
containing lysine residues K5, 8, 12 and 16 (H4 K5-16). This analysis 
showed that in HEK293 cells the peptide containing these residues is 
predominantly unmodified or acetylated on K16, representing approximately 
46% and 41% of all H4 K5-16 modifications respectively (Figure 4.8 A). Two 
other readily detectible forms were peptides acetylated on K12 and 16, and 
peptides acetylated on K5, representing being 4.5% of all modified versions 
we were able to detect.  
Next, we quantified the changes in acetylation on each of the lysine residues 
in the K5-16 peptide. Quantification of the ratio of acetylated versus 
unmodified K16 showed that this residue is not significantly affected by DNA 
damage, either globally or at the H2AX nucleosomes, as judged by one-way 
ANOVA test. However, we saw a small, but significant decrease in the global 
levels of K5 and 8 acetylation (Figure 4.8 B and C).  
 
4.4.2 H4K20 modifications 
 
Constitutive and abundant di-methylation of the histone H4K20 is involved in 
the recruitment and retention of 53BP1 at the site of DSBs upon damage 
induction (Botuyan et al., 2006b). Mono- and tri-methylation of H4K20 were 
previously reported to increase at the sites of DSBs (Pei et al., 2011). 
However, using H2AX-ChIP/MS, I found no significant changes in the 








Figure 4.8 IR-induced global decrease in H4 K5/8 acetylation. A) 
Distribution of H4 K5-16 modifications in HEK293 cells. The Chromatin was 
extracted with MNase from untreated HEK293 cells. The ratio of 10 
differentially modified H4 peptides containing lysine 5 to lysine 16 were 
quantified and expressed as a percentage of the total (average of n = 20 
technical replicates). The data is not corrected for ionisation efficiency. Un = 
unmodified, Ac = acetylated, m = one of two lysine residues in a single 
peptide demarked with “m” (maybe) is modified. B) Temporal quantification of 
global acetylation on the histone H4 K5 in response to 3 Gy X-ray. C) 
Temporal quantification of global acetylation on the histone H4 K8 in 
response to 3 Gy X-ray. Error bars show SEM (n = 5). P value was 






































Figure 4.9 Histone H4 K20 methylation is not significantly affected by 
ionising radiation. Quantification of histone H4K20 modifications following 
IR in H2AX (left panel) and Input (right panel) samples. HEK293 cells were 
treated with 3 Gy IR and collected at the indicated time points. Histone H3 
peptides (R.KVLR.D [amino acid residues 20 - 23]), either unmodified, mono-
, di-, tri-methylated on lysine 20 were targeted for MS analysis. Relative 
abundance of each peptide was quantified for each time point. Each 
biological replicate was run in technical duplicate. Error bars represent 








In this study, we used a novel ChIP-MS approach to quantify histone PTMs at 
H2AX-containing mono-nucleosomes following IR. We found that the majority 
of the histone marks examined were unaffected by DNA damage, both globally 
and at H2AX-containing nucleosomes. However, at this stage we cannot 
exclude the possibility that these marks show either transient changes or 
changes at a subset of DSBs. In considering this, it has to be appreciated that 
our procedure assesses the average change at multiple DSBs throughout the 
genome, in contrast to procedures using a site specific DSB. Our procedure 
may, therefore, lack sensitivity for the detection of subtle changes arising in a 
sub-class of DSBs. Additionally, by enriching for H2AX nucleosomes, which 
are depleted in close proximity to the break (1-2 Kbp) (Shroff et al., 2004b; 
Savic et al., 2009c; Iacovoni et al., 2010a), it is likely that we fail to detect PTMs 
that arise in non-H2AX containing regions. 
We observed a small, but significant bimodal decrease in global acetylation of 
H4 K5 and K8. Although the precise role of this deacetylation remains unclear, 
histone deacetylases (HDACs) have been reported to contribute to checkpoint 
arrest and p53-dependent transcriptional reprograming after DNA damage (Ho 
et al., 2005). Our findings are supportive of a role for histone deacetylation 
raising the possibility that HDACs contribute to the regulation of specific genes 
for the execution of these responses. 
The main modification we observed at the site of damage is ubiquitination of 
H2A(X) K15. This study allowed us to describe two important additional features 
for this damage induced PTM that may have potential functional relevance. 
Firstly, we found that ubiquitin is deposited initially at H2AX-like K15-containing 
peptides, while the ubiquitination of the other H2A variants proceeds with slower 
kinetics, suggesting that the H2AX-like peptide is a preferred substrate for 
RNF168. Secondly, we show that, in contrast to H2AX S139 phosphorylation, 
H2A(X) K15Ub is non-linear with dose. Even at 3 Gy, we do not observe the 
expected linear increase in signal, and at higher IR doses we see a decrease in 
ubiquitination per H2AX, and therefore by implication a decrease in 
ubiquitination per DSB. Other studies have shown that 53BP1 is not recruited 
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with linear kinetics, with the ubiquitin ligase, RNF168, being proposed to be the 
limiting factor, i.e. RNF168 levels stay constant following damage induction, 
therefore, it becomes diluted between increasing number of DSBs (Gudjonsson 
et al., 2012a). A 1 Gy X-ray treatment is expected to induce on average 20-40 
H2AX foci per cell by 30 minutes after treatment, decreasing to 5-10 foci at 4 
hours as a result of the DDR (Bauerschmidt et al., 2010). Given a linear 
increase in DSBs with increasing X-ray dose (Löbrich, Rydberg and Cooper, 
1995) we would expect to generate 60-120 DSBs at 30 minutes after 3 Gy IR, 
reducing to 15-30 DSBs at 4 hours. Our findings, therefore, suggest that 
ubiquitination may become limiting between 40 and 60 DSBs per cell. Another 
feature we observed was an increase in ubiquitination between 4-8 hours post 3 
Gy irradiation (Gudjonsson et al., 2012a). Although this could be explained by 
slow deposition of this mark, we favour the explanation that there could be  
increased availability of RNF168 at later time points as repair occurs and the 
number of H2AX foci diminish, in other words at earlier times RNF168 is 
saturated but becomes available as repair ensues. Such an explanation is 
consistent with, and might even be expected from, the restricted availability of 
RNF168 after 3 Gy. These estimates based on the non-linear behaviour of 
H2A(X)K15 ubiquitination are consistent with other estimates based on analysis 
of 53BP1 recruitment to DSBs, which is dependent on the ubiquitin mark (Ochs 
et al., 2016). Ochs et al, (2016) showed that in S/G2 phase robust 53BP1 
accumulation is required for RAD51 filament formation and faithful repair via HR, 
while insufficient 53BP1 accumulation was shown to redirect the repair towards 
mutagenic RAD52-dependent SSA. Here, I have showed that H2A(X) K15Ub, a 
binding platform necessary for 53BP1 recruitment to DSBs, decreases in 
response to high doses of IR, suggesting this ubiquitination is necessary for 
faithful repair of DSBs (Figure 4.10). These observations have an important 
implication when considering high dose exposures such as the doses received 




















Figure 4.10 Schematic representation of the proposed effect of high IR 
doses on H2A(X) K15 ubiquitination. Following DNA damage induction with 
IR in S/G2 phase, RNF168 is recruited to the DSB marked with H2AX (green), 
where it ubiquitinates histones H2A(X) K15. Below 3 Gy of IR sufficient amount 
of H2A(X) K15 ubiquitination takes place, leading to recruitment of 53BP1 and 
RAD51 to the sites of DSBs, which are then repaired by HR. As the IR doses 
increase above 3 Gy, limited amounts of RNF168 dilute between multiple 
breaks, leading to insufficient H2A(X) K15 ubiquitination, and thus decreased 
53BP1 recruitment, causing a switch from RAD51-dependent HR to RAD52-













5 CHAPTER FIVE: CHARACTERISATION 
OF THE CHROMATIN ASSOCIATED WITH 















5.1 INTRODUCTION  
 
H2AX is the most commonly used DSB marker. It is understood that chromatin 
presents a barrier to the repair of DSBs, and numerous histone acetylation, 
ubiquitination and methylation events have been reported to be associated with 
DSB signalling and repair (discussed in the Introduction). 
H2AX S139p is predominantly carried out by ATM kinase, but in its absence 
DNA-PK can also phosphorylate H2AX (Stiff et al., 2004). However, ATM is 
required for the repair of a subset (15-20%) of IR-induced breaks, representing 
those repaired with slower kinetics (Riballo et al., 2004). Significantly, there is 
evidence that these DSB co-localise with heterochromatic regions (Goodarzi et 
al., 2008). 
As discussed in the Introduction, KAP1 is a well-known heterochromatin 
building factor. Upon DSB induction, KAP1 is phosphorylated on S248 
throughout the nucleus to promote global relaxation of chromatin (Goodarzi et 
al., 2008). Phosphorylated KAP1 was also shown to form foci that co-localise 
with H2AX at heterochromatic lesions at late repairing time-points (Riballo et 
al., 2004). Cells lacking MDC1, RNF8 and RNF168, fail to form 53BP1 foci, 
leading to inefficient accumulation of Mre11-NBS1 and ATM, which leads to a 
failure in the formation of KAP1 S248phos foci (Riballo et al., 2004). 
Consequently, this results in a repair defect at slow component, 
heterochromatin-associated breaks. 
KAP1 is also a known silencing factor and was observed to associate with a 
variety of proteins involved in transcription regulation, such as histone 
acetylases and deacetylases, as well as histone and DNA methyltransferases 
(Cheng, Kuo and Ann, 2014). In the cell, KAP1 has been shown to localise to  
discrete compartments within the nucleus, including pericentric and centromeric 
heterochromatin, euchromatin, but was also found in the cytoplasm, implicating 
its function in diverse cellular activities (Ryan et al., 1999; Matsuda et al., 2001; 
Yang et al., 2013). Interestingly, it has been also demonstrated that KAP1, as 
well as other compacting factors, such as SUV39h1 and HP1, are recruited to 
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DSBs to promote chromatin condensation shortly following damage induction 
(Ayrapetov et al., 2014).  
5.2 AIMS OF THIS CHAPTER 
 
Given the observation that chromatin compacting factors are recruited to the 
sites of DNA damage, we asked the question whether the repair-defective, 
ATM-dependent DSBs originate in the heterochromatin or do they become 
heterochromatinised as a consequence of DDR. 
To investigate heterochromatin associated DSBs in mammalian cells, previous 
studies took advantage of murine cells, in which heterochromatin can be easily 
observed as large, DAPI-dense chromocenters (Goodarzi et al., 2008). The 
weakness of this approach is that it is indirect and simply relies on the co-
localisation between the damage markers and DAPI-stained chromocenters. 
Furthermore, it does not permit differentiation between pre-existing and new, 
damaged-induced, chromatin modifications. Importantly, heterochromatin 
organisation is different in murine cells, i.e. in murine cells heterochromatin 
organises to large structures known as chromocenters, while in human cells 
heterochromatin is spread throughout the nucleus (Jones, 1970; Pardue and 
Gall, 1970; Ou et al., 2017), and therefore the same repair mechanism may not 
be applicable to human cells.  
In this thesis I have presented a novel method for the enrichment and 
quantification of the nucleosomes containing H2AX in order to detect co-
occurring histone modifications. Here, I  further employ a label-switch strategy 
to immunoprecipitate persistent H2AX chromatin in ATM inhibited (ATMi) or A-
T cells, previously demonstrated to be enriched in heterochromatic regions of 
the genome (Goodarzi et al., 2008). I use heavy methyl SILAC labelling to 
distinguish between pre-existing and new methylation on histone H3K9. Here I 
present the analysis of the relative enrichment of heterochromatin modifications 





5.3 APPROACH TO STUDY HISTONE METHYLATION AT LATE REPAIRING 
DSBS USING HEAVY METHYL SILAC LABELLING 
 
Heavy methyl SILAC labelling was used in the past to distinguish pre-existing 
and new methyl marks on histones (Zee et al., 2010; Cao, Zee and Garcia, 
2013). I have combined the H2AX-ChIP/MS method described in Chapter 3 
with SILAC labelling using light and heavy methionine to study the origin of the 
heterochromatin associated with the slow repair component in ATM deficient 
cells. The basic principles of this method are depicted in the Figure 5.1 A. The 
cells were arrested in the G0/1 phase of the cell cycle by contact inhibition. 
Three days after the cells reached 100% confluence, cell growth media 
containing light methionine was switched to media containing heavy methionine 
and allowed 1 h for its incorporation (described in more detail in the 
Introduction).  Following damage induction, cells were collected at the indicated 
time-points. The Input and H2AX-IPed samples were analysed using LC-MS.  
 
5.3.1 G0/1 cell cycle arrest 
 
To reduce background H2AX related to replication stress, cells were arrested 
in the G0/1 stage of the cell cycle by contact inhibition. Fluorescence activated 
cell sorting (FACS) analysis was used to examine the cell cycle profile (see 
Method and Materials). This showed that growing cells to full confluence is 
sufficient to inhibit cell cycle progression and yield a population with 
predominantly G0/G1 phase cells and undetectable levels of S phase cells 






























Figure 5.1. Strategy for the approach to study DSB-associated H3K9 
methylation.  72 h after cells reach confluency and 1 h prior to IR, the cell 
media was switched from light to heavy methionine to allow time for 
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Figure 5.2. Contact inhibition of cells in G0/1 cell cycle phase. The 
FACS profile of cycling and contact inhibited 1BR (top panel) and A549 







5.3.2 ATM inhibition results in a defect in the slow repair component 
 
To confirm the repair defect related to ATM deficiency, first, I established that 
KU55933 (ATM inhibiting drug, ATMi) treatment is able to prevent ATM 
activation (Hickson et al., 2004). Upon IR treatment, ATM is known to undergo 
auto-phosphorylation on S1981 and to phosphorylate p53 on S15, which are 
often used as markers of ATM activity. Figure 5.3 shows that ATMi treatment 
prior to IR prevents the phosphorylation of these residues, consistent with 
inactivation of ATM kinase function. Moreover, consistent with previous reports, 
inactivation of ATM resulted in a repair defect at 24 h post IR, as judged by 
increased number of H2AX foci, as compared to wild type (wt) cells (Figure 5.4 
A and B). 
Similarly, I wanted to confirm that the repair defect also occurs in the A549 cells 
upon ATMi inhibition. These cells are much smaller in size and grow faster than 
fibroblasts, resulting in a much higher yield in a shorter period of time. 
Furthermore, A549 cells can be also arrested by contact inhibition (Figure 5.2).  
Upon ATM inhibition we observed a decrease in H2AX phosphorylation as 
judged by Western Blot analysis (Figure 5.5 A). Therefore, to determine 
whether ATM inhibition leads to the same repair defect of the late repair 
component as observed in 1BR3 cells, I enumerated IR induced H2AX that co-
localised with 53BP1 foci and observed the anticipated repair defect (Figure 5.5 
B and C). The reason behind enumerating co-localised foci was due to the fact 
that ATM inhibition leads to decreased phosphorylation of H2AX, and therefore, 
smaller and more difficult to detect foci. Unfortunately, due to technical issues 
with the chromatography, which led to loss of the data for multiple peptides, this 
experiment was not fit for quantification, and due to the time limitation A549 









Figure 5.3. KU55933 treatment inhibits ATM activity. Western blot 
analysis showing that ATMi treatment prevents ATM activation following 
IR. A549 cells were treated with 10 µM of KU55933 for 1h, damaged with 3 
Gy of X-rays and allowed 1 h recovery time prior to collection. ATM 
autophosphoryation was monitored using phospho-specific antibodies to 
the ATM autophosphoryation site, S1981 and phosphorylation of p53 was 








Figure 5.4. AT patient derived and ATMi treated cells show a repair 
defect 24 h following IR. A) 1BR -/+ ATMi and AT1BR fibroblast cells, 
undamaged or treated with 3 Gy X-rays, were immunostained for H2AX 
(green). The nucleus was stained with DAPI (blue). B) Quantification of 
H2AX foci from (A). The average of 50 cells/condition were counted. Error 








Figure 5.5. ATMi treatment of A549 cells results in a DSB repair defect. 
A) Western blot analysis of H2AX following 3 Gy of X-ray treatment in A549 
cells -/+ ATMi pre-treatment. B) ATMi treated A549 cells show repair defect 
24 h post-IR. IF analysis of H2AX (green) and 53BP1 (red) foci following 
ATMi treatment. The nucleus was stained blue with DAPI. C) Quantification of 
H2AX/53BP1 overlapping foci. Average of 100 cells per condition was 






5.4 QUANTIFICATION OF PRE-EXISTING AND NEW H3K9 METHYL MARKS 
ASSOCIATED WITH THE H2AX-NUCLEOSOMES IN THE WILD TYPE AND 
ATM DEFICIENT FIBROBLAST 
 
As previously discussed, heterochromatin-associated H3K9me3 marks have 
been shown to be enriched at late repairing DSBs. To quantify whether these 
late repairing breaks originate from pre-existing heterochromatin or become 
heterochromatinised as a consequence of the DDR, I have used heavy methyl 
SILAC labelling as described above. Surprisingly, quantification of H3K9me3 in 
the H2AX immunoprecipitated samples revealed that there was no enrichment 
of these marks at the 24 h time-point relative to 1 h either in the control or ATM 
inhibited/mutated cells. 
Furthermore, I quantified the turnover of H3K9 methylation on the H2AX 
nucleosomes associated with the late repairing breaks. As discussed in the 
Introduction, di- and tri-methylation of this residue was previously reported to 
increase at DSBs (Ayrapetov et al., 2014c). However, we did not observe any 
significant difference in the turnover of H3K9me2 at the H2AX nucleosomes 
relative to the global turnover of these marks (Appendix Figure 2 A). A small 
increase in new tri-methylation, created from pre-existing mono- and di-
methylation was observed at H2AX nucleosomes at 24 h in the 1BR and 
AT1BR cells, however this was not statistically significant (Appendix Figure 2 
B). The signal from fully new tri-methyl H3K9 (all heavy label) was too close to 
the background to be reliably quantified (Appendix Figure 3).  
Larger amounts of the sample should be loaded for MS analysis to improve the 
quantification of these peptides. This, however, could not be readily achieved 
with 1BR.3 cells. This is due to the fact that these cells are much larger than 
HEK293 or A549 cells. Based on the cell count, I have calculated on one 15 
cm2 plate one can grow on average ~4x107 HEK293 cells, while only ~5x106 of 
1BR.3 can fit into the same space. Additionally, ATM inhibition leads to 
decreased phosphorylation of H2AX. Therefore, substantial upscaling of the cell 
culture would be required to grow sufficient a amount of 1BR.3 cells to perform 





A previous study proposed a model whereby H3K9me3 marked 
heterochromatin poses a barrier to DSB repair processes and that this barrier is 
removed in an ATM-dependent manner for the repair to proceed (Goodarzi et 
al., 2008). However, de novo histone H3K9 methylation has been also shown to 
occur during the response to DNA DSBs (Ayrapetov et al., 2014a).  This 
suggested to us an alternative possibility that H3K9me3 marks associated with 
the late repairing breaks may be a consequence of DDR signalling, rather than 
pre-existing heterochromatin. 
To test that, I combined the H2AX-ChIP/MS method described in Chapter 3 
with heavy methyl SILAC labelling to differentiate between pre-existing and new 
H3K9 methyl marks. Surprisingly, quantification of H3K9me3 on H2AX-
nucleosomes showed no difference in the proportion of this mark in the late 
relative to early time points following IR in 1BR wt, AT1BR and ATMi treated 
1BR. I was not able to consolidate the previous findings from Goodarzi et al., 
(2008), which raises the concern about the use of the DAPI-stained 
chromocenters co-localisation method as a read-out for heterochromatic DSBs. 
This may be due to resolution microscope constraints, i.e. the co-localisation 
between chromocenters and H2AX foci maybe the effect of a poor spatial 
resolution, rather than actual co-localisation.  If correct, these data suggests 
that ATM-dependent late repairing breaks do not originate from heterochromatin 
and the issue underlying the requirement for ATM to repair those breaks is still 
to be determined. Another possibility is that those H2AX regions, although 
originated somewhere else in the genome, somehow became associated with 
the chromocenters following IR. However, to strengthen this conclusion, these 
experiments need to be repeated.   
Furthermore, we did not observe significant differences in the rate of 
methylation at the site of H2AX-nucleosomes as compared to the global 
turnover rate for this mark, suggesting that this modification does not change on 
the H2AX nucleosomes or the change is too small to be sensitively detected by 
this method. However, because the H2AX domains are very large, I may fail to 
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detect any changes in a smaller region at a defined distance from the DSB. 
Thus, I cannot exclude the possibility that this modification may occur at smaller, 
specific sub-domains of H2AX.   
Another possibility may be that this modification changes in the proximity of the 
break where the nucleosomes are depleted of H2AX, and since this system 
relies on the H2AX mark for the enrichment of DSB-associated nucleosomes, 
we would not be able to enrich for them using this method.  
An important constraint for this study was the limited yield of H2AX 
nucleosomes obtained from fibroblast cells and the extensive amount of time to 
grow large enough cultures for H2AX IP. In comparison to HEK293 cell, which 
were used for H2AX IP in the previous chapters, fibroblast cells are much 
larger and slower growing. This means that the cost of these experiments was 
prohibitively large, especially if I aimed to load higher levels of samples. 
Therefore, I have also optimised the conditions for performing these 
experiments in A549 cells, which are faster growing and have a potential of 
yielding higher amounts of sample. However time constraints stopped me 
pursuing further experiments. 
The nature of the late repairing DSBs remains an important unanswered 
question and the method I have used to investigate it has the potential of 
addressing it further. The initial data is thought-provoking and with further 
improvement in the yield of H2AX IP sample this method could be used to 










6 CHAPTER SIX: DEVELOPMENT OF A 


















In vivo proximity biotin labeling of proteins mediated by the E. coli derived biotin 
ligase enzyme, BirA, was previously described by several groups, who have 
used it to identify protein complexes, protein-protein interactions and to label 
sites of UV induced DNA damage (Fernández-Suárez, Chen and Ting, 2008; 
Kulyyassov et al., 2011; Lau and Cheung, 2013; Ma et al., 2013; Shoaib et al., 
2013). In this system, one of the proteins of interest is fused with the BirA biotin 
ligase, while the other is fused with a biotin acceptor peptide (BAP) containing a 
lysine residue in a sequence-specific context, which is amenable to biotinylation 
by BirA in a proximity-dependent manner. It has been shown in previous studies 
that BirA is not able to biotinylate endogenous proteins in mammalian cells; 
conversely mammalian biotin ligases do not recognize BAP (de Boer et al., 
2003; Chen et al., 2005; Howarth et al., 2005). 
The aim of this chapter was to establish an antibody-free system that allowed 
us to specifically label and pull-down chromatin from the site of DNA damage. 
 
6.2 EXPERIMENTAL APPROACH FOR IN VIVO BIOTIN LABELLING OF THE 
NUCLEOSOMES IN PROXIMITY OF DSBS.  
 
A schematic representation of the system to allow biotinylation in vivo is 
presented in Figure 6.1 A. Briefly, upon DNA damage induction and addition of 
biotin to the cell media, the BirA-tagged DDR protein becomes recruited to the 
site of DNA damage, where it can promote the biotinylation of BAP-tagged 
histones. Biotinylated nucleosomes can be than detected and pulled-down 
using streptavidin. 
To test the system, two DDR proteins known to be recruited to the site of breaks, 
RNF168 and 53BP1 were tagged with the BirA biotin ligase (Figure 6.1 B). 









Figure 6.1. Schematic representation of biotinylation system. A) Briefly, 
upon DNA damage induction DDR proteins tagged with BirA will be recruited 
to nucleosomes around the break containing BAP-tagged histones. Lysine 
residue within BAP sequence will be biotinylated by proximal BirA tagged to 
DDR protein. B) Schematic representation of BirA-tagged constructs. C) 







throughout the genome, we decided to fuse this histone with the BAP sequence 
(Figure 6.1 A).  
A previously described BirA-GFP and BAP-H3.1 pair were also used to test the 
method (Kulyyassov et al., 2011). Upon transient co-expression of BirA-GFP 
and BAP-H3.1 in U2OS cells we observed a pan-nuclear pattern of biotin 
staining, consistent with the nuclear localisation of histone H3, suggesting 
specific biotinylation of the BAP-tag (Figure 6.2).  
  
6.3 GENERATION OF CELL LINES STABLY EXPRESSING BAP-TAGGED 
HISTONE H4 
 
The vectors for expression of BirA-RNF168, BirA-53BP1 and 3xFLAG-BAP-H4 
and the method for the generation of the U2OS 3xFLAG-BAP-H4 stable cell line 
are described in the Methods and Materials section 2.1.1 and 2.1.2.  The 
expression of recombinant H4 was confirmed and quantified using 
immunofluorescence screening of selected single clones (Figure 6.3 A and B). 
Since Clone 6 showed the most uniform expression, it was selected for further 
experiments. The expected molecular weight of 3xFLAG-BAP-H4 protein of 17 
kDa was calculated using ProtParam tool (Walker, 2005), and confirmed by 
immunoblotting all cell lysates made from Clone 6 (Figure 6.3 C).  
 
6.4 BIRA-RNF168 LABELS NUCLEOSOMES AT THE SITE OF DSB WITH 
BIOTIN 
 
To follow, I have verified BirA-tagged DDR proteins are recruited to the sites of 
DSBs. To do that, U2OS 3xFLAG-BAP-H4 cells were transiently transfected 
with BirA-6xHis-RNF168 or BirA-6xHis-53BP1 vectors and cultured to grow 24 h 
allowing for expression of the recombinant proteins. DNA DSBs were induced 
with 50 ng/ml neocarzinostatin (NCS), with 1 h recovery time prior to fixation 





Figure 6.2. Test of the two-component biotinylation system. U2OS cells 
were transiently transfected with BirA-GFP and BAP-H3 expression 
plasmids. After 24 h, 50 µM biotin was introduced to the cell media for 5 min 
prior to fixation and visualisation. 
 
 





Figure 6.3. Generation of U2OS 3xFLAG-BAP-H4. A) Representative 
images of six U2OS clones stably expressing H4-BAP-3xFLAG construct. 
The cells were stained using α-FLAG antibody. Images were obtained on 
ScanR microscope (Olympus), 20X magnification B) Quantification of the 
percentage of cells expressing the 3xFLAG-BAP-H4 construct in each clone. 






Nuclear localisation of the recombinant proteins was confirmed by 
immunofluorescence. Furthermore, BirA-tagged proteins were recruited to the 
site of DNA damage, as assessed by co-localisation of the DSB marker, H2AX, 
and the His-tag (Figure 6.4).  
Due to the low transfection efficiency of the BirA-53BP1 construct, further 
experiments were continued using BirA-RNF168.  
 
6.5 BIRA-RNF168 BIOTINYLATES NUCLEOSOMES AT THE SITE OF DSBS  
 
To test whether BirA-tagged RNF168 was able to induce biotinylation at the site 
of DSBs, U2OS 3xFLAG-BAP-H4 cells were transiently transfected with the 
BirA-RNF168 construct as previously described. DSBs were introduced using 
50 ng/µl neocarzinostatin (NCS) treatment, followed by 1h recovery time and 
then 5 min treatment with biotin prior to fixation with formaldehyde.  
We observed a nuclear pattern of biotinylation upon addition of biotin to the 
media in the U2OS 3xFLAG-BAP-H4 cells transfected with the BirA-constructs 
but not in the U2OS wt cells (Figure 6.5). Importantly, biotin foci in the cells 
transfected with BirA-RNF168 co-localised with 53BP1 foci, suggesting specific 
biotinylation of BAP tagged histones around DSBs.  
Biotinylated nucleosomes were then pulled-down with streptavidin coated 
magnetic beads and analysed by immunoblotting.  Upon DNA damage 
induction and biotin treatment, the samples showed enrichment in components 
of the nucleosome, such as H3 and H4, and importantly H2AX, suggesting that 
we are indeed enriching for DSB-associated chromatin (Figure 6.6). However, 
some background biotinylation was also observed. This is due to the fact that 
biotin is an essential vitamin, therefore, cannot be completely depleted from the 
growth media, consequently DSBs caused by endogenous cellular activities 
also get biotinylated upon BirA-RNF168 recruitment.  
Next, I attempted to identify the proteins associated with nucleosomes 




Figure 6.4. Test of BirA-constructs. A and B) Cells were transfected with 
BirA-tagged DNA damage proteins and damaged with 100 ng/µl of NCS. 
After 30 min recovery time, cells were fixed. Immunofluorescence analysis 
shows that both of BirA-tagged constructs localize to the nucleus and are 
recruited to DNA damage-dependent H2AX foci. White arrows show 






Figure 6.5. BirA-RNF 168 biotinylates the chromatin specifically at the site of DSB. Biotinylation at the site of damage does 
not occur in wild type U2OS cells (top panel). U2OS cells stably expressing the 3xFLAG-BAP-H4 construct were transiently 
transfected with BirA-8xHis-GFP (middle panel) or BirA-8xHis-RNF168 (bottom panel). Biotinylation at the site of DSBs depends 





   
Figure 6.6 Biotinylated nucleosomes are enriched in the γH2AX variant 
marker of DSB. 3xFLAG-BAP-H4 U2OS cells were transiently transfected 
with BirA-RNF168 and incubated for 48h. Cells were damaged, or not, with 
NCS and treated, or not, with biotin for 5min. Biotinylated nucleosomes were 
pulled-down with streptavidin-coated magnetic beads. Expected size of the 






were transiently transfected with 3xFLAG-BAP-H4 and with or without BirA-
RNF168. Cells were damaged with 5 Gy X-rays and allowed 1 h recovery time. 
Prior to collection, biotin was introduced to the cell media for 5 min. A 
streptavidin pull-down was performed and the samples obtained in this way 
were run on the SDS-PAGE gel, stained with coomassie blue (Figure 6.7). 
Pulled-down samples were analysed using a DDA MS approach (full list of 
identified proteins and the peptide scores are in the Appendix Table 4). 
Consistent with the idea that we are pulling-down nucleosomes from the site of 
DNA damage, we identified several components of the nucleosome, as well as 



























Figure 6.7 MS analysis of streptavidin pull-down of biotinylated 
nucleosomes. Coomassie staining of streptavidin pull-down form HEK293 
cell transfected with 3xFLAG-BAP-H4 -/+ BirA-RNF168. Marker in the 








Here I have presented as a proof-of-principle, a two-component system for 
the labelling of DNA damage associated nucleosomes. I have shown BirA-
biotin ligase tagged RNF168 and 53BP1 are recruited to the sites of H2AX 
foci, where they induce biotinylation of BAP-tagged histone H4 in a proximity-
dependent manner (Figure 6.4 and Figure 6.5). Streptavidin has been used 
to pull-down biotinylated nucleosomes, and consistent with the idea that 
these nucleosomes are located at the site of DNA damage, they were 
enriched for H2AX (Figure 6.6), as well as other previously described DDR 
factors, such as RNF168 or DNA-PK (Figure 6.7). 
During this work, stable cell lines expressing the biotin acceptor peptide 
fused to H4 (HEK293 and U2OS 3xFLAG-BAP-H4) were produced (Figure 
6.6). Since biotin is an essential vitamin and the cells would be unable to 
grow healthily without it, BirA-tagged components were transiently 
transfected to avoid continuous biotinylation in response to endogenous 
DSBs. This system therefore relies on a high transfection efficiency. 
However, we found that the transfection efficiency varied from experiment to 
experiment (data not shown). Therefore, in future it would be necessary to 
optimise this process in order to be able to produce reproducible data. 
The particular strength of this method is that it does not rely on the use of 
antibodies. In contrast to the S139phos mark on histone H2AX, which is 
removed once repair has been completed, it has been previously shown that 
the biotin label is stable for at least 24 h, suggesting the possibility that 
tracking of the breaks that have been already repaired would be possible, 
and potentially with tracking continued to a daughter cell. This would be 
particularly useful in addressing questions about DNA damage inflicted 
epigenetic scaring, or in other words, can DDR modify chromatin in the way 
that indicates recent repair events.    
As mentioned in the introduction, H2AX is depleted in the immediate 
proximity of the break (1-2 kbp), therefore, it is not possible to map histone 
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modifications associated with those nucleosomes using the H2AX-ChIP 
method described in the Chapter 3. By fusing BirA to different DDR and 
repair proteins, such as Ku70/80 or XRCC4, which are known to be recruited 
only very close to the DNA break, it would be theoretically possible to biotin 


















































7.1 UNDERSTANDING OF MOLECULAR PATHWAYS INVOLVED IN DDR IS 
CLINICALLY RELEVANT 
 
On a daily basis we are exposed to factors that either directly or indirectly are 
able to induce DNA DSBs. A failure to repair them can be very detrimental to 
human health, which is illustrated by the range of pathologies associated 
with deficiencies in factors involved in repair or signalling processes. Some 
of the outcomes of improper repair include gene mutations, which may 
consequently lead to cancer development, or may cause cell death, which 
may be highly impacting if a given cell is a stem cell or post-mitotic neuron, 
as this may contribute to premature aging and neurodegeneration, 
respectively.  
DSB-inducing sources are commonly used in diagnostic medical devices, 
such as X-rays and computed tomography. Importantly, DNA damage-
inducing therapies, such as radiation therapy (RT) or chemotherapeutic 
drugs, for example etoposide, are the most common cancer treatments. 
During these treatments healthy tissue, as well as cancer are exposed to the 
DNA damaging agents.  
In developed countries, more than half of patients with cancer receive RT at 
some stage of disease management (Begg, Stewart and Vens, 2011). A 
small percentage of those patients (~5%) develop severe normal tissue 
toxicity, the mechanism of which is still not exactly clear, but is thought to be 
linked to an intrinsic inability to resolve IR-induced DSBs (Nahas and Gatti, 
2009). Importantly, based on the response of this small subgroup, RT doses 
for all the patients are decreased. Therefore a better understanding of the 
basis for this radiosensitivity would permit the development of predictive tests, 
which would identify these patients and allow dose escalation for well 
responding patients. 
RT induces intricate molecular responses in cells, which may repair the 
break (accurately or inaccurately) or prevent propagation of the damage by 
inducting cellular senesce or apoptosis. Since the DNA repair machinery is 
often compromised in cancer cells, they are frequently more susceptible to 
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the toxic effects of DSBs, leading to cell death and tumour shrinkage. As 
opposed to cancer cells, healthy tissue has been shown to be more efficient 
in accurately repairing DNA damage. However, repair capacity has been 
shown to be dependent on the damage dose, as well as age, gender and 
genetic background. While highly successful, RT has been shown to 
significantly increase the risk of development of secondary malignancies. 
Even exposure to very low doses of IR has been shown to be associated 
with increase in cancer risk and  the higher the accumulated dose, the 
greater risk of the cancer development (Mole, 1990; Leuraud et al., 2015). 
The faithful repair of DNA damage in healthy tissue is crucial to genomic 
integrity. Significant collective effort is going into the elucidating steps and 
factors involved in the repair and DDR. Improved understanding of molecular 
responses underlying these pathways is essential to promote the design of 
improved cancer therapies, and to advance the efficacy of RT.  
 
7.2 REQUIREMENT FOR A NEW METHOD TO EXAMINE THE CHROMATIN 
RESPONSE TO DSBS 
 
The discovery of DNA damage induced phosphorylation of the histone 
variant H2AX gave rise to a new area of research interest in the field of the 
DDR and repair, bringing about the realisation that chromatin plays an 
integral role in mediating these processes. Since that initial discovery, 
multiple reports have implicated a plethora of histone residues in the cellular 
response to DSBs, suggesting that dramatic remodelling of the chromatin is 
an essential part of the repair process (Hunt et al., 2013). However, 
conflicting reports can be found for many of these marks. 
One possible explanation for these discrepancies could be the use of 
antibodies. Owing to the nature of histone proteins being heavily modified, 
antibodies to histone modifications have often been shown to struggle with 
the recognition of their intended target, potentially due to epitope obstruction 
or to the antibody being biased to recognise the epitope only within a specific 
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PTM pattern. Additionally, the low throughput capabilities of antibody-based 
approaches constitute a major issue when studying multiple modifications 
simultaneously. This prompted us to develop a new method for investigation 
of histone modifications at the site of DNA damage, which I have presented 
in this thesis.  
 
7.3 IR DOES NOT INDUCE SIGNIFICANT CHANGES IN THE MAJORITY OF 
PTMS ON HISTONE H3 AND H4 
 
In Chapter 3 I have presented a novel method to study DSB associated 
histone PTMs. In this approach, a highly specific antibody to H2AX was 
used to recover nucleosomes flanking DSBs induced with IR. Using a 
targeted MS method, I was able to sensitively detect and quantify multiple 
histone peptides in a single run to gain insight into the temporal, as well as 
dose-dependent, dynamics of histone PTMs associated with IR-induced 
H2AX-nucleosomes. I was able to show that the majority of the associated 
histone PTMs remain stable over the large H2AX domains.   
Interestingly, these  results corroborate those found with recent ChIP studies, 
where it was found that H2AX is the major histone PTM changing over large 
(up to 1 Mbp) regions flanking the breaks (Clouaire et al., 2018). However, 
they found few changes happening over smaller regions, suggesting our 
H2AX-ChIP/MS is perhaps not sensitive enough to detect them.  
However, while this method has the advantage that it provides an average 
view over multiple DSBs, a disadvantage is that I cannot exclude the 
possibility that some of these changes may occur at a specific subset of 
breaks, or at regions much smaller than H2AX, i.e. if DNA damage induces 
the changes in the PTMs that do not spread as extensively as H2AX, there 
is a possibility that we would not be able to sensitively detect those changes. 
Similarly, since H2AX is depleted near the site of break, the PTMs in these 
regions cannot be quantified using H2AX-ChIP. In addition to that, we 
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cannot also exclude the possibility that some of the chromatin changes may 
occur in larger domains devoid of H2AX. To address that, an in vivo 
biotinylation system presented in Chapter 6 could theoretically be used to 
also pull down non-H2AX nucleosomes associated with DSBs. Additionally, 
by tagging DDR and repair proteins with BirA known to be recruited only near 
the sites of breaks (e.g. Ku70/80 or XRCC4), we could label the 
nucleosomes directly flanking the break, permitting us to analyse these 
regions. In the future, this method could be also combined with cross-linking 
to identify novel histone PTMs and components of the repair complexes. 
 
7.4 H2A(X) K15UB AS THE MAJOR PTM INDUCED ON H2AX-
NUCLEOSOMES IN RESPONSE TO IR AND ITS CLINICAL 
SIGNIFICANCE  
 
The main modification we observed on the H2AX-nucleosomes was 
ubiquitination of H2A(X) K15. The increase in the K15Ub mark was several 
fold higher on the H2AX-nucleosomes compared to the global level of this 
mark, suggesting that this mark is specifically induced at the site of damage. 
I found that H2AX-like K15 was ubiquitinated faster than H2A K15. 
Importantly, I showed that the ubiquitination response is non-linear with 
respect to dose since it gets saturated following exposure to doses as low as 
in the range 2-3 Gy, and the amount of H2A(X) K15Ub diminishes per H2AX 
with increasing doses of IR. 
These observations have an important implication when considering high 
dose exposures such as the doses received during radiotherapy.  It has been 
observed that at high IR doses, damaged cells struggle to recruit 53BP1, 
resulting in a switch from error-free RAD51-dependent homology-dependent 
repair to the more mutagenic RAD52-dependent SSA pathway, suggesting 
that 53BP1 is required for RAD51 foci formation and HR (Ochs et al., 2016). 
However, 53BP1, the recruitment of which requires H2AK15Ub, is also 
required to promote c-NHEJ, potentially affecting the fidelity of DSB re-
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joining. Dose fractionation during RT is known to enhance the normal tissue 
response to radiation and, in cellular studies, dose splitting or low dose rate 
radiation is also known to enhance survival (Bedford and Cornforth, 1987). In 
these cellular studies using G0/G1 cells where only c-NHEJ takes place, the 
number of chromosomal translocations closely parallels survival and dose 
splitting diminishes translocation events and enhances survival. C-NHEJ 
proteins are abundant and re-joining occurs efficiently even at high doses 
(Bedford and Cornforth, 1987; Cornforth and Bedford, 1987). This raises the 
possibility that chromatin changes (including PTMs) at the DSB site function 
to prevent translocations and that at higher doses a critical factor becomes 
limiting. Our findings raise the possibility that H2AK15Ub could be the PTM 
that is limiting at higher doses. Interestingly, standard RT protocols deliver 
daily fractions of 2 Gy, a dose which appears to lie in the linear dose 
response range for H2AK15Ub.   
 
7.5 ATM-DEPENDENT LATE REPAIRING BREAKS ARE NOT ENRICHED IN 
H3K9ME3 MARKS IN HUMAN CELLS 
 
Whilst the majority of IR induced DSBs are repaired within the first 2 h after 
damage induction, there is a subset of slow repairing DSBs, which requires 
ATM kinase activity. Previous studies in murine cells showed that these 
ATM-dependent breaks are associated with heterochromatin (Goodarzi et al., 
2008). It was suggested that heterochromatin poses a barrier to the repair 
process and that it needs to be de-condensed to allow efficient recruitment of 
the repair machinery and subsequent repair. It has been also shown that 
chromatin compaction occurs shortly after damage induction (Ayrapetov et 
al., 2014). Therefore we have questioned whether the ATM-dependent, late 
repairing breaks really originate in heterochromatin, or whether they could 
become heterochromatinised as a result of the DDR. 
Surprisingly, my preliminary data indicates that in human cells these late 
repairing breaks are not associated with heterochromatin per se. This 
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assumption is based on the fact that I did not observe enrichment in 
H3K9me2/3 at the late, as compared to early, repairing breaks. Furthermore, 
using the heavy methyl SILAC labelling method to monitor the turnover of the 
methylation of H3K9 residue, I found no significant difference between 
methylation at DSBs as compared to the global rate of turnover of this mark.  
DSBs within other chromatin types have also been proposed to require ATM 
function for their repair. Recent reports suggest that DSBs in regions of 
active transcription marked by H3K36me3 also show delayed repair kinetics, 
raising a possibility that they may also contribute to the slow DSB repair 
component (Aymard et al., 2017). Interestingly, the antibody used to detect 
H3K9me3 in both, Goodarzi et al. (2008) and Ayrapetov et al., (2014), has 
been shown to cross-react with other tri-methylated histone residues, 
including H3K4me3, H3K36me3 and H4K20me3 (The Histone Antibody 
Specificity Database, (Rothbart et al., 2015). This raises the possibility that 
the apparent increase in H3K9me3 at the site of a DSB may, in fact, be an 
artefact of the antibody used. 
ATM has also been shown to be required for the repair of breaks with ends 
blocked by covalent links and hairpin structures (Barlow et al., 1997; 
Bredemeyer et al., 2006; Álvarez-Quilón et al., 2014; Katyal et al., 2014). 
This suggests that difficult to repair break ends may also require ATM-
dependent damage response, further contributing to the list of break-types 
requiring ATM.  
Due to time constraints, at this stage I was not able to determine whether 
other types of chromatin, such as facultative heterochromatin or 
transcriptionally active chromatin are associated with those breaks. 
Therefore, the question of whether specific types of chromatin may require 
ATM for the repair of DSBs still remains open and additional work is clearly 
required to understand its role in repair. The H2AX-ChIP/MS method 







In summary, I have developed and optimised novel methods for the 
enrichment, detection and quantification of histone post-translational marks 
associated with DSBs. I have used a H2AX-ChIP/MS approach to 
demonstrate that H2AK15Ub is the major histone mark changing at DSBs. I 
have characterised the changes in H2AK15Ub and showed that it does not 
arise linearly with dose but becomes saturated at high doses. This could be 
explained by recent findings reporting that the ubiquitin ligase, RNF168, 
which deposits K15Ub becomes saturated at higher doses. Furthermore, I 
have discussed clinically relevant implications of this finding. Additionally, I 
have used this method to quantify histone H3K9 modifications in ATM 
deficient cells. The preliminary data from these experiments was contrary to 
what is currently believed, that ATM-dependent late repairing DSBs are not 
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HIST2H3A T[+56]K[+42]QTAR 401.7427 2 precursor K4me3 
HIST2H3A T[+56]K[+42]QTAR 401.7427 2 precursor 
[M+1] 
K4me3 
HIST2H3A T[+56]K[+42]QTAR 401.7427 2 precursor 
[M+2] 
K4me3 
HIST2H3A T[+56]K[+42]QTAR 401.7427 2 y4 K4me3 
HIST2H3A T[+56]K[+42]QTAR 401.7427 2 y1 K4me3 
HIST2H3A T[+56]K[+42]QTAR 401.7427 2 b1 K4me3 
HIST2H3A T[+56]K[+42]QTAR 401.7427 2 b3 K4me3 
232 
 
HIST2H3A T[+56]K[+42]QTAR 401.7427 2 b4 K4me3 
HIST2H3A T[+56]K[+42]QTAR 401.7427 2 b5 K4me3 
HIST2H3A T[+56]K[+28]QTAR 394.7348
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2 y4 K4me2 
HIST2H3A T[+56]K[+28]QTAR 394.7348
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2 y1 K4me2 
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2 b1 K4me2 
HIST2H3A T[+56]K[+28]QTAR 394.7348
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2 b3 K4me2 
HIST2H3A T[+56]K[+28]QTAR 394.7348
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2 b4 K4me2 
HIST2H3A T[+56]K[+28]QTAR 394.7348
8 
2 b5 K4me2 
HIST2H3A T[+56]K[+56]QTAR 816.4573
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1 y5 K4me0 
HIST2H3A T[+56]K[+56]QTAR 816.4573
9 
1 y3 K4me0 
HIST2H3A T[+56]K[+56]QTAR 816.4573
9 
1 y2 K4me0 
HIST2H3A T[+56]K[+56]QTAR 816.4573
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1 b2 K4me0 
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1 b2 -18 K4me0 
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1 b3 -18 K4me0 
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1 b4 -18 K4me0 
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1 b5 K4me0 
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1 b5 -18 K4me0 
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1 y3 K4me1 
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HIST2H3A K[+112.1]STGGK[+42]APR 528.2958
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2 y8 K9unmodK14Ac 
HIST2H3A K[+112.1]STGGK[+42]APR 528.2958
3 
2 y7 K9unmodK14Ac 
HIST2H3A K[+112.1]STGGK[+42]APR 528.2958
3 
2 y6 K9unmodK14Ac 
HIST2H3A K[+112.1]STGGK[+42]APR 528.2958
3 
2 y5 K9unmodK14Ac 
HIST2H3A K[+112.1]STGGK[+42]APR 528.2958
3 
2 b1 K9unmodK14Ac 
HIST2H3A K[+112.1]STGGK[+42]APR 528.2958
3 
2 b2 K9unmodK14Ac 
HIST2H3A K[+112.1]STGGK[+42]APR 528.2958
3 
2 b3 K9unmodK14Ac 
HIST2H3A K[+112.1]STGGK[+42]APR 528.2958
3 
2 b4 K9unmodK14Ac 
HIST2H3A K[+112.1]STGGK[+56]APR 535.3036
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2 y8 K9unmodK14unmod 
HIST2H3A K[+112.1]STGGK[+56]APR 535.3036
6 
2 y7 K9unmodK14unmod 
HIST2H3A K[+112.1]STGGK[+56]APR 535.3036
6 
2 y6 K9unmodK14unmod 
HIST2H3A K[+112.1]STGGK[+56]APR 535.3036
6 
2 y5 K9unmodK14unmod 
HIST2H3A K[+112.1]STGGK[+56]APR 535.3036
6 
2 y3 K9unmodK14unmod 
HIST2H3A K[+112.1]STGGK[+56]APR 535.3036
6 
2 y2 K9unmodK14unmod 
HIST2H3A K[+112.1]STGGK[+56]APR 535.3036
6 
2 b1 K9unmodK14unmod 
HIST2H3A K[+112.1]STGGK[+56]APR 535.3036
6 
2 b2 K9unmodK14unmod 
HIST2H3A K[+112.1]STGGK[+56]APR 535.3036
6 
2 b6 K9unmodK14unmod 
HIST2H3A K[+112.1]STGGK[+56]APR 535.3036
6 
2 b7 K9unmodK14unmod 
HIST2H3A K[+126.1]STGGK[+42]APR 535.3036
6 













2 y8 K9me1K14Ac 
HIST2H3A K[+126.1]STGGK[+42]APR 535.3036
6 
2 y7 K9me1K14Ac 
HIST2H3A K[+126.1]STGGK[+42]APR 535.3036
6 
2 y6 K9me1K14Ac 
HIST2H3A K[+126.1]STGGK[+42]APR 535.3036
6 
2 y5 K9me1K14Ac 
HIST2H3A K[+126.1]STGGK[+42]APR 535.3036
6 
2 y3 K9me1K14Ac 
HIST2H3A K[+126.1]STGGK[+42]APR 535.3036
6 
2 y2 K9me1K14Ac 
HIST2H3A K[+126.1]STGGK[+42]APR 535.3036
6 
2 b1 K9me1K14Ac 
HIST2H3A K[+126.1]STGGK[+42]APR 535.3036
6 
2 b2 K9me1K14Ac 
HIST2H3A K[+126.1]STGGK[+42]APR 535.3036
6 
2 b6 K9me1K14Ac 
HIST2H3A K[+126.1]STGGK[+42]APR 535.3036
6 
2 b7 K9me1K14Ac 
HIST2H3A K[+126.1]STGGK[+56]APR 542.3114
8 
2 precursor K9me1K14unmod 











2 y8 K9me1K14unmod 
HIST2H3A K[+126.1]STGGK[+56]APR 542.3114
8 
2 y7 K9me1K14unmod 
HIST2H3A K[+126.1]STGGK[+56]APR 542.3114
8 
2 y6 K9me1K14unmod 
HIST2H3A K[+126.1]STGGK[+56]APR 542.3114
8 
2 y5 K9me1K14unmod 
HIST2H3A K[+126.1]STGGK[+56]APR 542.3114
8 
2 y3 K9me1K14unmod 
HIST2H3A K[+126.1]STGGK[+56]APR 542.3114
8 
2 y2 K9me1K14unmod 
HIST2H3A K[+126.1]STGGK[+56]APR 542.3114
8 
2 b1 K9me1K14unmod 
HIST2H3A K[+126.1]STGGK[+56]APR 542.3114
8 
2 b2 K9me1K14unmod 
HIST2H3A K[+126.1]STGGK[+56]APR 542.3114
8 
2 b6 K9me1K14unmod 
HIST2H3A K[+126.1]STGGK[+56]APR 542.3114
8 
2 b7 K9me1K14unmod 
HIST2H3A K[+84.1]STGGK[+42]APR 514.2983
7 













2 y8 K9me2K14Ac 
HIST2H3A K[+84.1]STGGK[+42]APR 514.2983
7 
2 y7 K9me2K14Ac 
HIST2H3A K[+84.1]STGGK[+42]APR 514.2983
7 
2 y6 K9me2K14Ac 
HIST2H3A K[+84.1]STGGK[+42]APR 514.2983
7 
2 y5 K9me2K14Ac 
HIST2H3A K[+84.1]STGGK[+42]APR 514.2983
7 
2 y3 K9me2K14Ac 
HIST2H3A K[+84.1]STGGK[+42]APR 514.2983
7 
2 y2 K9me2K14Ac 
HIST2H3A K[+84.1]STGGK[+42]APR 514.2983
7 
2 b1 K9me2K14Ac 
HIST2H3A K[+84.1]STGGK[+42]APR 514.2983
7 
2 b2 K9me2K14Ac 
HIST2H3A K[+84.1]STGGK[+42]APR 514.2983
7 
2 b6 K9me2K14Ac 
HIST2H3A K[+84.1]STGGK[+42]APR 514.2983
7 
2 b7 K9me2K14Ac 
HIST2H3A K[+84.1]STGGK[+42]APR 514.2983
7 
2 b8 K9me2K14Ac 
HIST2H3A K[+84.1]STGGK[+56]APR 521.3062 2 precursor K9me2K14unmod 
HIST2H3A K[+84.1]STGGK[+56]APR 521.3062 2 precursor 
[M+1] 
K9me2K14unmod 
HIST2H3A K[+84.1]STGGK[+56]APR 521.3062 2 precursor 
[M+2] 
K9me2K14unmod 
HIST2H3A K[+84.1]STGGK[+56]APR 521.3062 2 y8 K9me2K14unmod 
HIST2H3A K[+84.1]STGGK[+56]APR 521.3062 2 y7 K9me2K14unmod 
HIST2H3A K[+84.1]STGGK[+56]APR 521.3062 2 y6 K9me2K14unmod 
HIST2H3A K[+84.1]STGGK[+56]APR 521.3062 2 y5 K9me2K14unmod 
HIST2H3A K[+84.1]STGGK[+56]APR 521.3062 2 y3 K9me2K14unmod 
HIST2H3A K[+84.1]STGGK[+56]APR 521.3062 2 y2 K9me2K14unmod 
HIST2H3A K[+84.1]STGGK[+56]APR 521.3062 2 b1 K9me2K14unmod 
HIST2H3A K[+84.1]STGGK[+56]APR 521.3062 2 b2 K9me2K14unmod 
HIST2H3A K[+84.1]STGGK[+56]APR 521.3062 2 b6 K9me2K14unmod 
HIST2H3A K[+84.1]STGGK[+56]APR 521.3062 2 b7 K9me2K14unmod 
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HIST2H3A K[+84.1]STGGK[+56]APR 521.3062 2 b8 K9me2K14unmod 
HIST2H3A K[+98]STGGK[+42]APR 521.2880
1 













2 y8 K9AcK14Ac 
HIST2H3A K[+98]STGGK[+42]APR 521.2880
1 
2 y7 K9AcK14Ac 
HIST2H3A K[+98]STGGK[+42]APR 521.2880
1 
2 y6 K9AcK14Ac 
HIST2H3A K[+98]STGGK[+42]APR 521.2880
1 
2 y5 K9AcK14Ac 
HIST2H3A K[+98]STGGK[+42]APR 521.2880
1 
2 y4 K9AcK14Ac 
HIST2H3A K[+98]STGGK[+42]APR 521.2880
1 
2 y2 K9AcK14Ac 
HIST2H3A K[+98]STGGK[+42]APR 521.2880
1 
2 b1 K9AcK14Ac 
HIST2H3A K[+98]STGGK[+42]APR 521.2880
1 
2 b2 K9AcK14Ac 
HIST2H3A K[+98]STGGK[+42]APR 521.2880
1 
2 b6 K9AcK14Ac 
HIST2H3A K[+98]STGGK[+42]APR 521.2880
1 
2 b7 K9AcK14Ac 
HIST2H3A K[+98]STGGK[+42]APR 521.2880
1 
2 b8 K9AcK14Ac 
HIST2H3A K[+98]STGGK[+56]APR 528.2958
3 













2 y8 K9AcK14unmod 
HIST2H3A K[+98]STGGK[+56]APR 528.2958
3 
2 y7 K9AcK14unmod 
HIST2H3A K[+98]STGGK[+56]APR 528.2958
3 
2 y6 K9AcK14unmod 
HIST2H3A K[+98]STGGK[+56]APR 528.2958
3 
2 y5 K9AcK14unmod 
HIST2H3A K[+98]STGGK[+56]APR 528.2958
3 
2 b1 K9AcK14unmod 
HIST2H3A K[+98]STGGK[+56]APR 528.2958
3 
2 b2 K9AcK14unmod 
HIST2H3A K[+98]STGGK[+56]APR 528.2958
3 
2 b3 K9AcK14unmod 
HIST2H3A K[+98]STGGK[+56]APR 528.2958
3 
2 b4 K9AcK14unmod 
HIST2H3A K[+98.1]STGGK[+42]APR 521.3062 2 precursor K9me3K14Ac 
HIST2H3A K[+98.1]STGGK[+42]APR 521.3062 2 precursor 
[M+1] 
K9me3K14Ac 
HIST2H3A K[+98.1]STGGK[+42]APR 521.3062 2 precursor 
[M+2] 
K9me3K14Ac 
HIST2H3A K[+98.1]STGGK[+42]APR 521.3062 2 y8 K9me3K14Ac 
HIST2H3A K[+98.1]STGGK[+42]APR 521.3062 2 y7 K9me3K14Ac 
HIST2H3A K[+98.1]STGGK[+42]APR 521.3062 2 y6 K9me3K14Ac 
HIST2H3A K[+98.1]STGGK[+42]APR 521.3062 2 y5 K9me3K14Ac 
HIST2H3A K[+98.1]STGGK[+42]APR 521.3062 2 y3 K9me3K14Ac 
HIST2H3A K[+98.1]STGGK[+42]APR 521.3062 2 y2 K9me3K14Ac 
HIST2H3A K[+98.1]STGGK[+42]APR 521.3062 2 b2 K9me3K14Ac 
HIST2H3A K[+98.1]STGGK[+42]APR 521.3062 2 b6 K9me3K14Ac 
HIST2H3A K[+98.1]STGGK[+42]APR 521.3062 2 b7 K9me3K14Ac 


















2 y8 K9me3K14unmod 
HIST2H3A K[+98.1]STGGK[+56]APR 528.3140
2 
2 y7 K9me3K14unmod 
HIST2H3A K[+98.1]STGGK[+56]APR 528.3140
2 
2 y6 K9me3K14unmod 
HIST2H3A K[+98.1]STGGK[+56]APR 528.3140
2 
2 y5 K9me3K14unmod 
HIST2H3A K[+98.1]STGGK[+56]APR 528.3140
2 
2 y3 K9me3K14unmod 
HIST2H3A K[+98.1]STGGK[+56]APR 528.3140
2 
2 y2 K9me3K14unmod 
HIST2H3A K[+98.1]STGGK[+56]APR 528.3140
2 
2 b2 K9me3K14unmod 
HIST2H3A K[+98.1]STGGK[+56]APR 528.3140
2 
2 b4 K9me3K14unmod 
HIST2H3A K[+98.1]STGGK[+56]APR 528.3140
2 
2 b6 K9me3K14unmod 
HIST2H3A K[+98.1]STGGK[+56]APR 528.3140
2 
2 b7 K9me3K14unmod 
HIST2H3A K[+98.1]STGGK[+56]APR 528.3140
2 
2 b8 K9me3K14unmod 
HIST2H3A K[+112.1]QLATK[+42]AAR 570.8404
1 













2 y8 K18unmodK23Ac 
HIST2H3A K[+112.1]QLATK[+42]AAR 570.8404
1 
2 y7 K18unmodK23Ac 
HIST2H3A K[+112.1]QLATK[+42]AAR 570.8404
1 
2 y6 K18unmodK23Ac 
HIST2H3A K[+112.1]QLATK[+42]AAR 570.8404
1 
2 y5 K18unmodK23Ac 
HIST2H3A K[+112.1]QLATK[+42]AAR 570.8404
1 
2 b1 K18unmodK23Ac 
HIST2H3A K[+112.1]QLATK[+42]AAR 570.8404
1 
2 b3 K18unmodK23Ac 
HIST2H3A K[+112.1]QLATK[+56]AAR 577.8482
3 













2 y8 K18unmodK23unmod 
HIST2H3A K[+112.1]QLATK[+56]AAR 577.8482
3 
2 y6 K18unmodK23unmod 
HIST2H3A K[+112.1]QLATK[+56]AAR 577.8482
3 
2 y5 K18unmodK23unmod 
HIST2H3A K[+112.1]QLATK[+56]AAR 577.8482
3 
2 b1 K18unmodK23unmod 
HIST2H3A K[+112.1]QLATK[+56]AAR 577.8482
3 
2 b3 K18unmodK23unmod 
HIST2H3A K[+126.1]QLATK[+42]AAR 577.8482
3 













2 y8 K18me1K23Ac 
HIST2H3A K[+126.1]QLATK[+42]AAR 577.8482
3 
2 y6 K18me1K23Ac 






2 b1 K18me1K23Ac 
HIST2H3A K[+126.1]QLATK[+42]AAR 577.8482
3 
2 b3 K18me1K23Ac 
HIST2H3A K[+126.1]QLATK[+56]AAR 584.8560
6 













2 y8 Precursor K18me1K23un 
HIST2H3A K[+126.1]QLATK[+56]AAR 584.8560
6 
2 y6 Precursor K18me1K23un 
HIST2H3A K[+126.1]QLATK[+56]AAR 584.8560
6 
2 y5 Precursor K18me1K23un 
HIST2H3A K[+126.1]QLATK[+56]AAR 584.8560
6 
2 b1 Precursor K18me1K23un 
HIST2H3A K[+126.1]QLATK[+56]AAR 584.8560
6 
2 b3 Precursor K18me1K23un 
HIST2H3A K[+98]QLATK[+42]AAR 563.8325
8 













2 y8 Precursor K18AcK23Ac 
HIST2H3A K[+98]QLATK[+42]AAR 563.8325
8 
2 y6 Precursor K18AcK23Ac 
HIST2H3A K[+98]QLATK[+42]AAR 563.8325
8 
2 y5 Precursor K18AcK23Ac 
HIST2H3A K[+98]QLATK[+42]AAR 563.8325
8 
2 b1 Precursor K18AcK23Ac 
HIST2H3A K[+98]QLATK[+42]AAR 563.8325
8 
2 b3 Precursor K18AcK23Ac 
HIST2H3A K[+98]QLATK[+56]AAR 570.8404
1 













2 y8 K18AcK23unmod 
HIST2H3A K[+98]QLATK[+56]AAR 570.8404
1 
2 y6 K18AcK23unmod 
HIST2H3A K[+98]QLATK[+56]AAR 570.8404
1 
2 y5 K18AcK23unmod 
HIST2H3A K[+98]QLATK[+56]AAR 570.8404
1 
2 b1 K18AcK23unmod 
HIST2H3A K[+98]QLATK[+56]AAR 570.8404
1 







































3 b1 k27unmodK36me2 
HIST2H3A K[+112.1]SAPATGGVK[+42]K[+
56]PHR 
548.6579 3 precursor K27unmodK36me3 
HIST2H3A K[+112.1]SAPATGGVK[+42]K[+
56]PHR 












548.6579 3 y13 K27unmodK36me3 
HIST2H3A K[+112.1]SAPATGGVK[+42]K[+
56]PHR 
548.6579 3 y12 K27unmodK36me3 
HIST2H3A K[+112.1]SAPATGGVK[+42]K[+
56]PHR 
548.6579 3 y11 K27unmodK36me3 
HIST2H3A K[+112.1]SAPATGGVK[+42]K[+
56]PHR 







































































































2 y11 K27unmodK36me1 
HIST2H3A K[+126.1]SAPATGGVK[+28]K[+
56]PHR 
548.6579 3 precursor K27me1K36me2 
HIST2H3A K[+126.1]SAPATGGVK[+28]K[+
56]PHR 










548.6579 3 y13 K27me1K36me2 
HIST2H3A K[+126.1]SAPATGGVK[+28]K[+
56]PHR 
548.6579 3 y12 K27me1K36me2 
HIST2H3A K[+126.1]SAPATGGVK[+28]K[+
56]PHR 
548.6579 3 y11 K27me1K36me2 
HIST2H3A K[+126.1]SAPATGGVK[+28]K[+
56]PHR 
548.6579 3 b1 K27me1K36me2 
HIST2H3A K[+126.1]SAPATGGVK[+28]K[+
56]PHR 





























3 y12 K27me1K36me3 













































































2 y11 K27me1K36unmod 
HIST2H3A K[+126.1]SAPATGGVK[+70]K[+
56]PHR 
843.4885 2 precursor K27me1K36me1 
HIST2H3A K[+126.1]SAPATGGVK[+70]K[+
56]PHR 










843.4885 2 y13 K27me1K36me1 
HIST2H3A K[+126.1]SAPATGGVK[+70]K[+
56]PHR 
843.4885 2 y11 K27me1K36me1 
HIST2H3A K[+126.1]SAPATGGVK[+70]K[+
56]PHR 
843.4885 2 y9 K27me1K36me1 
HIST2H3A K[+126.1]SAPATGGVK[+70]K[+
56]PHR 
843.4885 2 y8 K27me1K36me1 
HIST2H3A K[+126.1]SAPATGGVK[+70]K[+
56]PHR 
843.4885 2 y5 K27me1K36me1 
HIST2H3A K[+126.1]SAPATGGVK[+70]K[+
56]PHR 
843.4885 2 y4 K27me1K36me1 
HIST2H3A K[+126.1]SAPATGGVK[+70]K[+
56]PHR 
843.4885 2 y3 K27me1K36me1 
HIST2H3A K[+126.1]SAPATGGVK[+70]K[+
56]PHR 
843.4885 2 y13 K27me1K36me1 
HIST2H3A K[+126.1]SAPATGGVK[+70]K[+
56]PHR 


























































































































































3 b10 K27me2K36unmod 
HIST2H3A K[+84.1]SAPATGGVK[+70]K[+5
6]PHR 
548.6579 3 precursor K27me2K36me1 
HIST2H3A K[+84.1]SAPATGGVK[+70]K[+5
6]PHR 










548.6579 3 y5 K27me2K36me1 
HIST2H3A K[+84.1]SAPATGGVK[+70]K[+5
6]PHR 
548.6579 3 y4 K27me2K36me1 
HIST2H3A K[+84.1]SAPATGGVK[+70]K[+5
6]PHR 
548.6579 3 y3 K27me2K36me1 
HIST2H3A K[+84.1]SAPATGGVK[+70]K[+5
6]PHR 
548.6579 3 b3 K27me2K36me1 
HIST2H3A K[+84.1]SAPATGGVK[+70]K[+5
6]PHR 
548.6579 3 b8 K27me2K36me1 
HIST2H3A K[+84.1]SAPATGGVK[+70]K[+5
6]PHR 
548.6579 3 b9 K27me2K36me1 
HIST2H3A K[+84.1]SAPATGGVK[+70]K[+5
6]PHR 
548.6579 3 b10 K27me2K36me1 
HIST2H3A K[+84.1]SAPATGGVK[+70]K[+5
6]PHR 







































3 b4 K27me3K36me2 













3 b9 K27me3K36me2 
HIST2H3A K[+98.1]SAPATGGVK[+56]K[+5
6]PHR 
548.6579 3 precursor K27me3K36unmod 
HIST2H3A K[+98.1]SAPATGGVK[+56]K[+5
6]PHR 










548.6579 3 y5 K27me3K36unmod 
HIST2H3A K[+98.1]SAPATGGVK[+56]K[+5
6]PHR 
548.6579 3 y4 K27me3K36unmod 
HIST2H3A K[+98.1]SAPATGGVK[+56]K[+5
6]PHR 
548.6579 3 y3 K27me3K36unmod 
HIST2H3A K[+98.1]SAPATGGVK[+56]K[+5
6]PHR 
548.6579 3 y8 K27me3K36unmod 
HIST2H3A K[+98.1]SAPATGGVK[+56]K[+5
6]PHR 
548.6579 3 b3 K27me3K36unmod 
HIST2H3A K[+98.1]SAPATGGVK[+56]K[+5
6]PHR 
548.6579 3 b5 K27me3K36unmod 
HIST2H3A K[+98.1]SAPATGGVK[+56]K[+5
6]PHR 
548.6579 3 b6 K27me3K36unmod 
HIST2H3A K[+98.1]SAPATGGVK[+56]K[+5
6]PHR 
548.6579 3 b8 K27me3K36unmod 
HIST2H3A K[+98.1]SAPATGGVK[+56]K[+5
6]PHR 
548.6579 3 b11 K27me3K36unmod 
HIST2H3A K[+98.1]SAPATGGVK[+56]K[+5
6]PHR 
548.6579 3 b12 K27me3K36unmod 
HIST2H3A K[+98.1]SAPATGGVK[+56]K[+5
6]PHR 










































































3 b9 K27me3K36me1 
HIST2H3A EIAQDFK[+56]TDLR 696.3619 2 precursor control K79unmod 
missed2ndprop unmod 








HIST2H3A EIAQDFK[+56]TDLR 696.3619 2 y9 control K79unmod 
missed2ndprop unmod 
HIST2H3A EIAQDFK[+56]TDLR 696.3619 2 y7 control K79unmod 
missed2ndprop unmod 




HIST2H3A EIAQDFK[+56]TDLR 696.3619 2 y4 control K79unmod 
missed2ndprop unmod 
HIST2H3A EIAQDFK[+56]TDLR 696.3619 2 y2 control K79unmod 
missed2ndprop unmod 

















2 y9 K79me2 
HIST2H3A E[+56]IAQDFK[+28]TDLR 710.3775
5 
2 y7 K79me2 
HIST2H3A E[+56]IAQDFK[+28]TDLR 710.3775
5 
2 y6 K79me2 
HIST2H3A E[+56]IAQDFK[+28]TDLR 710.3775
5 
2 y2 K79me2 
HIST2H3A E[+56]IAQDFK[+28]TDLR 710.3775
5 
2 b7 K79me2 
HIST2H3A E[+56]IAQDFK[+28]TDLR 710.3775
5 
2 b9 K79me2 
HIST2H3A E[+56]IAQDFK[+56]TDLR 724.3750
1 













2 y8 K79unmod 
HIST2H3A E[+56]IAQDFK[+56]TDLR 724.3750
1 
2 y7 K79unmod 
HIST2H3A E[+56]IAQDFK[+56]TDLR 724.3750
1 
2 y6 K79unmod 
HIST2H3A E[+56]IAQDFK[+56]TDLR 724.3750
1 
2 y5 K79unmod 
HIST2H3A E[+56]IAQDFK[+56]TDLR 724.3750
1 
2 y4 K79unmod 
HIST2H3A E[+56]IAQDFK[+56]TDLR 724.3750
1 
2 b7 K79unmod 
HIST2H3A E[+56]IAQDFK[+70]TDLR 731.3828
3 













2 y8 K79me1 
HIST2H3A E[+56]IAQDFK[+70]TDLR 731.3828
3 
2 y7 K79me1 
HIST2H3A E[+56]IAQDFK[+70]TDLR 731.3828
3 
2 y6 K79me1 
HIST2H3A E[+56]IAQDFK[+70]TDLR 731.3828
3 
2 y4 K79me1 
HIST2H3A E[+56]IAQDFK[+70]TDLR 731.3828
3 
2 y2 K79me1 
HIST2H3A E[+56]IAQDFK[+70]TDLR 731.3828
3 


































2 b5 GK-H2A control 4-11 
HIST1H2AB H2AFM; G[+56]K[+56]QGGK[+56]AR 485.2774 2 b6 GK-H2A control 4-11 
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2 y1 KGNYSER 
H2AFX G[+56]K[+56]TGGK[+56]AR 471.7719
9 










GK-H2AX control 4-11 
H2AFX G[+56]K[+56]TGGK[+56]AR 471.7719
9 
2 b2 GK-H2AX control 4-11 
H2AFX G[+56]K[+56]TGGK[+56]AR 471.7719
9 
2 b3 GK-H2AX control 4-11 
H2AFX G[+56]K[+56]TGGK[+56]AR 471.7719
9 
2 b5 GK-H2AX control 4-11 
H2AFX G[+56]K[+56]TGGK[+56]AR 471.7719
9 
2 b6 GK-H2AX control 4-11 
H2AFX G[+56]K[+56]TGGK[+56]AR 471.7719
9 
2 b7 GK-H2AX control 4-11 
H2AFX G[+56]K[+56]TGGK[+56]AR 471.7719
9 
2 y6 GK-H2AX control 4-11 
H2AFX G[+56]K[+56]TGGK[+56]AR 471.7719
9 
2 y5 GK-H2AX control 4-11 
H2AFX G[+56]K[+56]TGGK[+56]AR 471.7719
9 
2 y4 GK-H2AX control 4-11 
H2AFX G[+56]K[+56]TGGK[+56]AR 471.7719
9 
2 y3 GK-H2AX control 4-11 
H2AFX G[+56]K[+56]TGGK[+56]AR 471.7719
9 
2 y2 GK-H2AX control 4-11 
H2AFX A[+56]K[+56]AK[+56]SR 414.7505
3 













2 b2 H2AX K13unK15un 
H2AFX A[+56]K[+56]AK[+56]SR 414.7505
3 
2 b3 H2AX K13unK15un 
H2AFX A[+56]K[+56]AK[+56]SR 414.7505
3 
2 b4 H2AX K13unK15un 
H2AFX A[+56]K[+56]AK[+56]SR 414.7505
3 
2 b5 H2AX K13unK15un 
H2AFX A[+56]K[+56]AK[+56]SR 414.7505
3 
2 y5 H2AX K13unK15un 
H2AFX A[+56]K[+56]AK[+56]SR 414.7505
3 
2 y4 H2AX K13unK15un 
H2AFX A[+56]K[+56]AK[+56]SR 414.7505
3 
2 y3 H2AX K13unK15un 
H2AFX A[+56]K[+56]AK[+56]SR 414.7505
3 
2 y2 H2AX K13unK15un 
H2AFX A[+56]K[+56]AK[+56]SR 414.7505
3 
2 y1 H2AX K13unK15un 
H2AFX A[+56]K[+56]AK[+170.1]SR 471.7719
9 













2 y4 H2AX K13unK15ub 






2 y2 H2AX K13unK15ub 
H2AFX A[+56]K[+56]AK[+170.1]SR 471.7719
9 
2 b4 H2AX K13unK15ub 
H2AFX K[+112.1]GHYAER 486.7485
2 










KGHYAER H2AX only 
H2AFX K[+112.1]GHYAER 486.7485
2 
2 b1 KGHYAER H2AX only 
H2AFX K[+112.1]GHYAER 486.7485
2 
2 b3 KGHYAER H2AX only 
H2AFX K[+112.1]GHYAER 486.7485
2 
2 b4 KGHYAER H2AX only 
H2AFX K[+112.1]GHYAER 486.7485
2 
2 b5 KGHYAER H2AX only 
H2AFX K[+112.1]GHYAER 486.7485
2 
2 b6 KGHYAER H2AX only 
H2AFX K[+112.1]GHYAER 486.7485
2 
2 y6 KGHYAER H2AX only 
H2AFX K[+112.1]GHYAER 486.7485
2 
2 y5 KGHYAER H2AX only 
H2AFX K[+112.1]GHYAER 486.7485
2 
2 y4 KGHYAER H2AX only 
H2AFX K[+112.1]GHYAER 486.7485
2 
2 y3 KGHYAER H2AX only 
H2AFX K[+112.1]GHYAER 486.7485
2 
2 y2 KGHYAER H2AX only 
H2AFX K[+98]GHYAER 479.7406
9 













2 b1 Acetylated version 
H2AFX K[+98]GHYAER 479.7406
9 
2 b2 Acetylated version 
H2AFX K[+98]GHYAER 479.7406
9 
2 b3 Acetylated version 
H2AFX K[+98]GHYAER 479.7406
9 
2 b4 Acetylated version 
H2AFX K[+98]GHYAER 479.7406
9 
2 b5 Acetylated version 
H2AFX K[+98]GHYAER 479.7406
9 
2 b6 Acetylated version 
H2AFX K[+98]GHYAER 479.7406
9 
2 y6 Acetylated version 
H2AFX K[+98]GHYAER 479.7406
9 
2 y5 Acetylated version 
H2AFX K[+98]GHYAER 479.7406
9 
2 y4 Acetylated version 
H2AFX K[+98]GHYAER 479.7406
9 
2 y3 Acetylated version 
H2AFX K[+98]GHYAER 479.7406
9 
2 y2 Acetylated version 
H2AFX K[+98]GHYAER 479.7406
9 
2 y1 Acetylated version 
H2AFX H[+56]LQLAIR 453.7796
2 










2nd strongest H2A pep 
H2AFX H[+56]LQLAIR 453.7796
2 
2 b1 2nd strongest H2A pep 
H2AFX H[+56]LQLAIR 453.7796
2 
2 b2 2nd strongest H2A pep 
H2AFX H[+56]LQLAIR 453.7796
2 





2 b4 2nd strongest H2A pep 
H2AFX H[+56]LQLAIR 453.7796
2 
2 b5 2nd strongest H2A pep 
H2AFX H[+56]LQLAIR 453.7796
2 
2 b6 2nd strongest H2A pep 
H2AFX H[+56]LQLAIR 453.7796
2 
2 y6 2nd strongest H2A pep 
H2AFX H[+56]LQLAIR 453.7796
2 
2 y5 2nd strongest H2A pep 
H2AFX H[+56]LQLAIR 453.7796
2 
2 y4 2nd strongest H2A pep 
H2AFX H[+56]LQLAIR 453.7796
2 
2 y3 2nd strongest H2A pep 
H2AFX H[+56]LQLAIR 453.7796
2 
2 y2 2nd strongest H2A pep 
H2AFX H[+56]LQLAIR 453.7796
2 
2 y1 2nd strongest H2A pep 
H2AFJ G[+56]K[+56]QGGK[+56]VR 499.2930
9 










GK-H2AJ control 4-11 
H2AFJ G[+56]K[+56]QGGK[+56]VR 499.2930
9 
2 b2 GK-H2AJ control 4-11 
H2AFJ G[+56]K[+56]QGGK[+56]VR 499.2930
9 
2 b3 GK-H2AJ control 4-11 
H2AFJ G[+56]K[+56]QGGK[+56]VR 499.2930
9 
2 b4 GK-H2AJ control 4-11 
H2AFJ G[+56]K[+56]QGGK[+56]VR 499.2930
9 
2 b5 GK-H2AJ control 4-11 
H2AFJ G[+56]K[+56]QGGK[+56]VR 499.2930
9 
2 b6 GK-H2AJ control 4-11 
H2AFJ G[+56]K[+56]QGGK[+56]VR 499.2930
9 
2 b7 GK-H2AJ control 4-11 
H2AFJ G[+56]K[+56]QGGK[+56]VR 499.2930
9 
2 y7 GK-H2AJ control 4-11 
H2AFJ G[+56]K[+56]QGGK[+56]VR 499.2930
9 
2 y6 GK-H2AJ control 4-11 
H2AFJ G[+56]K[+56]QGGK[+56]VR 499.2930
9 
2 y5 GK-H2AJ control 4-11 
H2AFJ K[+112.1]GNYAER 475.2405
2 













2 b1 KGNYAER 
H2AFJ K[+112.1]GNYAER 475.2405
2 
2 b2 KGNYAER 
H2AFJ K[+112.1]GNYAER 475.2405
2 
2 b3 KGNYAER 
H2AFJ K[+112.1]GNYAER 475.2405
2 
2 b4 KGNYAER 
H2AFJ K[+112.1]GNYAER 475.2405
2 
2 b5 KGNYAER 
H2AFJ K[+112.1]GNYAER 475.2405
2 
2 b6 KGNYAER 
H2AFJ K[+112.1]GNYAER 475.2405
2 
2 y6 KGNYAER 
H2AFJ K[+112.1]GNYAER 475.2405
2 
2 y5 KGNYAER 
H2AFJ K[+112.1]GNYAER 475.2405
2 
2 y4 KGNYAER 
H2AFJ K[+112.1]GNYAER 475.2405
2 
2 y3 KGNYAER 
H2AFJ K[+112.1]GNYAER 475.2405
2 
2 y2 KGNYAER 
H2AFJ K[+112.1]GNYAER 475.2405
2 
2 y1 KGNYAER 
















2 y4 H2AZ 
H2AFZ H[+56]LK[+56]SR 376.7243
1 
2 y3 H2AZ 
H2AFZ H[+56]LK[+56]SR 376.7243
1 











































































































































































































































































































































































































































2 y6 H4 1Ac 
K5AcK8unK12unK16un 
HIST1H4A G[+56]K[+42]GGK[+56]GLGK[+ 768.9464 2 y5 H4 1Ac 
249 
 




































































































































































































































































































































































































































































1 y2 H4K20unmod 
HIST1H4A K[+112.1]VLR 627.4188
2 
1 b1 H4K20unmod 
HIST1H4A K[+112.1]VLR 627.4188
2 
1 b2 H4K20unmod 
HIST1H4A K[+112.1]VLR 627.4188
2 
1 b3 H4K20unmod 
HIST1H4A K[+126.1]VLR 641.4344
7 













1 y3 H4K20me1 
HIST1H4A K[+126.1]VLR 641.4344
7 
1 y2 H4K20me1 
HIST1H4A K[+126.1]VLR 641.4344
7 
1 b1 H4K20me1 
HIST1H4A K[+126.1]VLR 641.4344
7 
1 b2 H4K20me1 
HIST1H4A K[+126.1]VLR 641.4344
7 
1 b3 H4K20me1 
HIST1H4A K[+84.1]VLR 300.2155
9 













2 y3 H4K20me2 
HIST1H4A K[+84.1]VLR 300.2155
9 
2 y1 H4K20me2 
HIST1H4A K[+84.1]VLR 300.2155
9 
2 b1 H4K20me2 
HIST1H4A K[+84.1]VLR 300.2155
9 
2 b2 H4K20me2 
HIST1H4A K[+84.1]VLR 300.2155
9 
2 b3 H4K20me2 
HIST1H4A K[+98.1]VLR 307.2234
2 













2 y3 H4K20me3 
HIST1H4A K[+98.1]VLR 307.2234
2 
2 y1 H4K20me3 
HIST1H4A K[+98.1]VLR 307.2234
2 
2 b1 H4K20me3 
HIST1H4A K[+98.1]VLR 307.2234
2 
2 b2 H4K20me3 
HIST1H4A K[+98.1]VLR 307.2234
2 
2 b3 H4K20me3 
HIST1H4A D[+56]AVTYTEHAK[+56]R 701.8517 2 precursor H4 control 68-78 
HIST1H4A D[+56]AVTYTEHAK[+56]R 701.8517 2 precursor 
[M+1] 
H4 control 68-78 
HIST1H4A D[+56]AVTYTEHAK[+56]R 701.8517 2 precursor 
[M+2] 
H4 control 68-78 
HIST1H4A D[+56]AVTYTEHAK[+56]R 701.8517 2 y8 H4 control 68-78 
HIST1H4A D[+56]AVTYTEHAK[+56]R 701.8517 2 y7 H4 control 68-78 
HIST1H4A D[+56]AVTYTEHAK[+56]R 701.8517 2 y6 H4 control 68-78 
HIST1H4A D[+56]AVTYTEHAK[+56]R 701.8517 2 y4 H4 control 68-78 
HIST1H4A D[+56]AVTYTEHAK[+56]R 701.8517 2 y3 H4 control 68-78 
HIST1H4A D[+56]AVTYTEHAK[+56]R 701.8517 2 b3 H4 control 68-78 
252 
 
HIST1H4A D[+56]AVTYTEHAK[+56]R 701.8517 2 b4 H4 control 68-78 
HIST1H4A D[+56]AVTYTEHAK[+56]R 701.8517 2 b9 H4 control 68-78 
HIST1H4A D[+56]AVTYTEHAK[+56]R 701.8517 2 b10 H4 control 68-78 





















Sample 1 Mono-nucleosomal 232.13  
94.4 Poly-nucleosomal 13.84 
Sample 2 Mono-nucleosomal 92.06  
96.5 Poly-nucleosomal 3.33 
Sample 3 Mono-nucleosomal 307.29  
99.0 Poly-nucleosomal 3.15 
Sample 4 Mono-nucleosomal 223.19  
98.1 Poly-nucleosomal 4.35 
Sample 5 Mono-nucleosomal 196.59  






Appendix Table 2. Quantification of the nucleosomal DNA size. MNase 
extracted chromatin samples indicated with the red stars on Figure 3.2 B 
were examined by Bioanalyzer analysis to verify the extent of digestion. For 
each Bioanylazer trace, the area under the peak corresponding to mono- and 
poly-nucleosomal DNA sizes was calculated. The percentage of mono-
nucleosomal DNA was calculated relative to the total amount of DNA of all 







Sample 6 Mono-nucleosomal 241.79  
97.3 Poly-nucleosomal 6.75 
Sample 7 Mono-nucleosomal 271.14  
98.6 Poly-nucleosomal 3.72 
Sample 8 Mono-nucleosomal 227.96  
96.1 Poly-nucleosomal 9.32 
Sample 9 Mono-nucleosomal 396.49  
97.9 Poly-nucleosomal 8.49 
Sample 10 Mono-nucleosomal 355.93  





















Histone  Peptide name %CV  %CV  
H3 H3 K4unmod 2.2 15 
H3 K4me1 16.8 17 
H3 K4me2 21.7 28 
H3 K4me3 28.8 N/D 
H3 K9unmodK14unmod 8.8 7.7 
H3 K9me1K14unmod 10 7.7 
H3 K9me2K14unmod 2.6 3.5 
H3 K9me3K14unmod 4.6 4.5 
H3 K9acK14unmod 13.1 26.2 
H3 K9unmodK14ac 11 11 
255 
 
H3 K9me1K14ac 9.9 5.7 
H3 K9me2K14ac 3.3 4.3 
H3 K9me3K14ac 4.2 3.7 
H3 K9acK14ac 18.6 19.1 
H3 K27unmodK36unmod 9.1 8 
H3 K27unmodK36me1 14.5 14.9 
H3 K27unmodK36me2 8.6 10 
H3 K27unmodK36me3 10.8 14.4 
H3 K27me1K36unmod 13.3 11.6 
H3 K27me1K36me1 10.7 14.3 
H3 K27me1K36me2 11.3 8.1 
H3 K27me1K36me3 11.9 10.1 
H3 K27me2K36unmod 7.8 4.7 
H3 K27me2K36me1 10 5.7 
H3 K27me2K36me2 7.2 14.2 
H3 K27me2K36me3 9.4 18.6 
H3 K27me3K36unmod 8.6 7 
H3 K27me3K36me1 7.4 6.5 
H3 K27me3K36me2 9.2 N/D 
H3 K79unmod 1 24.6 
H3 K79me1 69.3 76.8 
H3 K79me2 10 56.6 
H4 H4 K5AcK8AcK12AcK16Ac 8.4 13.8 
H4 K5AcK8AcK12AcK16un 14.4 33.4 
H4 K5AcK8AcK12mK16m 5.8 15.9 
256 
 
H4 K5AcK8AcK12unK16un 9.3 17.3 
H4 K5mK8mK12AcK16Ac 7.6 9.1 
H4 K5AcK8unK12unK16un 7.4 4.5 
H4 K5unK8AcK12AcK16Ac 11 27.1 
H4 K5unK8unK12AcK16Ac 16.9 3.4 
H4 K5unK8unK12unK16Ac 5.8 2 
H4 K5unK8unK12unK16un 5.7 2.6 
H4 K20un 9.7 6.5 
H4 K20me1 7.4 7.4 
H4 K20me2 2.7 2.3 
H4 K20me3 16.8 5.8 
H2A type 1-B/E Amino acids 4-11 0.5 5.8 
Amino acids 36-42 8.2 10.3 
H2A K13unK15un 0.4 1 
H2A K13unK15ub 29.1 23 
H2AX Amino acids 4-11 8.8 4.2 
Amino acids 36-42 9.9 7 
H2AX-like K13unK15un 0.1 0.5 
H2AX-like K13unK15ub 17.1 13 
H2AJ Amino acids 4-11 14.7 N/D 
Amino acids 36-42 3.8 7.4 
 
Appendix Table 3. Table showing %CV for each of the targeted peptides 
























































































































































































































54.37 0.00024 VTEGLVDVILYHQPDDK 



















































































































































































































































































51.59 0.00037 YGGPPPDSVYSGQQPSVGTEIFVGK 



















































































































































































































































































68.83 1.30E-05 NGPLEVAGAAVSAGHGLPAK 



















































































































































































































































































54.27 0.00024 LRDLEDSLAR 



















































































































































































































































































67.61 1.20E-05 VPQVSTPTLVEVSR 




















































































































































































































































































58.46 0.00011 SKAEAESLYQSKYEELQITAGR 




















































































































































































































































































70.08 5.20E-06 WELLQQVDTSTR 




















































































































































































































































































74.6 2.80E-07 GSGGGSSGGSIGGR 






































































































































































































































































































45.63 0.002 LEGLTDEINFLR 



















































































































































































































































































57.82 4.00E-05 ADKDYHFKVDNDENEHQLSLR 



















































































































































































































































































100.12 1.00E-08 MSVQPTVSLGGFEITPPVVLR 























































































































































































































































































57.06 8.20E-05 TDLEKDIISDTSGDFRK 



















































































































































































































































































61.57 5.60E-05 MIAGQVLDINLAAEPK 



















































































































































































































































































52.67 0.00014 SELDMLDIR 



















































































































































































































































































44.8 0.0014 ETNLDSLPLVDTHSK 



















































































































































































































































































83.49 4.40E-07 ISLPLPNFSSLNLR 



















































































































































































































































































66.67 1.90E-05 ETSGNLEQLLLAVVK 



















































































































































































































































































51.92 0.00028 GFGFVTYATVEEVDAAMNARPHK 



















































































































































































































































































43.86 0.0012 GDEELDSLIK 



















































































































































































































































































47.27 0.0012 LKYENEVALR 



















































































































































































































































































78.82 1.10E-07 GSLGGGFSSGGFSGGSFSR 



















































































































































































































































































52.31 0.00068 KPAAATVTKK 




















































































































































































































































































64.31 9.80E-07 GFGFVDFNSEEDAK 



















































































































































































































































































121.44 1.60E-11 GLSEDTTEETLKESFDGSVR 



















































































































































































































































































45.78 0.0022 GFGFVTFDDHDPVDKIVLQK 



















































































































































































































































































57.15 0.00012 LFVGGIKEDTEEHHLR 



















































































































































































































































































67.84 1.00E-05 LFVGGIKEDTEEHHLR 



















































































































































































































































































73.41 3.80E-07 GFGFVTFDDHDPVDK 



















































































































































































































































































130.51 1.30E-13 NMGGPYGGGNYGPGGSGGSGGYGGR 



















































































































































































































































































46.03 0.00051 QGVDADINGLR 






























































































58.97 2.80E-05 QGVDADINGLR 
P35527|K1C9_HU
MAN 


















































































































































































79.05 2.60E-07 DIENQYETQITQIEHEVSSSGQEVQSSAK 































































































































































































































































































51.65 0.00033 LKGEATVSFDDPPSAK 








































































































































































































































43.96 0.0012 KYEDEINKR 
P35908|K22E_HU
MAN 








































34.78 0.00048 GSSSGGGYSSGSSSYGSGGR 





























































































44.71 3.40E-05 GSSSGGGYSSGSSSYGSGGR 
P35908|K22E_HU
MAN 




















63.5 2.10E-05 SISISVAGGGGGFGAAGGFGGR 
P35908|K22E_HU
MAN 






















62.91 1.50E-05 SKEEAEALYHSK 
P35908|K22E_HU
MAN 
730.9 68.79 1.20E-05 VDLLNQEIEFLK 
P35908|K22E_HU
MAN 
























































































































75.63 8.00E-07 SKEEAEALYHSK 






































80.32 4.10E-07 SISISVAGGGGGFGAAGGFGGR 
P35908|K22E_HU
MAN 








































































































































































































































92.32 2.90E-08 LFIGGLNTETNEK 



















































































































































































































































































65.6 2.70E-05 VIHLSNLPHSGYSDSAVLK 



















































































































































































































































































51.07 0.00041 AFITNIPFDVK 



















































































































































































































































































61.7 4.80E-05 KGISLNPEQWSQLK 



















































































































































































































































































41.65 0.0046 IILDLISESPIK 



















































































































































































































































































73.78 4.70E-06 IITITGTQDQIQNAQYLLQNSVK 



















































































































































































































































































67.82 1.00E-05 VAQLEQVYIR 



















































































































































































































































































43.3 0.00066 DAVTYTEHAK 



















































































































































































































































































68.51 9.40E-06 TVTAMDVVYALKR 


















































































































































































































91.18 5.60E-08 KTVTAMDVVYALK 
P62805|H4_HUM
AN 





94.18 2.80E-08 KTVTAMDVVYALK 
P62805|H4_HUM
AN 
719.9 95.61 1.50E-08 KTVTAMDVVYALK 
P62805|H4_HUM
AN 





95.72 1.40E-08 KTVTAMDVVYALK 
P62805|H4_HUM
AN 



































124.2 2.40E-11 KTVTAMDVVYALKR 



















































































































































































































































































51.69 0.00032 IQDKEGIPPDQQR 



















































































































































































































































































54.27 7.80E-05 YPIEHGIITNWDDMEK 



















































































































































































































































































39.42 0.0013 GYFEYIEENKYSR 























































































































































































































































































95.09 2.10E-08 NFILDQTNVSAAAQR 





















































































































































































































































































50.61 0.00017 TKDIEDVFYK 



















































































































































































































































































64.47 3.20E-05 VQSDGQIVLVDDWIK 




















































































































































































































































































47.98 0.00043 EDITQSAQHALR 









































































58.28 9.20E-05 LFPDTPLALDANK 
Q12906|ILF3_HU
MAN 





































































































































































































91.49 7.00E-08 LFIGGLNVQTSESGLR 



















































































































































































































































































52.42 0.00034 ATGATQQDANASSLLDIYSFWLK 



















































































































































































































































































40.75 0.00064 LPPNTNDEVDEDPTGNK 



















































































































































































































































































65.58 1.20E-05 NDEELNKLLGR 



















































































































































































































































































64.85 3.30E-05 VKEPSVQEATSTSDILK 



















































































































































































































































































49.78 0.00061 IIDDSEITKEDDALWPPPDR 



















































































































































































































































































41.35 0.0049 TVPEELVKPEELSK 


































































































































































































































y = 0.9081x + 4.4771
R² = 0.9977
y = 0.7632x + 3.421
R² = 0.9651
y = 0.6915x + 3.0483
R² = 0.973





























Amount injected  [Log(ng)]





y = 0.8623x + 4.4063
R² = 0.9965
y = 0.8151x + 2.8915
R² = 0.9766
y = 0.7279x + 3.1821
R² = 0.997






























Amount injected  [Log(ng)]












y = 0.7409x + 5.1241
R² = 0.9868
y = 0.8371x + 4.8938
R² = 0.9945
y = 0.951x + 5.091
R² = 0.9989
y = 0.9935x + 4.7138
R² = 0.9976
y = 0.6249x + 3.6269
R² = 0.8994
y = 0.7785x + 4.9686
R² = 0.9962
y = 0.6916x + 4.7546
R² = 0.9759
y = 0.9601x + 4.9814
R² = 0.9991
y = 0.976x + 4.4113
R² = 0.997
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y = 0.757x + 4.8829
R² = 0.9882
y = 0.7025x + 4.238
R² = 0.9912
y = 0.8867x + 4.9849
R² = 0.9995
y = 0.9188x + 4.6321
R² = 0.9991
y = 0.6771x + 3.4072
R² = 0.9575
y = 0.7788x + 4.7259
R² = 0.98
y = 0.5968x + 4.2452
R² = 0.9835
y = 0.8935x + 4.9323
R² = 0.9994
y = 0.9348x + 4.3508
R² = 0.9991
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y = 1.1161x + 4.3538
R² = 0.9944
y = 1.0012x + 3.771
R² = 0.9809
y = 1.3687x + 4.5623
R² = 0.9876































Amount injected  [Log(ng)]





y = 0.9413x + 3.9943
R² = 0.9973
y = 0.8913x + 3.0513
R² = 0.994
y = 1.2954x + 3.7555
R² = 0.9808
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y = 0.9299x + 3.525
R² = 0.9959
y = 0.8805x + 2.8276
R² = 0.9589
y = 1.4567x + 3.3105
R² = 0.9853































Amount injected  [Log(ng)]





y = 1.4041x + 4.8913
R² = 0.993
y = 1.4523x + 4.4485
R² = 0.9822
y = 1.4606x + 3.8711
R² = 0.8415
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y = 1.4041x + 4.8913
R² = 0.993
y = 1.4523x + 4.4485
R² = 0.9822
y = 1.4606x + 3.8711
R² = 0.8415































Amount injected  [Log(ng)]





y = 1.4314x + 4.0406
R² = 0.9915
y = 1.4522x + 3.1916
R² = 0.9762
y = 1.7858x + 2.4077
R² = 0.8748
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y = 1.4544x + 4.5763
R² = 0.9663
y = 1.2841x + 4.0678
R² = 0.9439
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y = 1.596x + 3.5325
R² = 0.985
y = 1.378x + 2.7569
R² = 0.9443
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y = 0.7745x + 3.7613
R² = 0.9917
y = 0.6241x + 3.1085
R² = 0.9547
y = 0.6952x + 3.6701
R² = 0.977
y = 0.7978x + 3.9496
R² = 0.996
y = 0.8177x + 4.0085
R² = 0.9834
y = 0.9591x + 4.5569
R² = 0.9933
y = 0.7135x + 3.1492
R² = 0.9768
y = 0.9178x + 4.7742
R² = 0.9969
y = 0.9338x + 5.4931
R² = 0.9974
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y = 0.8671x + 3.5034
R² = 0.9831
y = 0.7364x + 2.8775
R² = 0.9609
y = 0.7992x + 3.3803
R² = 0.9981
y = 0.7616x + 3.7039
R² = 0.9995
y = 0.8064x + 3.7792
R² = 0.9899
y = 0.8493x + 4.1838
R² = 0.9945
y = 0.7762x + 2.936
R² = 0.9956
y = 0.865x + 4.4574
R² = 0.995
y = 0.8811x + 5.0828
R² = 0.9978
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y = 0.8807x + 4.6871
R² = 0.9975
y = 0.8574x + 4.6399
R² = 0.9982
y = 0.9184x + 5.9121
R² = 0.9973
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y = 0.8433x + 4.6417
R² = 0.9992
y = 0.837x + 4.2528
R² = 0.9985
y = 0.8677x + 5.8365
R² = 0.9985
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y = 0.7745x + 4.6857
R² = 0.9936
y = 0.7671x + 5.4583
R² = 0.9975
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y = 0.8114x + 5.6655
R² = 0.9974
y = 0.8336x + 3.5242
R² = 0.9913
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Appendix Figure 1. Peptide response curve. The input samples linearly 
increasing from 0.8 – 100 ng and B) IP samples linearly increasing from 0.1 
– 12.5 % of IP samples were injected into chromatography column and 
analysed by mass spectrometry. The raw intensities for each peptide were 
plotted on the double-Log scale. R2 and slope of the linear trendline for each 






































Appendix Figure 2. Heavy methyl SILAC labelling shows no 
significant difference in the turnover of H3K9me2/3 marks at the site 
of DSBs compared to global turnover. A) Turnover of H3K9me2 and B) 
H3K9me3 globally (ST) and on H2AX-containing nucleosomes (IP) 24 h 
after 10 Gy of IR in 1BR, AT1BR and ATM-inhibited (ATMi) fibroblast. ST = 














Appendix Figure 3. Analysis of histone H3K9me3 methylation 
labelled with heavy methionine. Example of extracted ion spectrum 
showing matched fragment ions of H3K9me3-peptide containing three 
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The Ku-binding motif is a conserved module for
recruitment and stimulation of non-homologous
end-joining proteins
Gabrielle J. Grundy1,*, Stuart L. Rulten1,*, Raquel Arribas-Bosacoma1,2, Kathryn Davidson1, Zuzanna Kozik1,
Antony W. Oliver1,2, Laurence H. Pearl1,2 & Keith W. Caldecott1
The Ku-binding motif (KBM) is a short peptide module ﬁrst identiﬁed in APLF that we now
show is also present in Werner syndrome protein (WRN) and in Modulator of retrovirus
infection homologue (MRI). We also identify a related but functionally distinct motif in XLF,
WRN, MRI and PAXX, which we denote the XLF-like motif. We show that WRN possesses
two KBMs; one at the N terminus next to the exonuclease domain and one at the C terminus
next to an XLF-like motif. We reveal that the WRN C-terminal KBM and XLF-like motif
function cooperatively to bind Ku complexes and that the N-terminal KBM mediates
Ku-dependent stimulation of WRN exonuclease activity. We also show that WRN accelerates
DSB repair by a mechanism requiring both KBMs, demonstrating the importance of WRN
interaction with Ku. These data deﬁne a conserved family of KBMs that function as molecular
tethers to recruit and/or stimulate enzymes during NHEJ.
DOI: 10.1038/ncomms11242 OPEN
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D
NA double-strand breaks (DSBs) arise as a consequence
of both endogenous and exogenous DNA damage and
during normal cellular processes such as the generation
of antibody diversity1,2. DSB repair pathways exist to ensure
that chromosomal integrity is maintained but mis-regulation
or inappropriate engagement of such pathways can lead to
potentially oncogenic translocations, mutagenesis or cell death3.
Moreover, loss or mutation of non-homologous end joining
(NHEJ) factors in mice or humans can result in a range of
phenotypes including immunodeﬁciency, cancer predisposition,
neurological defects and embryonic lethality4,5. Mammalian cells
possess two major types of DSB repair pathway; homologous
recombination and NHEJ6. Homologous recombination employs
sister chromatids as a template for accurate repair during
S/G2 phase of the cell cycle, whereas NHEJ ligates DSB termini
directly and can occur throughout the cell cycle.
The core protein factors involved in NHEJ are DNA protein
kinase (DNA–PK), XRCC4-like factor (XLF) and XRCC4/DNA
ligase IV7–9. While these core factors are sufﬁcient to repair DSBs
with ligatable termini the repair of most physiologically relevant
DSBs require additional protein factors to process the DSB
termini before ligation, including nucleases, DNA polymerases
and polynucleotide kinase/phosphatase. An increasing number
of accessory protein factors have been implicated in NHEJ, many
of which appear to interact with DNA–PK10. DNA–PK is
comprised of a protein kinase catalytic subunit (DNA–PKcs)
and Ku heterodimer; the latter being composed of Ku70 and
Ku80. Recently, we and others identiﬁed a novel Ku-binding
peptide motif (now denoted the KBM) of 10–15 amino acids
in the accessory protein Aprataxin-and-polynucleotide kinase/
phosphatase-like Factor (APLF), which we showed interacts
directly with a hydrophobic pocket in the vWA domain of
Ku80 (refs 11,12). Here we have identiﬁed and characterized
analogous KBMs in two additional NHEJ proteins, revealing
this motif to be an evolutionary conserved Ku-binding module. In
particular, we identify two KBMs in the exonuclease/helicase
mutated in Werner syndrome (WRN) and show that these
motifs are employed by WRN to accelerate chromosomal DSB
repair, deﬁning the functional importance of these motifs in vitro
and in cells.
Results
A conserved KBM. The interaction between APLF and Ku80
was previously mapped to a conserved motif in APLF of
10–15 amino acids, denoted the KBM11,12. PSI-BLAST13 analysis
using this sequence, and subsequent additional searching by eye,
suggested that similar KBMs are present at the N terminus and
C terminus of WRN protein; the DNA helicase and exonuclease
mutated in Werner syndrome and an established partner of
Ku (Fig. 1a)14,15. We also identiﬁed a putative KBM in Modulator
of retroviral infection homologue (MRI, C7orf49); a poorly
characterized protein that we recovered in a yeast two-hybrid
screen using the Ku80 vWA-like domain as bait (Fig. 1a). MRI
was reported previously to interact with Ku and to stimulate
NHEJ, in vitro16. Similar to the KBM in APLF11, the putative
KBMs in WRN and MRI are conserved among vertebrate species
(Supplementary Fig. 1). Our analyses also revealed a distinct but
related motif at the C terminus of XLF, Paralog of XRCC4 and
XLF (PAXX), WRN and MRI, which we denoted the XLF-like
motif (Fig. 1a, right). Interestingly, the XLF-like motif in WRN is
present in tandem with the putative C-terminal KBM, raising the
possibility that these motifs function cooperatively.
APLF-like KBMs bind Ku by a common mechanism. To
examine Ku binding by the putative KBMs and XLF-like motifs,
we employed recombinant Ku heterodimer and ﬂuorescent
peptides spanning these domains in ﬂuorescence polarization
assays. We employed recombinant Ku70/Ku80DC heterodimer
(denoted KuDC) lacking the ﬂexible Ku80 C-terminal helical
domain for these experiments, since KuDC exhibits
greater structural homogeneity than does full-length Ku
heterodimer11,17–19. Similar to the KBM in APLF, which binds
Ku with an afﬁnity of B0.6 mM (ref. 11), peptides spanning
the APLF-like KBMs from WRN or MRI bound KuDC with Kd
values of 0.5–1.7mM (Fig. 1b, top panels). Mutation of the
conserved tryptophan in the APLF-like KBMs greatly reduced or
ablated KuDC interaction, suggesting that these motifs share a
common mechanism of Ku80 binding (Fig. 1b, top panels).
Indeed, a peptide encoding the APLF KBM competed efﬁciently
in KuDC binding assays with peptides encoding each of the three
APLF-like KBMs from WRN and MRI, suggesting that these
motifs compete for the same hydrophobic pocket in the Ku80
vWA-like domain that binds APLF11 (Fig. 1b, bottom right).
In contrast to the APLF-like KBMs none of the peptides spanning
the XLF-like motifs interacted with KuDC heterodimer in
ﬂuorescence polarization assays (Supplementary Fig. 2a), and
the XLF-like motif in WRN also failed to improve KuDC binding
by the adjacent C-terminal KBM (Fig. 1b, bottom left).
To examine whether the APLF-like KBMs are sufﬁcient to bind
Ku in cells, we employed UVA laser microirradiation. With the
exception of the N-terminal KBM from WRN (‘WRN-nA’) each of
the green ﬂuorescent protein (GFP)-tagged KBMs accumulated at
sites of UVA-induced chromosome damage in U2-OS cells, albeit
with different efﬁciencies, and did so with similar kinetics to red
ﬂuorescent protein (RFP)-Ku80 (Fig. 2a and Supplementary Fig. 3).
The XLF-like motifs from XLF and PAXX also accumulated at sites
of UVA-induced chromosome damage, albeit relatively weakly,
despite their inability to bind Ku in ﬂuorescence polarization assays
(Supplementary Fig. 2b). In contrast, the XLF-like motifs from
MRI and WRN were unable to accumulate at sites of UVA laser
damage (Supplementary Fig. 2b), although the latter did increase
accumulation of the adjacent C-terminal KBM (Fig. 2a; compare
‘WRN-cA’ and ‘WRN-cAX’). Importantly, recruitment of the GFP-
tagged APLF-like KBMs to sites of UVA laser damage was reduced
by mutation of the Ku80 vWA-like domain (L68R) that we showed
previously binds the APLF KBM11 (Fig. 2b), further suggesting that
each of the KBMs interact with the same site in Ku80.
The WRN C-terminal tandem domains bind Ku cooperatively.
Mutations in WRN protein result in Werner syndrome, a rare
genetic disease characterized by genome instability, premature
ageing and cancer20,21. WRN is a member of the RecQ family of
helicases and is involved in multiple DNA repair processes20.
Since WRN possesses multiple KBMs and also an XLF-like
motif, we addressed the role and relative importance of these
for Ku binding. Once again, as described above, the C-terminal
KBM targeted GFP to sites of UVA laser-induced damage
when expressed in cells as a fusion peptide and did so more
efﬁciently if present together with the adjacent XLF-like motif
(Fig. 3b, compare ‘WRN-cA’ and ‘WRN-cAX’). Moreover, this
accumulation was reduced if either the C-terminal KBM or
XLF-like motif were mutated, further suggesting that these two
motifs function cooperatively. Similar results were observed
in pull-down experiments, in which GFP-tagged KBM
co-precipitated Ku protein complexes from cell extract more
efﬁciently if present in tandem with the XLF-like motif, despite
the latter being unable to co-precipitate Ku complexes by itself
(Fig. 3a). In addition, whereas co-precipitation of Ku by
full-length GFP–WRN was reduced by only B30% by mutation
of either the C-terminal KBM or the XLF-like motif separately
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(Fig. 3c, lane 7 and Fig. 3d, lane 10), it was reduced by495% by
deletion of the entire C-terminal tandem domain (Fig. 3d, lane 8).
Notably, recombinant Ku was also co-precipitated by puriﬁed
full-length recombinant Strep-tagged WRN in vitro, and this
co-precipitation was again greatly reduced by deletion of the
C-terminal tandem domain (Fig. 3e). This experiment conﬁrms
that WRN and Ku interact directly and do so in a manner that is
mediated primarily by the C-terminal tandem domain.
The N-terminal KBM cooperates with WRN exonuclease. In
contrast to the C-terminal KBM, the N-terminal KBM was unable
to accumulate at sites of UVA laser-induced chromosome
damage or co-precipitate Ku protein complexes if over-expressed
by itself as a GFP-fusion protein (Figs 2a and 3a; ‘WRN-nA’).
Mutation of the N-terminal KBM reduced Ku co-precipitation by
full-length GFP–WRN by only B10% (Fig. 3c, lane 6), and
reduced Ku co-precipitation by Strep-tagged WRN in vitro to a
lesser extent than deletion of the C-terminal tandem domain
(Fig. 3e). Nevertheless, mutation of the N-terminal KBM further
reduced Ku co-precipitation toB7% of normal if combined with
mutation of the C-terminal KBM (Fig. 3d, lane 7), and to almost
undetectable levels if combined with deletion of the C-terminal
tandem domain (Fig. 3d, lane 9). We thus conclude that both the
N-terminal KBM and the C-terminal tandem domain contribute
to the stable interaction of WRN with Ku, with the C-terminal
tandem domain contributing the most.
Given the close proximity of the N-terminal KBM and
exonuclease domain (Fig. 1a), we considered the possibility that
these domains might function cooperatively. In support of this,
in contrast to GFP-tagged N-terminal KBM alone (see above), a
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b
Figure 1 | Conserved Ku-binding motifs (KBMs). (a) Cartoon of NHEJ proteins containing putative APLF-like KBMs (red squares) and/or the related
XLF-like motif (blue squares). Peptide sequences (lower panels) highlight the conserved basic (blue), hydrophobic (green), proline (purple), and
tryptophan/phenylalanine (green bold) residues characteristic of these motifs. The tryptophan residues mutated for the ﬂuorescence polarization (FP)
assays described below are underlined. (b) Top and bottom left panels, FP assays measuring direct interaction between synthetic ﬂuorescein-labeled
peptides (100 nM) encoding the indicated KBMs and the indicated concentration of Ku heterodimer (KuDC). Peptide sequences are those shown in a, but
additionally preceded at the N terminus by ﬂuorescein-GGYG. Mutant peptides have alanine instead of tryptophan at the positions underlined in
a. WRN-cAX peptide encodes both the APLF-like KBM (residues 1,399–1,414) and XLF-like motif (residues 1,415–1,432) from the WRN C terminus. Bottom
right panel, MRI-A, WRN-nA or WRN-cAX peptides (2.1 mM) were employed in FP competition assays with KuDC (1mM) and the indicated concentration
(X-axis) of unlabeled APLF KBM peptide. All data points are the mean of three independent experiments (±1 s.d.). Kd values are indicated in parentheses
(±1 s.d.) unless too weak to be determined (‘ND’).
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exonuclease domain (WRN1–236; denoted ‘WRN-Exo’)
accumulated at sites of UVA laser-induced chromosome damage
in human U2-OS cells (Fig. 4a, left and middle). Importantly,
however, WRN-Exo accumulation was diminished by the
mutation of either the N-terminal KBM (Fig. 4a, middle) or the
KBM-binding site in Ku80 (Fig. 4a, right), indicating that
KBM-mediated interaction with Ku was required for WRN-Exo
accumulation at chromosome damage. Similarly, GFP-tagged
WRN-Exo co-precipitated Ku protein complexes in pull-down
experiments, and this required the KBM because the W18G
mutation greatly reduced or ablated Ku co-precipitation (Fig. 4b).
Notably, WRN-Exo co-precipitated Ku even in the presence of
DNAse and RNAse in these experiments, suggesting that the
interaction between these proteins is not mediated by nucleic
acid. Similar results were observed in yeast two-hybrid assays, in
which WRN-Exo transactivated a b-galactosidase reporter gene if
co-expressed with Ku80 (but not Ku70) in a manner dependent
on both the KBM in WRN-Exo and the KBM-binding site in
Ku80 (Supplementary Fig. 4).
Next, we examined the role of the N-terminal KBM in the
stimulation of WRN exonuclease activity by Ku14,15. WRN-Exo
was stimulated by either full-length Ku heterodimer or the
truncated KuDC heterodimer employed in our ﬂuorescence
polarization assays, and this stimulation was greatly reduced by
mutation of either the KBM (Fig. 4c) or the KBM-binding site in
Ku80 (Fig. 4d). This did not reﬂect a non-speciﬁc effect of the
KBM mutation on WRN exonuclease activity; however, because
wild-type and mutant WRN-Exo were equally active if stimulated
independently of Ku by replacing magnesium with manganese in
the assay (Supplementary Fig. 5)22. Finally, fusion of the tandem
peptide from the C terminus of WRN to the C terminus of
WRN-ExoW18G rescued stimulation by Ku, suggesting that
the KBM stimulates WRN exonuclease by acting as a
position-independent molecular tether (Fig. 4e).
The WRN KBMs accelerate chromosomal DSB repair.
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Figure 2 | KBM accumulation at sites of UVA laser-induced chromosome damage. (a) U2-OS cells were transiently transfected with expression
constructs encoding GFP alone (Vector) or the indicated GFP-tagged KBM and subjected to UVA laser-induced micro-irradiation. The expressed
peptide sequences for each KBM were APLF (177–193), WRN-cAX (1,399–1,432), WRN-nA (10–23), WRN-cA (1,399–1,414), MRI-A (6–19). Images were
captured immediately before and at 10 s intervals following treatment. Representative images are shown on the left and quantiﬁed data on the right.
(b) Ku80 / mouse embryonic ﬁbroblasts (MEFs) were co-transfected with expression constructs encoding the GFP-tagged KBM from APLF or the
indicated GFP-tagged APLF-like KBMs from WRN or MRI, mRFP-Ku70, and either mRFP (‘vector’), mRFP-Ku80 or mRFP-Ku80L68R. Cells were micro-
irradiated with UVA as above. All data are the mean GFP ﬂuorescence (±s.e.m.) in the laser track relative to the mean GFP ﬂuorescence before irradiation
(set at 100%) from 420 cells per experiment.
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biochemical and cellular assays14,15,23–26, but a role in promoting
chromosomal DSB repair has not been demonstrated. We
showed recently that the interaction of the APLF KBM
with Ku accelerates NHEJ, as measured using gH2AX as a
surrogate marker of DSBs11. Given the similarity of the
APLF-like KBMs, we examined whether this was also the
case for WRN. Indeed, we observed a small but signiﬁcant
reduction in NHEJ rate in Werner Syndrome cells arrested
in G0, as suggested by the slower loss of gH2AX foci in
these cells following ionizing radiation (Fig. 5a). We
employed cells arrested in G0 in these experiments to avoid


























































































































































































































Figure 3 | The WRN C-terminal KBM and XLF-like motif bind Ku protein complexes cooperatively. (a) HEK293T cells were co-transfected with
expression constructs encoding GFP or the indicated GFP-tagged KBMs and GFP-tagged proteins recovered using GFP-TRAP beads. Aliquots of the input
and eluate samples were fractionated by SDS–PAGE and immunoblotted for GFP, Ku80 and DNA–PKcs (CS). Right, cartoon depicting WRN and the
position of the KBMs and XLF-like motif and the mutations employed in these experiments. (b) HEK293Tcells were transfected with expression constructs
encoding the indicated wild-type or mutated GFP-tagged WRN C-terminal KBM, XLF-like motif (‘X’), or KBM plus XLF-like motif in tandem. Cells were
micro-irradiated with UVA as in Fig. 2. Representative images (left) and quantiﬁcation (right) are shown. All quantiﬁed data are the mean GFP ﬂuorescence
(±s.e.m.) in the laser track relative to the mean GFP ﬂuorescence before irradiation (set at 100%) from 420 cells per experiment. (c,d) Expression
constructs encoding full-length wild-type (‘WT’) GFP–WRN or derivatives harbouring the indicated point mutations in the N-terminal KBM (W18G),
C-terminal KBM (W1410G) or deleted C-terminal tandem domain (DcAX) or XLF-like motif (DX ) were transfected into HEK293Tcells and recovered using
GFP-TRAP beads. Input and eluates were immunoblotted for GFP and Ku80. Numbers in parentheses are the fraction of Ku co-precipitated by the indicated
GFP-tagged WRN protein, relative to wild-type WRN, quantiﬁed by ImageJ. Data are from two to six independent experiments, except for W18G/DcAX in
which Ku recovery was too low to be determined (‘nd’). (e) Direct interaction of puriﬁed full-length Strep-tagged WRN with recombinant human Ku.
Recombinant Strep-tagged WRN, WRNDcAX or WRNW18G was immobilized on Streptavidin Mag sepharose beads and incubated with recombinant Ku
heterodimer. Aliquots of the recombinant proteins employed in the experiment are shown on the left (lanes 1–3) and proteins pulled down by the
indicated Strep-tagged WRN protein are shown on the right (lanes 4–7). Lane 6 contains the proteins recovered in a control pull-down that lacked
Strep-tagged WRN. Proteins were fractioned by SDS–PAGE and stained with Coomassie Blue.
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substrates for homologous recombination-mediated repair.
To our knowledge this is the ﬁrst report of a reduced
rate of chromosomal NHEJ in Werner Syndrome cells. The
slower loss of gH2AX foci reﬂected the loss of WRN because it
was complemented by expression of wild-type recombinant
human WRN (Fig. 5b,c). In contrast, this defect was not
complemented by recombinant WRN protein harbouring
mutations in either of the two KBMs, conﬁrming the
importance of these motifs for WRN functionality during NHEJ
(Fig. 5b,c). However, WRN protein harbouring a mutated
exonuclease or helicase domain was still able to complement
the defect, suggesting that the acceleration of NHEJ detected
here reﬂects the scaffolding function of WRN23 rather than its
catalytic activity.
Discussion
The NHEJ accessory factor APLF possesses a short conserved
peptide motif denoted the KBM that interacts with the vWA-like
domain in Ku80 (refs 11,12). Here we show that the KBM is
present and conserved in several other NHEJ proteins, including
two in WRN protein and one in MRI; a poorly characterized
protein that interacts with Ku and promotes NHEJ by an
unclear mechanism16,27. Each of these KBMs interact with Ku
heterodimer with sub/low micromolar afﬁnity in vitro, and do so
by interacting with the same hydrophobic pocket in the
Ku80 vWA domain that binds APLF. Each of the KBMs also
accumulate at cellular sites of laser-induced chromosome damage
in a Ku80- and vWA-dependent manner when expressed as a
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Figure 4 | The WRN N-terminal KBM promotes WRN exonuclease activity. (a) Left, cartoon illustrating the GFP-tagged truncated recombinant WRN
proteins employed in these experiments. The WRN N-terminal (‘nA’) and C-terminal (‘cA’) KBMs are indicated by red boxes and XLF-like motif (‘X’) by a
blue box. The exonuclease domain is indicated by a black box, and the position of the KBM mutation (W18G) by an asterisk and dotted line. Middle, U2-OS
cells transiently expressing the indicated recombinant GFP-tagged WRN protein were imaged for GFP before and after UVA microirradiation, as in Fig. 2.
Right, Ku80 / MEFs transiently co-expressing GFP-tagged WRN-Exo, RFP-Ku70, and either RFP (vector), RFP-Ku80 or RFP-Ku80L68R as indicated were
micro-irradiated as in Fig. 1. Data are the mean GFP ﬂuorescence (±s.e.m.) in the laser track relative to the mean GFP ﬂuorescence before irradiation (set
at 100%) from420 cells per experiment. (b) The indicated GFP-tagged WRN proteins were recovered from transiently transfected HEK293T cell lysates
pre-treated or not as indicated with Benzonase and RNAse in pull-down assays using GFP-TRAP beads. Aliquots of the bead eluate were fractionated by
SDS-PAGE and silver stained to detect GFP-WRN, GFP-WRNW18G, Ku80, and DNA-PKcs (‘CS’). (c) Cy3-labeled 30 bp duplex oligonucleotide
(20 nM) with a 50 overhang was incubated with 500, 100, 20 or 5 nM HIs-tagged WRN-Exo or WRN-ExoW18G in the absence or presence of 100 nM Ku
heterodimer (Ku70/Ku80, ‘Ku’) and 5mMMgCl2. Exonuclease products were resolved on a 16% TBE-Urea gel. (d) Exonuclease assays were conducted as
above in the presence of 5mM MgCl2 using 10 nM His-tagged WRN-Exo and 100, 20, 4 or 0.8 nM of either Ku heterodimer (Ku70/Ku80; ‘Ku’),
KuDC heterodimer (Ku70/Ku80DC; ‘KuDC’), or mutant KuDC heterodimer harbouring the Ku80 mutation, L68R (KuDCL68R). (e) Exonuclease assays
were conducted as above using 100, 20 and 4 nM of the indicated His-tagged WRN protein and 10 nM wild-type Ku heterodimer (Ku70/Ku80; ‘Ku’) in
5mM Mg2þ .
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N terminus of WRN, which accumulates at these sites
cooperatively with the adjacent exonuclease domain.
Intriguingly, database searches using Pattinprot and the core
minimal KBM sequence (R-X-X-P-X-W) identiﬁed more than
600 proteins with this motif (Supplementary Data 1). More
sophisticated bioinformatic analyses and experimental validation
are needed to identify which of these are true KBMs.
We also identiﬁed a motif in XLF, WRN, PAXX and MRI that
is similar in sequence to the KBM but which is structurally and
functionally distinct, and which we denoted the XLF-like motif.
KBMs and XLF-like motifs are similar in sequence in that both
are comprised of a basic patch followed by a highly conserved
aromatic residue, but they differ in several key respects. Whereas
KBMs possess a highly conserved proline and tryptophan the
XLF-like motifs possess a conserved phenylalanine. In addition,
whereas KBMs are found at different locations the XLF-like
motifs are typically present at protein C termini. Finally, in
contrast to KBMs, none of the XLF-like motifs interacted
measurably with Ku heterodimer in ﬂuorescence polarization
assays. This is surprising, because the XLF and PAXX motifs
promote accumulation of the full-length proteins at sites of
laser-induced chromosome damage in a Ku-dependent manner
and/or associate with Ku complexes in vitro28–30. Consequently,
we suggest that XLF-like motifs associate with Ku complexes only
in the presence of DNA and/or other cellular protein/s. This idea
is consistent with a previous report that mutation of this motif in
XLF inﬂuences binding to DNA31.
Werner syndrome is a progeroid disease characterized by
premature ageing, genetic instability and predisposition to
cancer20,21, and WRN protein is implicated in multiple
aspects of DNA metabolism including telomere maintenance,
base-excision repair, homologous recombination, replication fork
processing and NHEJ (reviewed in ref. 20). Intriguingly, WRN
protein possesses two KBMs and an XLF-like motif, with the
N-terminal KBM located next to the exonuclease domain and
the C-terminal KBM located in tandem with the XLF-like motif.
WRN interacts with multiple protein components of these
pathways including MRN nuclease, RAD51, XPG and Ku
heterodimer14,15,32–34. The interaction with Ku was reported to
occur towards both the N and C termini of WRN14,15,35, and our
identiﬁcation of N- and C-terminal KBMs has ﬁne-mapped these
interactions and allowed us to disrupt them individually or
together. All of the KBM interactions with Ku detected to date are
with the vWA-like domain of Ku80. This is in agreement with
two of the above reports, which also concluded that the N and C
termini of WRN interact with Ku80 (ref. 15), but disagrees with
the study of Karmakar et al.35 in which the WRN N terminus was
reported to interact with Ku70. The source of this discrepancy is
not clear but our conclusion that Ku80 is the partner of both the
N-terminal and C-terminal KBMs is based on a variety of
biochemical, cellular and yeast two-hybrid experiments.
Whereas mutation of the individual KBMs in full-length WRN
did not greatly reduce the interaction with Ku, as measured by
co-immunoprecipitation experiments, pair-wise mutation or
deletion greatly reduced or ablated it. However, only the
C-terminal KBM was able by itself to accumulate at sites of
chromosomal damage or efﬁciently co-precipitate Ku from cell
extract, suggesting that this KBM is the major contributor to
stable Ku binding by WRN. It is not clear why this was not
reﬂected in our ﬂuorescence polarization assays in vitro, in which
the two KBMs interacted with Ku with similar afﬁnities.
Importantly, the adjacent XLF-like motif functioned coopera-
tively with the C-terminal KBM, greatly enhancing Ku interaction
and accumulation at chromosome damage. It is possible that the
XLF-like motif simply promotes Ku binding by the adjacent
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Figure 5 | WRN KBMs accelerate DSB repair. (a) Conﬂuence-arrested
(G0/G1) hTERT-immortalised ﬁbroblasts from two WRN patients
(73–26 and AG03141) and normal controls (82–6 and 1BR) were
treated with g-rays (2Gy) and gH2Ax foci counted at the time-points
indicated. Inset, Actin and WRN protein levels in the indicated cell lines.
(b) WRN cells (73–26) stably transduced with empty vector (V) or vector
encoding wild-type (WT) WRN, WRNW18G harbouring a mutated
N-terminal KBM (W18G), or WRN harbouring a mutated exonuclease
domain WRNE84A (E84A), were examined for DSB repair rates as
described above. (c) Werner syndrome cells (73–26) stably transduced
with empty vector (V) or vector encoding WT WRN, WRNW1410G
harbouring a mutated C-terminal KBM (W1410G), or WRN harbouring a
mutated helicase domain (WRNK577M) were examined as above. Data
points are the mean (±s.e.m.) number of foci per cell from four
independent experiments. *Po0.05, **Po0.01, ***Po0.001 by paired
t-test when compared with WT cells.
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KBM for Ku in ﬂuorescence polarization assays, in vitro. Rather,
we suggest that the XLF-like motif interacts with another
component of DNA–PK complexes that is positioned near the
KBM-binding site in Ku80, such as DNA–PKcs. An interaction
between WRN and DNA–PKcs has been reported previously24,
and in our experiments the XLF-like motif promoted
co-precipitation of DNA–PKcs to a greater extent than Ku
when present either in tandem with the C-terminal KBM
(Figs 3a). While more experiments are required to conﬁrm this
idea, we suggest that the XLF-like motif in WRN interacts directly
with the catalytic subunit of DNA–PK, thereby promoting the
assembly of more stable DNA–PK protein complexes.
The N-terminal KBM in WRN was unable by itself to
accumulate at sites of chromosome damage or to precipitate
Ku from cell extract, despite the afﬁnity of this KBM for Ku
in vitro being similar to that of the C-terminal KBM. However,
the N-terminal KBM both accumulated at sites of UVA laser
damage and promoted co-precipitation of Ku if present together
with the adjacent exonuclease domain. These data suggest that
while the N-terminal KBM possesses intrinsic Ku-binding activity
it requires the adjacent exonuclease domain for Ku binding in
cells and for accumulation at sites of chromosome damage.
The reason for this difference between in vitro and cellular
functionality is currently unclear, but nevertheless the
cooperativity between the KBM and exonuclease domain
extended to the activity of the latter, which was stimulated
by Ku in a largely KBM-dependent manner. Intriguingly, fusion
of the C-terminal KBM to the C terminus of the WRN
exonuclease domain also supported Ku-dependent stimulation
of WRN exonuclease activity, even in the absence of a
functional N-terminal KBM. This suggests that the KBMs
act in an orientation-independent but proximity-dependent
manner to tether the WRN exonuclease domain to Ku–DNA
complexes.
WRN has been implicated in NHEJ previously. For example,
the interaction with Ku stimulates WRN exonuclease activity on a
variety of DSB termini, including those harbouring different
types of recessed termini and termini harbouring oxidized
nucleotides14,15,36. This is consistent with a role for WRN in
processing DSB termini during NHEJ in advance of gap ﬁlling
and DNA ligation. A number of phenotypes are also consistent
with aberrant NHEJ in WRN syndrome cells, such as mild
hypersensitivity to ionizing radiation24, reduced accuracy and
joining efﬁciency at plasmid-borne DSBs23,25, and elevated
deletion sizes at the chromosomal HPRT locus37. However, to
our knowledge, the current work is the ﬁrst in which an impact of
WRN on the rate of chromosomal NHEJ has been observed.
While this phenotype is similar to that reported for APLF,
another KBM-mediated partner of Ku80, it is unique in that it
was detected only in cells arrested in G0. We do not yet
understand the reason for this observation, but one possibility is
that the role detected here for WRN is redundant with other
proteins in other cell cycle phases. Surprisingly, although both
WRN KBMs were required for acceleration of NHEJ, the catalytic
activity of WRN was not required. This does not rule out an
involvement of WRN catalytic activity during NHEJ, because it is
possible that the fraction of DSBs requiring this activity is too
small to detect or that other enzymes can also provide this
activity. Nevertheless, our data suggest that the acceleration of
NHEJ that we have detected in this work reﬂects an impact of
WRN on the structure and stability of NHEJ protein complexes.
Such a structural role for WRN has been suggested previously, in
which WRN stabilizes DNA–PK complexes and protects DSB
termini from excessive degradation by other nucleases23.
On the basis of these data, we propose the following model
(Fig. 6). We suggest that the N- and C-terminal KBMs enable
WRN to interact with Ku80 and thereby promote the stability of
DNA–PK protein complexes. The two KBMs may interact with
Ku80 simultaneously, sequentially or both. For example, a
high-afﬁnity interaction of the C-terminal KBM tandem domain
could tether WRN to DNA–PK, with the N-terminal KBM either
displacing the C-terminal KBM from Ku80 when exonuclease
activity is required for end processing (Fig. 6, left) or,
alternatively, interacting with a second molecule of Ku on the
opposite DSB terminus to bridge the break (Fig. 6, right). Either
of these possibilities can explain the need to mutate or delete both
KBMs to greatly reduce or ablate Ku interaction, and the
requirement for both KBMs for normal rates of NHEJ.
Methods
WRN cells. The hTERT-immortalised ﬁbroblast cell lines ‘73–26’ (Werner
syndrome)24 and wild-type sibling control (‘82–6’)24 were kindly provided by Judy
Campisi (Buck Institute, CA), and the Werner syndrome cell line AG03141
(ref. 38) was kindly provided by David Kipling (Cardiff University). Retroviruses
encoding wild-type or mutant human WRN protein were packaged in GP2–293
cells using the Retro-X Universal Packaging System (Clontech) according to
the manufacturer’s instructions. GP2–293 supernatants were used to transduce
73–26 hTERT cells in the presence of 4 mgml 1 hexadimethrine bromide
(Polybrene, Sigma) for 24 h. Following three successive rounds of transduction,
cells were selected in 0.5mgml 1 G418 for 4–6 weeks. Resulting cultures were
screened for WRN expression by western blotting using mouse anti-WRN
(Abcam 66601, 1:500). All cell lines were tested and found to be mycoplasma-free
before use.
Plasmids. Primers employed for cloning and mutagenesis are detailed in
Supplementary Table 1. pET16b-WRN-Exo, encoding WRN residues 1–236
(UniProt accession number Q14191) and including a C-terminal octahistidine tag,
was generated by PCR using pEGFP-C3-WRN (a gift from Will Bohr) as a template
and subsequent subcloning of the PCR product into the NcoI and XhoI sites of
pET16b. GST-fusion or enhanced GFP (eGFP)-fusion peptides encoding the KBMs
or XLF-like motifs WRN-nA (KBM sequence; LETTAAQQRKCPEWMNVQ),
WRN-cA (KBM sequence: TSSAERKRRLPVWFAK), WRN-X (KBM sequence:
SKKLMDKTKRGGLFS), MRI-A (KBM sequence: SETKTRVLPSWLTA), MRI-X
(KBM sequence; VLKYVREIFFS), XLF (KBM sequence; VKRKKPRGLFS) and
PAXX (KBM sequence; FKSKKPAGGVDFDET) were generated by annealing
appropriate complementary oligonucleotides and ligation into the BamHI/XhoI sites
of pGEX6p1 or the BglII/SalI sites of pEGFP-C1, respectively. For GST-fused and
eGFP-fused WRN-cAX, residues 1,399–1,432 (SSAERKRRLPVWFAKSKKLMDK
TKRGGLFS) were ampliﬁed by PCR and subcloned as above. GFP-tagged
WRN-Exo-cAX was generated by PCR ampliﬁcation of WRN-Exo (see above) and
insertion of the resulting BglII fragment into the BamHI site of pGEX6-cAX. To
generate pEGFP-WRN encoding full-length WRN, a stop codon was introduced by
site-directed mutagenesis of pEGFP-C3-WRN after S1432, to remove exogenous
plasmid-derived C-terminal residues present in pEGFP-C3-WRN (see above)39.
Alternatively, to generate pGFP-WRNDcAX, a stop codon was introduced at position
S1399. Derivatives harbouring point mutations were generated by site-directed
mutagenesis using the primers in Supplementary Table 1. pmRFP-Ku70,
pmRFP-Ku80 and pmRFP-Ku80L68R were generated by subcloning from
pGFP-Ku70, pGFP-Ku80 and pGFP-Ku80L68R (ref. 11). pLXSN, pLXSN-WRN,
pLXSN-WRNE84A and pLXSN-WRNK577M were kind gifts from Junko Oshima23.
For yeast two-hybrid plasmids, the NcoI/XhoI fragments from pET16b-WRN-Exo
and pET16b-WRN-ExoW18G were ligated into the NcoI/SalI sites of pGBKT7.
pACT2-Ku80 vWA (encoding residues 1–258) was constructed using the XhoI
fragment from pACT Clone 5, which was recovered from a previous pACT human
complementary DNA library screen using APLF as bait11. pACT2-Ku80 vWAL68R
mutant was also subcloned in this way. pACT2-Ku70 vWA was cloned by PCR
ampliﬁcation of a fragment encoding amino acids 1–272 of Ku70 and insertion into
the BamHI and XhoI restriction sites of pACT2.
Yeast two-hybrid experiments. For interaction analysis, yeast Y190 cells were
co-transformed with the indicated pACT2 and pGBKT7 plasmids and selected on
minimal media plates lacking leucine and tryptophan. Transformed cells were
screened for activation of the LacZ reporter gene by b-galactosidase ﬁlter lift assays11.
Recombinant proteins. Strep-tagged WRN, Ku, KuDC and KuDCL68R were
expressed and puriﬁed from insect cells using a baculovirus expression system and
puriﬁed using immobilized metal-chelate chromatography and gel ﬁltration11.
Strep-tagged WRN was puriﬁed using an afﬁnity Strep-Tactin Superﬂow Plus
cartridge (Qiagen) followed by Superose 6 gel ﬁltration. KuDC is comprised of
full-length Ku70 and Ku80DC lacking the C-terminal residues 591–732.
His-tagged WRN-Exo was expressed from pET16b-WRN-Exo in BL21(DE3)
(pLysS) by induction with 1mM IPTG in 0.5 l cultures in LB containing
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50mgml 1 ampicillin, and 30mgml 1 chloramphenicol for 16 h at 16 C.
Harvested cells were frozen and subsequently lysed in 20mM Tris-HCl pH 7.5,
0.5 M NaCl, 5% glycerol, 1.4mM b-mercaptoethanol, 1% Triton X-100, 1mM
phenylmethylsulphonyl ﬂuoride, 10mM imidazole, pH 8.0. Cells were sonicated
(3 20 s) and the cell extracts clariﬁed by centrifugation 12,000g for 30min.
The supernatant was incubated with 0.5ml pre-washed Ni-agarose beads (Qiagen)
for 20min at 4 C and the beads washed twice with 10ml wash buffer (lysis buffer
lacking detergent) before being transferred to a gravity-ﬂow column. The resin was
washed with a further 10ml wash buffer containing 50mM imidazole and proteins
then eluted with wash buffer containing 250mM imidazole. Fractions containing
WRN-Exo were pooled and puriﬁed further by gel ﬁltration using Superdex 200
equilibrated with 20mM Tris-HCl pH 7.5, 0.3M NaCl, 10% glycerol, 1mM DTT.
GST-tagged KBMs were expressed as above and puriﬁed using glutathione
sepharose afﬁnity chromatography.
Fluorescence polarization assays. 100 nM ﬂuorescein-labeled peptides
(Peptide Protein Research) were incubated at room temperature for 10min with
the indicated concentrations of Ku70/Ku80DC (KuDC) in 20mM HEPES pH 7.5,
200mM NaCl, and 0.5mM TCEP. Fluorescence polarization was measured in a
POLARstar Omega microplate reader (BMG Labtech GmbH, Ortenberg,
Germany). Fifty ﬂashes were recorded for each well with an excitation wavelength
of 485nm, and simultaneous detection of emission at 520 nm with parallel and
perpendicular polarizers in-line. Background ﬂuorescence in wells containing only
buffer was subtracted from all values obtained for the samples. Polarization data
were analysed using GraphPad Prism 5.0 by non-linear ﬁtting with a one-site total
binding model. All data represent the mean of at least three separate experiments
and error bars represent 1 s.d. Peptide sequences are those depicted in Fig. 1a, in
each case additionally preceded with ﬂuorophore and four amino acid linker
(Flu-GGYG). For competition assays, 1 mM KuDC was incubated with 2.1 mM
ﬂuorescently labeled WRN-nA, WRN-cAX or MRI-A peptides for 10min at room
temperature followed by the indicated concentration of unlabeled APLF peptide
(highest concentration; 29mM).
Laser microirradiation. 2 105 U2-OS cells or Ku80 / mouse embryonic
ﬁbroblasts40 were seeded in glass-bottomed 35-mm dishes (Mattek) in DMEM
(þ 10% FCS) and 2 days later transfected with either (U2-OS cells) 1 mg plasmid
DNA and 3 ml Genejuice (Merck Millipore) or (Ku80 / mouse embryonic
ﬁbroblasts) 7.5 ml GeneJuice and 0.5 mg of the indicated GFP-KBM plasmid, 1 mg of
pmRFP-Ku70, and 1 mg of either pmRFP-C1 vector, pmRFP-Ku80 or pmRFP-
Ku80L68R. 24 h after transfection, cells were pre-treated with 10 mgml 1 Hoechst
34580 (Sigma) and micro-irradiated (210 nJ mm 2) with a 405 nm laser focused
through a  60 oil objective (Intelligent Imaging Innovations). Images were
captured at 10 s intervals after treatment and image analysis was carried out using
Slidebook software.
GFP pull-down assays. HEK293T cells were cultured in DMEM supplemented
with 10% FCS, glutamine and antibiotics in 15 cm culture dishes and at B70%
conﬂuence the media was replaced with 18ml Hybridoma-SFM media
(supplemented with 1% FCS and antibiotics) and supplemented with 2ml
transfection mix containing PEI (80 mg) and the appropriate plasmid (20 mg). Cells
were harvested 48 h later, washed with cold PBS and ﬂash frozen. Thawed pellets
(5 106 cells) were lysed in 400 ml lysis buffer (25mM Tris-HCl pH 7.5, 150mM
NaCl, 10% glycerol, 0.5% Triton X-100, 1mM DTT) containing protease and
phosphatase inhibitors (Sigma) for 20min at 4 C. Samples were sonicated in
water-bath sonicator for 10min at 30 s intervals (30 s on/30 s off). Cell extracts
were clariﬁed by centrifugation (13,000g, 10min, 4 C) and 40 ml removed for the
‘input’ sample. GFP-TRAP beads (20 ml; Chromotek) were washed three times with
lysis buffer then incubated with the supernatant for 1 h at 4 C. Unbound proteins
were recovered by gentle centrifugation (2,700g, 2min, 4 C) and the beads were
washed with 3 500 ml lysis buffer. Proteins were then eluted from the beads using
SDS–PAGE loading buffer, heated at 95 C for 5min, and aliquots fractionated by
10% SDS–PAGE and transferred to Hybond-C membrane (GE Healthcare).
Proteins were detected by immunoblotting using anti-GFP (Cell Signalling #2555S,
1/1,000 dilution), anti Ku80 (Abcam Ab80592, 1/10,000 dilution), anti DNA–PKcs
(Abcam Ab80514, 1/1,000 dilution) or anti-RFP (Abcam, Ab62341, 1:1,000)
antibodies. Pictures of the full membranes containing the blotted eluates from these
experiments are shown in Supplementary Figs 6–8.
Strep-tag pull-down assays. Streptavidin Mag Sepharose beads (100 ml; GE
Healthcare) were washed three times with sample buffer (20mM Hepes pH 7.5,
150mM NaCl, 5% glycerol, 0.5mM TCEP, 0.05% IGEPAL-CA640) then incubated















Figure 6 | A Model for WRN KBM function during NHEJ. Top, DNA–PK holoenzyme binds to a DSB. Bottom left, WRN is recruited into DNA–PK
complexes by high afﬁnity interaction between the C-terminal KBM (red circle) and the hydrophobic pocket in the vWA domain of Ku80. The XLF-like motif
(blue circle) functions cooperatively, perhaps stabilizing the association of Ku with DNA–PKcs. Following autophosphorylation, DNA–PKcs dissociates and
the C-terminal KBM is replaced by the N-terminal KBM to stimulate WRN 30-exonucease activity. Bottom right, The N-terminal and C-terminal KBMs bind
two Ku molecules simultaneously, bridging the DSB. Note that WRN may fulﬁl both enzymatic and structural roles during NHEJ.
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protein was recovered by applying magnetic force to the slurry, and the beads
washed with 3 500 ml sample buffer. Recombinant untagged Ku protein (50 nM)
was then incubated with the beads for 1 h at 4 C, the unbound fraction removed
and washes performed as above. Bound proteins were eluted from the beads using
SDS–PAGE loading buffer, heated at 95 C for 5min, and aliquots fractionated by
10% SDS–PAGE and stained with Instant Blue (Expedeon).
Exonuclease assays. A 50 Cy3-labeled 30-bp oligonucleotide (50 cy3-CCGTTTCG
CTCAAGTTAGTATGTCAAAGCA-30) was annealed to a complementary
unlabeled 30-bp oligonucleotide (50-CGTTGAAGCCTGCTTTGACATACT
AACTTG-30) to produce a 20-bp duplex with 10 nucleotide 50 overhangs. 20 nM of
DNA duplex was incubated at 37 C for 30min with 10nM or the indicated titration
of WRN-Exo or WRN-ExoW18G in reaction buffer (20mM Tris-HCl, pH 7.5, 50mM
KCl, 10mM MgCl2, 1mM DTT and 0.1mgml 1 BSA). Where indicated, reactions
also contained 10nM or the indicated titration of Ku, Ku70/Ku80DC or Ku70/
Ku80DCL68R and where indicated 5mM of either MgCl2 or MnCl2. Reactions were
stopped using 90% (v/v) Formamide/TBE and heated at 95 C for 5min. Products
were fractionated on 16% TBE-Urea gels in 1 TBE (89mM Tris, 89mM Boric
Acid, 2mM EDTA) and imaged on a Fuji imager using a Cy3 ﬁlter.
cH2Ax assays. 3 105 of the indicated cells were seeded and grown on coverslips
in 35-mm dishes and grown to conﬂuence for 1 week. Cells were then treated with
2Gy gIR, ﬁxed with paraformaldehyde at the time-points indicated, and
immunolabeled as previously described41. Cells were co-labeled with CENPF to
conﬁrm that cell populations were conﬂuence-arrested.
References
1. Cannan, W. J. & Pederson, D. S. Mechanisms and consequences of
double-strand DNA break formation in chromatin. J. Cell. Physiol. 231, 3–14
(2016).
2. Soulas-Sprauel, P. et al. V(D)J and immunoglobulin class switch
recombinations: a paradigm to study the regulation of DNA end-joining.
Oncogene 26, 7780–7791 (2007).
3. Bunting, S. F. & Nussenzweig, A. End-joining, translocations and cancer.
Nat. Rev. Cancer 13, 443–454 (2013).
4. McKinnon, P. J. & Caldecott, K. W. DNA strand break repair and human
genetic disease. Annu. Rev. Genomics Hum. Genet. 8, 37–55 (2007).
5. Woodbine, L., Gennery, A. R. & Jeggo, P. A. The clinical impact of deﬁciency in
DNA non-homologous end-joining. DNA Repair (Amst) 16, 84–96 (2014).
6. Chapman, J. R., Taylor, M. R. G. & Boulton, S. J. Playing the end game: DNA
double-strand break repair pathway choice. Mol. Cell 47, 497–510 (2012).
7. Mahaney, B. L., Meek, K. & Lees-Miller, S. P. Repair of ionizing radiation-
induced DNA double-strand breaks by non-homologous end-joining. Biochem.
J. 417, 639–650 (2009).
8. Davis, A. J., Chen, B. P. C. & Chen, D. J. DNA-PK: a dynamic enzyme in a
versatile DSB repair pathway. DNA Repair (Amst) 17, 21–29 (2014).
9. Ochi, T. et al. Structural biology of DNA repair: spatial organisation of the
multicomponent complexes of nonhomologous end joining. J. Nucleic Acids
2010, pii: 621695 (2010).
10. Grundy, G. J., Moulding, H. A., Caldecott, K. W. & Rulten, S. L. One ring to
bring them all-The role of Ku in mammalian non-homologous end joining.
DNA Repair (Amst) 17, 30–38 (2014).
11. Grundy, G. J. et al. APLF promotes the assembly and activity of non-
homologous end joining protein complexes. EMBO J. 32, 112–125 (2013).
12. Shirodkar, P., Fenton, A. L., Meng, L. & Koch, C. A. Identiﬁcation and
functional characterization of a Ku-binding motif in Aprataxin polynucleotide
kinase/phosphatase-like factor (APLF). J. Biol. Chem. 288, 19604–19613 (2013).
13. Altschul, S. F. et al. Gapped BLAST and PSI-BLAST: a new generation of
protein database search programs. Nucleic Acids Res. 25, 3389–3402 (1997).
14. Cooper, M. P. et al. Ku complex interacts with and stimulates the Werner
protein. Genes Dev. 14, 907–912 (2000).
15. Li, B. & Comai, L. Functional interaction between Ku and the werner syndrome
protein in DNA end processing. J. Biol. Chem. 275, 28349–28352 (2000).
16. Slavoff, S. A., Heo, J., Budnik, B. A., Hanakahi, L. A. & Saghatelian, A. A human
short ORF-encoded peptide that stimulates DNA end joining. J. Biol. Chem.
C113, 533968 (2014).
17. Harris, R. et al. The 3D solution structure of the C-terminal region of Ku86
(Ku86CTR). J. Mol. Biol. 335, 573–582 (2004).
18. Rivera-Calzada, A., Spagnolo, L., Pearl, L. H. & Llorca, O. Structural model of
full-length human Ku70-Ku80 heterodimer and its recognition of DNA and
DNA-PKcs. EMBO Rep. 8, 56–62 (2007).
19. Walker, J. R., Corpina, R. A. & Goldberg, J. Structure of the Ku heterodimer
bound to DNA and its implications for double-strand break repair. Nature 412,
607–614 (2001).
20. Rossi, M. L., Ghosh, A. K. & Bohr, V. A. Roles of Werner syndrome protein in
protection of genome integrity. DNA Repair (Amst) 9, 331–344 (2010).
21. Muftuoglu, M. et al. The clinical characteristics of Werner syndrome: molecular
and biochemical diagnosis. Hum. Genet. 124, 369–377 (2008).
22. Perry, J. J. P. et al. WRN exonuclease structure and molecular mechanism
imply an editing role in DNA end processing. Nat. Struct. Mol. Biol. 13,
414–422 (2006).
23. Chen, L. et al. WRN, the protein deﬁcient in Werner syndrome, plays a critical
structural role in optimizing DNA repair. Aging Cell 2, 191–199 (2003).
24. Yannone, S. M. et al. Werner syndrome protein is regulated and
phosphorylated by DNA-dependent protein kinase. J. Biol. Chem. 276,
38242–38248 (2001).
25. Oshima, J., Huang, S., Pae, C., Campisi, J. & Schiestl, R. H. Lack of WRN results
in extensive deletion at nonhomologous joining ends. Cancer Res. 62, 547–551
(2002).
26. Li, B. & Comai, L. Requirements for the nucleolytic processing of DNA ends by
the Werner syndrome protein-Ku70/80 complex. J. Biol. Chem. 276, 9896–9902
(2001).
27. Agarwal, S. et al. Isolation, characterization, and genetic complementation of a
cellular mutant resistant to retroviral infection. Proc. Natl Acad. Sci. USA 103,
15933–15938 (2006).
28. Ochi, T. et al. DNA repair. PAXX, a paralog of XRCC4 and XLF, interacts
with Ku to promote DNA double-strand break repair. Science 347, 185–188
(2015).
29. Xing, M. et al. Interactome analysis identiﬁes a new paralogue of XRCC4 in
non-homologous end joining DNA repair pathway. Nat. Commun. 6, 6233
(2015).
30. Yano, K.-I., Morotomi-Yano, K., Lee, K.-J. & Chen, D. J. Functional signiﬁcance
of the interaction with Ku in DNA double-strand break recognition of XLF.
FEBS Lett. 585, 841–846 (2011).
31. Andres, S. N. et al. A human XRCC4-XLF complex bridges DNA. Nucleic Acids
Res. 40, 1868–1878 (2012).
32. Cheng, W.-H. et al. Linkage between Werner syndrome protein and the Mre11
complex via Nbs1. J. Biol. Chem. 279, 21169–21176 (2004).
33. Otterlei, M. et al. Werner syndrome protein participates in a complex with
RAD51, RAD54, RAD54B and ATR in response to ICL-induced replication
arrest. J. Cell Sci. 119, 5137–5146 (2006).
34. Trego, K. S. et al. The DNA repair endonuclease XPG interacts directly and
functionally with the WRN helicase defective in Werner syndrome. Cell Cycle
10, 1998–2007 (2011).
35. Karmakar, P., Snowden, C. M., Ramsden, D. A. & Bohr, V. A. Ku heterodimer
binds to both ends of the Werner protein and functional interaction occurs at
the Werner N-terminus. Nucleic Acids Res. 30, 3583–3591 (2002).
36. Orren, D. K. et al. A functional interaction of Ku with Werner
exonuclease facilitates digestion of damaged DNA. Nucleic Acids Res. 29,
1926–1934 (2001).
37. Fukuchi, K., Martin, G. M. & Monnat, R. J. Mutator phenotype of Werner
syndrome is characterized by extensive deletions. Proc. Natl Acad. Sci. USA 86,
5893–5897 (1989).
38. Wyllie, F. S. et al. Telomerase prevents the accelerated cell ageing of Werner
syndrome ﬁbroblasts. Nat. Genet. 24, 16–17 (2000).
39. Kobbe, von C. et al. Colocalization, physical, and functional interaction
between Werner and Bloom syndrome proteins. J. Biol. Chem. 277,
22035–22044 (2002).
40. Lo¨ser, D. A. et al. Sensitization to radiation and alkylating agents by inhibitors
of poly(ADP-ribose) polymerase is enhanced in cells deﬁcient in DNA double-
strand break repair. Mol. Cancer Ther. 9, 1775–1787 (2010).
41. Rulten, S. L. et al. PARP-3 and APLF function together to accelerate
nonhomologous end-joining. Mol. Cell 41, 33–45 (2011).
Acknowledgements
This work was funded by a CR-UK Programme grants to K.W.C (C6563/A16771), L.H.P.
and A.W.O. (C302/A14532).
Author contributions
S.L.R. and G.J.G. conducted all cell biology experiments, pull-down experiments from cell
extracts, and exonuclease assays. K.D. and Z.K. contributed to early experiments in the
study. R.A.-B. conducted FP assays and pull-down experiments with puriﬁed proteins.
A.W.O. and L.H.P. supervised and designed the FP assay, biophysical and structural
aspects of the project with R.A.-B., and K.W.C. supervised and designed the cell biology
and biochemical aspects of the project with S.L.R. and G.J.G. K.W.C. conceived and
managed the overall project. K.W.C. wrote the manuscript with input and editing from
all of the authors.
Additional information
Supplementary Information accompanies this paper at http://www.nature.com/
naturecommunications
Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms11242
10 NATURE COMMUNICATIONS | 7:11242 |DOI: 10.1038/ncomms11242 | www.nature.com/naturecommunications
Reprints and permission information is available online at http://npg.nature.com/
reprintsandpermissions/
How to cite this article: Grundy, G. J. et al. The Ku-binding motif is a conserved module
for recruitment and stimulation of non-homologous end-joining proteins. Nat. Commun.
7:11242 doi: 10.1038/ncomms11242 (2016).
This work is licensed under a Creative Commons Attribution 4.0
International License. The images or other third party material in this
article are included in the article’s Creative Commons license, unless indicated otherwise
in the credit line; if the material is not included under the Creative Commons license,
users will need to obtain permission from the license holder to reproduce the material.
To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms11242 ARTICLE
NATURE COMMUNICATIONS | 7:11242 | DOI: 10.1038/ncomms11242 | www.nature.com/naturecommunications 11
1Scientific REPORTS |  (2018) 8:3850  | DOI:10.1038/s41598-018-21806-y
www.nature.com/scientificreports
Large XPF-dependent deletions 
following misrepair of a DNA 
double strand break are prevented 
by the RNA:DNA helicase 
Senataxin
Julien Brustel1, Zuzanna Kozik1, Natalia Gromak2, Velibor Savic3,4 & Steve M. M. Sweet1,5
Deletions and chromosome re-arrangements are common features of cancer cells. We have established 
a new two-component system reporting on epigenetic silencing or deletion of an actively transcribed 
gene adjacent to a double-strand break (DSB). Unexpectedly, we find that a targeted DSB results in 
a minority (<10%) misrepair event of kilobase deletions encompassing the DSB site and transcribed 
gene. Deletions are reduced upon RNaseH1 over-expression and increased after knockdown of the 
DNA:RNA helicase Senataxin, implicating a role for DNA:RNA hybrids. We further demonstrate that 
the majority of these large deletions are dependent on the 3′ flap endonuclease XPF. DNA:RNA hybrids 
were detected by DNA:RNA immunoprecipitation in our system after DSB generation. These hybrids 
were reduced by RNaseH1 over-expression and increased by Senataxin knock-down, consistent with 
a role in deletions. Overall, these data are consistent with DNA:RNA hybrid generation at the site of a 
DSB, mis-processing of which results in genome instability in the form of large deletions.
DNA is the target of numerous genotoxic attacks that result in different types of damage. DNA double-strand 
breaks (DSBs) occur at low frequency, compared with single-strand breaks and other forms of DNA damage1, 
however DSBs pose the risk of translocations and deletions and their repair is therefore essential to cell integrity. 
The majority of DSBs are repaired by either homologous recombination (HR) or non-homologous end-joining 
(NHEJ), with a smaller fraction repaired by non-canonical alternative end joining and single-strand annealing 
pathways2–5. In order to study the repair of a DSB at a known site in the genome, rare-cutting endonucleases 
such as I-SceI are employed6. DSBs generated by endonucleases have ‘clean’ ends, i.e. intact 5′-phosphate and 
3′-hydroxyl groups, and are in most cases repaired without end-processing and associated deletions7,8.
R-loops consist of an RNA:DNA hybrid, with the RNA displacing the non-transcribed DNA strand9. R-loops 
are a source of genome instability9,10. Indeed, collisions between replication or transcription machineries with 
R-loops can result in DSBs. It has recently been shown that Fanconi anemia proteins prevent instability result-
ing from replication fork progression and R-loops11,12. Furthermore, the displaced single-stranded DNA result-
ing from R-loop formation is susceptible to damage or processing. For example it has been shown that the 
transcription-coupled nucleotide excision repair (TC-NER) pathway, including flap endonucleases XPF/ERCC4 
and XPG/ERCC5, can generate DSBs after R-loop formation13. Recently it has been demonstrated in S. pombe that 
DNA:RNA hybrids can occur in a DSB-dependent manner, associated with PolII recruitment to the DSB region14. 
These DNA:RNA hybrids are presumed to originate from transcription from the DSB and the displaced DNA 
strand is either resected or free-floating. DNA damage-dependent DNA:RNA hybrids have also been detected 
in human cells15. Transcription initiated from DSBs in human, Drosophila and plant cells has been reported16–19.
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To prevent the formation of R-loops, RNA-binding proteins interact with the RNA transcript, preventing it 
from invading the DNA duplex10. In parallel, topoisomerase enzymes resolve R-loop-promoting negative super-
coiling, generated behind polymerases10,20. In addition, the cell possesses two different mechanisms to remove 
R-loops: the DNA-associated RNA can be specifically digested by enzymes of the RNase H family; the DNA:RNA 
hybrid can be dissociated by DNA:RNA helicases such as Senataxin, Aquarius and others13,21,22. Removing the 
protective function of Senataxin results in an increase in DNA strand breakage and γH2AX: these effects are 
reduced with overexpression of RNaseH1, implicating increased R-loops in the damage23.
In this report, we have established a new system to study the deleterious consequences of DSBs utilising a 
proximal transcription unit as a marker. We show that targeted DSB induction and repair is correlated with an 
appearance of a subpopulation where the neighbouring gene is lost due to a large deletion. Knockdown of the 
DNA:RNA helicase Senataxin increases deletions, while RNaseH1 over-expression and knockdown of the 3′ flap 
endonuclease XPF/ERCC4 has the opposite effect. DNA:RNA hybrids were only detected after DSB induction. 
These results suggest a role of DNA:RNA hybrids in DSB processing, defects in which can result in genome insta-
bility in the form of large deletions.
Results
A two-component system to study the long-term effect of DNA damage on a neighbouring 
gene. To study the long-term and inherited effect of DNA DSB repair on gene expression, we established 
a two-component system allowing the quantification of long-term loss of gene expression close to DNA dam-
age. The U2OS cell line was created by stable integration of two independent sequences (Fig. 1A and S1A). The 
first insertion is composed of a restriction endonuclease (RE) site array (containing recognition sites for the 
rare-cutter enzymes I-SceI, I-PpoI and I-AniY2) localized 2 kb upstream of an actively transcribed bicistronic 
cassette coding for the TetR and Neomycin-Resistance (NeoR) genes under control of the CMV promotor. The 
second component is a bicistronic cassette coding for a nuclear GFP and the Puromycin-Resistance (PuroR) 
genes under the control of a TetO cassette. The TetR protein, expressed by the first component, represses the GFP 
and the PuroR (Figure S1B). This system is reversible either by doxycycline disruption of the TetR:TetO interac-
tion (Figure S1B) or by loss of the TetR protein.
To induce the site-specific DSB, cells are transiently transfected with a plasmid coding for a nuclear-localisation 
inducible form of I-SceI (I-SceI-GR-LBD)24: the nuclease is re-localized from the cytoplasm to the nucleus upon 
triamcinolone acetonide (TA) hormone treatment (2 hours) (Figure S1C). Nuclear entry is associated with acti-
vation of the local DNA damage response, as indicated by γH2AX and 53BP1 foci adjacent to the lacO array 
(Figure S1D). To evaluate the percentage of breaks occurring after I-SceI nuclear induction, the genomic DNA 
was extracted and the RE array amplified by qPCR, alongside a genomic control region. A DSB is associated 
with a lack of amplification of the RE array. Under our experimental conditions, around 35% of cells contain an 
unrepaired DSB at the I-SceI sites two hours after DSB induction (Figure S1E). This new two-component system 
allows the quantification and characterization of long-term loss of gene expression induced by a DSB.
A double-strand break induces loss of TetR expression. Strikingly, following site-specific DSB and 
repair, a new population of cells characterized by the expression of the bicistronic cassette GFP-IRES-PuroR 
appears. This GFP-positive population was quantified by fluorescence-activated cell sorting (FACS) analysis 
seven days after I-SceI-induced DSB (Fig. 1B), or by a clonogenic survival assay, following puromycin selection 
(Fig. 1C). It is important to note that this phenomenon appears to be independent of the chromosomal insertion 
location of the cassette, as this result has been reproduced in six different polyclonal cell lines (independently 
established) as well as in thirteen different monoclonal cell lines (Figure S1F,G). It is also independent of the LacO 
repeat sequences (Figure S1H). Furthermore, the appearance of this subpopulation is dependent on RE cutting: it 
was not observed in a cell line where the RE array was deleted (Figure S1F). We obtained similar results with other 
site-specific endonucleases: I-PpoI (Figure S2) and I-AniIY2 (Fig. 1D). Interestingly, the expression of the nickase 
mutant I-AniIY2-K227M which can induce only a single-strand break25,26 was not associated with the appearance 
of this GFP-expressing subpopulation (Fig. 1D).
All together, these data suggest that after DSB and repair, a subset of cells (<10%) lose the expression of the 
neighbouring gene. This could be due to long-term silencing mediated by a change of the local chromatin state27 
or simply by a large deletion including the neighbouring gene28,29.
A double-strand break induces large deletions. In order to investigate the mechanism of loss of 
expression after DSB, puromycin selection was employed to isolate the subpopulation of cells expressing 
GFP-IRES-PuroR after DNA damage. Antibiotic selection after DSB induction gave polyclonal cell lines char-
acterized by expression of GFP and the absence of the TetR protein (Fig. 1E). Genomic DNA was extracted and 
sites proximal to the DSB site were compared to a distant control region by quantitative PCR (qPCR) assay (sites 
annotated in Fig. 1A)30. The qPCR signals obtained for each set of primers were normalized to the signal from the 
parental cell line, i.e. the cell line without DSB induction and puromycin selection. Interestingly, the results from 
three independently established polyclonal cell lines show a near complete loss of DNA template around the DSB 
site (Fig. 1F), demonstrating that the loss of TetR is caused predominantly by large deletions of at least 9 kb. To 
confirm this result, we also isolated clones showing GFP appearance after DSB by limited dilution, without antibi-
otic selection, into 96 well plates. After plating, GFP-expressing clones (≤1 per well) were selected through puro-
mycin resistance and colonies derived from single cells (Figure S3A) were investigated for deletions. The qPCR 
assay was carried out as above and a similar pattern of loss of DNA was observed on 43 different GFP-positive 
clones (Figure S3B,C).
Our data indicate that we have established a new tool to study the mechanism behind large, DSB-dependent, 
deletions, in contrast to the majority of I-SceI systems which are only designed to monitor deletions up to a certain 
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Figure 1. Two-component system to study large deletions following a DSB: (A) Schematic representation of 
the cell line, named U2OS-RE-TetR-GFP. Two components have been stably integrated in the U2OS cell line: 
the first (top panel) is composed of LacO repeats, an array with specific RE sites for I-SceI, I-PpoI and I-AniY2, 
and a TetR-IRES-NeoR gene under control of a CMV promotor; the second component (bottom panel) is a 
bicistronic GFP-IRES-PuroR cassette under the control of two TetO sites. The red arrows indicate the location of 
the primers used in F, and the black arrows the distance to the RE array. (B) Flow cytometry analysis of the GFP-
positive subpopulation seven days after I-SceI induction. Top panel: representative dot plots of FACS analysis 
seven days after I-SceI induction in I-SceI-transfected or in control cells (Mock). The green square indicates 
the gate used to quantify the percentage of positive cells. Bottom panel: quantification of the percentage of 
GFP-positive cells seven day after I-SceI induction (n = 11 for a single U2OS-RE-TetR-GFP clone (mc#5). (C) 
Clonogenicity assay: 3 days after I-SceI induction cells were treated with puromycin for one week, then fixed 
and stained with brilliant blue (top panel). Bottom panel: ImageJ quantification of colony numbers (n = 3). (D) 
The loss of TetR expression is dependent on DSB: fold-change of GFP-positive cells induced by different RE, 
as indicated (I-SceI, I-AniY2 wt and the nickase mutant I-AniY2-K227M) normalised to I-SceI (n = 3). (E) 
Immunoblot analysis of a polyclonal cell line selected by puromycin treatment following I-SceI induction, with 
specific antibodies directed against TetR, GFP and tubulin (as a loading control). (F) Relative quantification of 
genomic DNA in 3 independently established puromycin-selected cell lines evaluated by qPCR using specific 
primers localized around the break site (as indicated in A), compared to a genomic control region (Genomic 
control #1) and normalized to the signal from untreated cells (n = 3). All p-values are from two-tailed, paired 
T-tests. All error bars represent the standard error of the mean, unless stated otherwise.
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size, e.g. 500 bp from the I-SceI cut site31. Given that we never observed GFP-positive cells without a corresponding 
deletion, for brevity we refer to I-SceI-dependent increases in GFP-positive cells as ‘I-SceI-dependent deletions’.
The DSB-induced large deletions are independent of ATM, ATR and DNA-PK activation and 
cell cycle stage at the time of damage. We first tested if this deletion requires activation of early damage 
response kinases. Using inhibitors of the kinases ATM, DNA-PK and ATR (Figure S4A,B) we did not observe 
significant changes in the levels of large deletions (inhibition from one hour before I-SceI nuclear localization 
until 24 h after damage induction for ATM and DNA-PK inhibitors or 4 h after for the ATR inhibitor; Fig. 2A). 
This observation suggests that the activation of these canonical kinases at the time of the DSB is not required for 
this phenomenon.
Secondly, we hypothesized that collision between DSB repair and DNA replication could be a cause of this 
genomic instability. To test the role of replication fork progression in the appearance of DSB-induced deletions, 
the I-SceI cutting was carried out in arrested cells. Cells were arrested either at the G1/S phase boundary by thy-
midine treatment, or in G2 phase by CDK1 inhibitor treatment (Fig. 2B). TA treatment of arrested cells allowed 
I-SceI nuclear localisation and, after 4 hours to allow damage and repair, cells were released. After seven days, we 
did not observe any significant change in the population of I-SceI-dependent GFP-positive cells that were arrested 
at the time of damage, compared to asynchronous cells (Fig. 2C). This suggests that the deletions are not restricted 
to cells undergoing DNA replication at the time of damage.
R-loop modulators alter DSB-induced deletion frequencies. R-loop structures, associated with 
transcription, have been identified as an important source of genetic instability9,10. We hypothesised that these 
molecular structures could be one of the causes of our deletions. To test the hypothesis that DNA:RNA hybrid are 
involved in DSB-dependent large deletions we employed three approaches. We first asked whether knockdown 
of Senataxin, an DNA:RNA helicase, capable of resolving DNA:RNA hybrid21, would alter the level of deletions. 
After depletion of Senataxin I-SceI-dependent deletions are significantly increased (Fig. 3A, S5A,B). We next 
over-expressed RNaseH1 (Figure S5C), an enzyme capable of removing transcription-associated DNA:RNA 
hybrids11,32,33. This resulted in a strong (80%) reduction in I-SceI-dependent deletions (Fig. 3B, S5D). To control 
for possible confounding effects, we confirmed that RNaseH1 over-expression did not reduce the cutting effi-
ciency of I-SceI (Figure S1E), or alter the level of transcription of the TetR-IRES-Neo gene (Figure S5E). Finally, 
we inhibited TopI to increase negative supercoiling behind the transcription complex, an approach that has previ-
ously been shown to increase R-loops34,35. TopI inhibition with camptothecin (CPT) induced a two-fold increase 
in DSB-associated deletions (Fig. 3C, S5C,F). In addition to increasing negative supercoiling, CPT-stabilised 
TopI-cleavage complexes lead to DSBs upon collision with the DNA replication machinery36. To control for a 
possible CPT damage-dependent effect on I-SceI-dependent deletions, we carried out TopI knockdown; this 
is expected to increase transcription-generated negative supercoiling in the absence of stabilised TopI-cleavage 
complex damage. TopI knockdown (Figure S5G) also resulted in an increase in DSB-dependent deletions, similar 
to that seen with CPT (compare Figure S5F and G).
R-loops are a 3-stranded structure: it has been shown that this structure can be a target for structure-specific 
endonucleases such as XPF/ERCC4 and XPG/ERCC513,37, as part of the transcription-coupled nucleotide exci-
sion repair (TC-NER) pathway. To study the influence of these endonucleases, XPF and XPG were depleted 
by siRNA in our DSB deletion reporter system. The depletion of XPF led to a significant decrease in deletions, 
suggesting a role for this endonuclease in the DSB deletion mechanism (Fig. 3D and S5A,H). By contrast, the 
depletion of XPG by siRNA did not prevent DSB-induced deletion (Fig. 3E and S5A,I). In addition, the depletion 
of ERCC8, a subunit of CSA38, involved in the early stages of TC-NER upstream of XPF/XPG activity, did not 
affect the DSB-induced deletion (Figure S5J). These data suggest an NER-independent role of XPF, which also 
has roles in alternative error-prone and deletion associated DSB repair pathways, namely alternative end joining 
(Alt-NHEJ) and single strand annealing (SSA)5,39–42.
Overall, the SETX, RNaseH1 and TopI data are consistent with a role for R-loops in our DSB-dependent dele-
tions. We next asked whether inhibiting transcription reduced the level of DSB-dependent deletions and whether 
R-loops could be detected locally by DNA:RNA immunoprecipitation (DRIP).
Deletions are unaffected by modulation of transcription and R-loops are not detected by DRIP in 
undamaged cells. To test the influence of transcriptional activity on our phenotype, cells were first treated with 
an inhibitor of transcription elongation, DRB, one hour before and concomitant with DSB induction (2 h)43. This 
short and global transcription elongation inhibition did not significantly reduce the level of deletions (Fig. 4A; S6A).
Transient global inhibition of transcription is a crude tool: to more selectively study the potential role of local 
transcriptional activity on deletion, our two-component system was modified by integration of two TetO cassettes 
between the CMV promotor and the TetR-IRES-PuroR gene (Fig. 4B). This modification allows regulation of the 
gene transcription activity: in the presence of doxycycline, the interaction between TetR and the TetO cassette is 
prevented, and consequently the TetR gene is highly expressed, as is the GFP gene. In contrast, when doxycycline 
is removed, there is an auto-repression of TetR transcription by the TetR protein (schematic in Figure S6B, GFP 
expression in both condition Figure S6C); this results in a 60% decrease of TetR protein level (Fig. 4C) and a cor-
responding drop in mRNA level (Fig. 4D). This system allows deletion quantification with the same cell line, in 
a context of high (+Dox) or low (−Dox) transcription. It is important to note that for the high expression level 
condition, the doxycycline was removed 24 h after TA induction. This allows a high level of transcription during 
the break and the repair, and subsequent repression of GFP over the next six days, prior to scoring GFP-positive 
cells (Fig. 4B). Induction of DSBs in the context of high or low transcription is equally efficient (Figure S6D) and 
led to similar levels of deletions (Fig. 4E). This result suggests that the level of expression of the neighbouring gene 
does not play a major role in misrepair deletions, in concordance with the literature44.
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To evaluate the presence of DNA:RNA hybrids at the highly expressed TetR-IRES-NeoR gene, immunoprecip-
itation with the DNA:RNA specific antibody S9.6 followed by qPCR analysis (DRIP-qPCR) was performed (cell 
line in Fig. 1). While we detect a specific R-loop signal at the APOE positive control locus12,33, we did not detect 
Figure 2. The DSB-induced deletions are independent of ATM, ATR and DNA-PK activation and DNA 
replication at the time of damage: (A) I-SceI-dependent increase in deletions in cells treated with or without 
inhibitors from 1 h before DSB induction (and until 24 h after for ATM and DNA-PK inhibitors, 4 h after 
for ATRi), normalised to control cells (n = 3 for ATMi and DNA-PKi, n = 4 for ATRi). (B) Cell cycle profile 
quantifying PI-stained DNA of proliferating cells (top panel), thymidine-arrested cells (G1/S; middle panel) or 
CDK1-I-treated cells (RO-3306; G2; bottom panel); (C) DSB-induced deletions are independent of cell-cycle 
stage at the time of damage. Top panel: experimental design to study the impact of cell-cycle stage at the time 
of DSB induction on deletion: after I-SceI transfection, cells are arrested with 18 h treatment with the drug 
pre-I-SceI induction, as indicated. During the arrest, I-SceI nuclear localisation is induced. Cells are released 
4 hours after the induction. Bottom panel: I-SceI-dependent increase in deletions normalised to asynchronous 
cells (asynchronous n = 5; G1/S arrested (thymidine) n = 3; G2 arrested (CDKi) n = 2, each dot represents one 
experiment).
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R-loop levels above background at the TetR gene (background estimated by treatment with RNaseH in vitro, 
pre-IP; Fig. 4F). Based on the transcription-level independent nature of the deletions, and the lack of detectable 
R-loops, we conclude that canonical R-loop processing is not responsible for the DSB-dependent deletions.
DNA:RNA hybrids occur at the break site. We next considered the possibility that DNA:RNA hybrids 
were generated as a consequence of local transcription occurring after the I-SceI DSB. Two hours after I-SceI 
induction, cells were collected and DRIP was performed. We detected an increase in DNA:RNA signal after I-SceI 
cleavage adjacent to the I-SceI array and at the TetR gene but not at the intergenic control region or APOE gene 
(Fig. 5A). The DSB-dependent DRIP signal was increased further after Senataxin knockdown (Fig. 5A, IsceI + siS-
ETX condition). By contrast, DNA:RNA hybrids at the break site were prevented by RNaseH1 over-expression 
(Fig. 5A, IsceI + RNaseH1 condition). These trends, while not statistically significant, due to large variability in 
the DRIP signal, are consistent with a role for DSB-dependent DNA:RNA hybrids in the deletion process.
Discussion
In this report, we have established a cell line to study DSB-induced large deletions based on the loss of a gene 
in the proximity of an RE array. The fact that TetR sequence was missing in all the clones analysed (Figure S3) 
strongly suggests that silencing due to epigenetic changes, as previously described for a system utilising a 
promoter known to undergo DNA methylation-dependent silencing27, does not account for the loss of TetR 
expression in our system. Large deletions induced by I-SceI have previously been observed28,29. However the 
requirement for selection to observe these large deletions usually precludes an estimate of frequency and the 
mechanism resulting in these large deletions has not been determined28,29. The gain of GFP-expression associated 
with deletions in our system allows the quantification of rare events. We observe the frequency of DSB-induced 
large deletions to vary between 0.3% and 22% of transfected cells, across nineteen independently integrated cell 
lines (Figure S1F; taking into account background, I-SceI independent loss and transfection efficiency of ~35% 
Figure 3. R-loop modulators alter DSB-induced deletion frequencies: (A) Knockdown of the helicase Senataxin 
increases the level of DSB-induced deletions. I-SceI-dependent increase in deletions in Senataxin-depleted cells 
normalised to siCtrl cells (n = 3). (B) RNAseH1 expression prevents DSB-induced deletions: I-SceI-dependent 
increase in deletions in RNaseH1-expressing cells normalised to control cells (n = 4). (C) Camptothecin 
(CPT) treatment increases DSB-induced deletions: I-SceI-dependent increase in deletions in CPT treated 
cells normalised to control cells (n = 7). (D,E) Knockdown of the endonucleases XPF/ERCC4 (D) and XPG/
ERCC5 (E). I-SceI-dependent increase in deletions four days after I-SceI induction in XPF/ERCC4-depleted 
cells (siXPF) normalised to control cells (siCtrl) (n = 6 for siXPF#1; n = 3 for siXPF#2, siXPG). Knockdown 
efficiencies shown in Figure S5A.
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(Figure S1D). These frequencies are not per DSB: I-SceI will cut repeatedly, until a misrepair event removes the 
cleavage motif, therefore the rate of deletion per DSB will be lower than the rate per transfected cell.
LacO repeats, in the presence of LacI repressor, have been shown to act as fragile sites, generating DSBs45. In 
our system we are confident that the lacO repeats are not playing a significant role in the DSB-induced deletion 
Figure 4. DSB-dependent deletions are unaffected by modulation of transcription: (A) I-SceI-dependent 
increase in deletions seven days after I-SceI induction in cells treated with the transcription inhibitor DRB 
compared to control cells (n = 7). (B) Schematic representation of the transcription regulation system. Upper 
panel: two TetO cassettes are inserted in front of TetR-IRES-NeoR. Lower panel: experimental design to study 
deletions in a context of high (+Dox) or low (−Dox) transcriptional activity, indicating I-SceI transfection 
and induction, doxycycline treatment and FACS analysis. (C) Immunoblot analysis of the cell line treated with 
or without doxycycline for six days, using antibodies against TetR, GFP and tubulin (as a loading control) (left 
panel). Right panel: relative quantification (n = 2). (D) TetR mRNA quantification by RT-qPCR, normalized 
to GAPDH mRNA level (n = 4). (E) Percentage of GFP-positive cells after I-SceI induction in high (+Dox) or 
low (−Dox) transcriptional activity context (n = 3). (F) DRIP-qPCR analysis of DNA:RNA hybrid structure at 
TetR-IRES-NeoR gene in undamaged cells (no I-SceI induction). Primers targeting the APOE gene are used as a 
positive control for R loop formation, and primers specific to an intergenic region are used as a negative control. 
The values, corresponding to the signal following S9.6 IP of isolated DNA (dark grey bar) or of in vitro RNaseH-
treated DNA (clear grey bar), are represented as fold increase normalised to the APOE positive control (n = 7).
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for three reasons: (i) our experiments are carried out in the absence of LacI protein (with the exception of the 
co-localization experiment with γH2AX and 53BP1 in S1C); (ii) we inserted only 59 LacO repeats, fewer than the 
256 repeats shown to generate a fragile site45; (iii) the DSB-induced large deletions are independent of replication 
fork progression at the time of I-SceI cleavage (Fig. 2C). Furthermore, we generated a cell line without LacO 
repeats and found the frequency of DSB-induced deletions to be unchanged compared to the original cell line, as 
expected (Figure S1H).
The detection of DNA:RNA hybrid formation at a DSB is in agreement with a recent observation in fission 
yeast14, and laser-stripe damage-dependent accumulation of DNA:RNA hybrid in mammalian cells15. DNA:RNA 
hybrids formation at the break site could be explained by the previously documented local initiation of transcrip-
tion in response to the DSB16–18. The lack of effect of transient DRB treatment on the observed deletions may indi-
cate a delayed or non-canonical transcriptional activity at the DSB: DRB acts by inhibiting the CDK9-dependent 
transition of PolII from initiation to elongation46. Ohle et al. found that efficient removal of RNA:DNA hybrids 
was required for homologous recombination repair and viability after DSB induction in fission yeast14. This 
shared link between RNA:DNA hybrid removal and DSB repair is intriguing, however while controlled levels 
of RNA:DNA hybrids in the S. pombe system appear to promote repair, it is unclear what physiological role 
RNA:DNA hybrids play in the repair of our I-SceI DSB.
A DSB flanked by homologous sequences may undergo single-strand annealing (SSA), including XPF cleav-
age, generating a deletion5,47. The speculative model we propose involves mis-repair of a targeted DSB associated 
Figure 5. DNA:RNA hybrids occur at the break site: (A) DRIP-qPCR analysis of DNA:RNA hybrid structure 
at TetR-IRES-NeoR gene in undamaged cells or after DSB induction. Primers targeting the APOE gene are used 
as a positive control for R loop formation, and primers specific to an intergenic region are used as a negative 
control. The values, corresponding to the signal following S9.6 IP of isolated DNA (dark grey bar) or of in vitro 
RNaseH-treated DNA (clear grey bar), are represented as fold increase normalised to the APOE positive control 
(Undamaged, n = 7 (from Fig. 4(F)); I-SceI, n = 7; I-SceI + RNaseH1, n = 3; I-SceI + siSETX, n = 4). (B) Model 
of DSB-induced large deletion dependent on a DNA:RNA hybrid associated with transcription from the DSB: 
Generally a DSB occurring in close proximity to a gene is efficiently repaired, either by HR or NHEJ, and the 
transcription program is not affected over the long term (left side). Alternatively (right side), transcription and 
DNA:RNA hybrid generation displaces the 5′ DNA strand. Senataxin is shown reversing this, promoting correct 
repair. ERCC1/XPF is required to cleave the displaced 3′ DNA strands.
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with DNA:RNA hybrid processing. Transcription from the DSB end will displace the 5′ end of the DNA, promot-
ing SSA. SSA entails resection of the 5′ end until homologous sequences are revealed. This is followed by anneal-
ing and subsequent cleavage of 3′ overhangs by XPF to complete the deletion (Fig. 5B). Alternatively, Senataxin 
can reverse the DNA:RNA hybrid at an early stage, before resection occurs. While the model involving SSA has 
the advantage of linking XPF activity with a DSB-linked deletion, we have no evidence that SSA occurs in our sys-
tem, and other models are possible. For instance, it is possible that the subset of breaks generating a large deletion 
are repaired slowly48,49, and loss of Senataxin may be destabilising DNA replication forks50, promoting deletions 
at these sites of repair. Genetic instability is a common feature of most types of cancer51. Deletions of between 
1–100 kb are a signature of BRCA1 and 2-negative breast cancers52. Deletions may in most cases be tolerable to 
a cell, as indicated by the surprisingly high proportion of post-mitotic neurons containing Mb-scale deletions, 
revealed by single-cell sequencing53. Nonetheless, loss of DNA repair or tumour-suppressor genes will contribute 
to the development of further genetic instability or cancer.
Altogether, data from our two-component system suggests DSB-induced DNA:RNA hybrid formation may be 
mechanistically associated with a minor mis-repair pathway generating large deletions.
Experimental Procedures
Plasmids. The plasmid pcDNA4-GFP-IRES-PuroR was generated by insertion of the bicistronic cassette 
GFP-IRES-PuroR (amplified from pGIPZ-GFP(nls)-IRES-PURO (Murray lab, University of Sussex)) in pcD-
NA4-CMV-TetO (Invitrogen).
The plasmid pIRES-LacOR-REsites-TetR-IRES-NeoR was generated in three steps: (i) TetR gene (amplified 
from pcDNA6 (Invitrogen) was inserted in pIRESneo3 (Clontech) (ii) The LacO repeats were integrated: 16 
LacO repeats (amplified from the plasmid Holo16 (Sweet lab, University of Sussex)) and 43 LacO repeats (from 
PLAU4354) were inserted in pIRESneo3-TetR (iii) The RE sites array containing specific sequence for I-SceI (3 
times), AniI-Y2 and Ppo-I (synthesized by Invitrogen) was integrated in the plasmid obtained at step (ii).
The pIRES-LacOR-REsites-TetO-TetR-IRES-Neo was generated by integration of two TetO cassettes (gener-
ated by Thermofisher) in pIRES-LacOR-REsites-TetR-IRES-Neo.
All primer sequences and cloning details are available on request.
Other plasmids used in this study are pdsRED-I-SceI24, pCVL-HA.NLS.I-AniIY2wt, pCVL-HA.
NLS.I-AniIY2-K227M25, pBABE-IPpoI (Puromycin resistant gene was removed.), pCMV6-AC-RNaseH1 (O. 
Wells, University of Sussex), pLacI-GFP (Savic Lab, University of Sussex).
Cell culture, DNA transfection, establishment of stable cell lines, siRNA transfection and 
drug treatment. U2OS cells were obtained from ATCC, tested for mycoplasma contamination and grown 
in Dulbecco’s modified Eagle’s medium (Gibco) supplemented with 10% foetal bovine serum (PAN biotech), 
Penicillin/Streptomycin (Corning) and L-Glutamin (Gibco). All plasmid transfections utilised the Jet-Pei trans-
fection reagent (Polyethylenimine 25000, PolyScience) as previously described30.
The “U2OS RE-Sites TetR GFP” cell line was generated in two steps: (i) stably integration of pcD-
NA4-GFP-IRES-Puromycin through transfection followed by a Puromycin selection (Sigma, 2.5 µg/ml) then (ii) 
stably integration of HpaI-linearized pIRES-LacOR-REsites-TetR-IRES-Neo through G418 selection (200 μg/ml). 
Monoclonal cell lines were generated by limited dilution.
Cells expressing PpoI were established after transduction with retroviral vectors. Virus production and cell 
infection were performed as previously described30.
Smart-pool siRNA (siCtrl, siSETX#1, siTOP1, siXPF#1, siERCC8) and individual siRNA (siSETX#2, siXFP#2, 
siXPG) were ordered from Dharmacon (see Supp. Table 1: references and sequences). All siRNA transfections 
were done with Lipofectamine RNAimax (Invitrogen) following the manufacturer’s instructions.
The chemical compounds (and their final concentrations) used in this study were: ATMi: Ku-55933 (Abcam; 
10 μM), ATRi: VE-822 (STRATECH SCIENTIFIC; 10 µM), Camptothecin (Sigma; 5 μM), CDK1i: RO-3306 
(Sigma; 10 µM) DNA-PKi: NU-7026 (Abcam; 20 μM), Doxycycline cyclate (Sigma; 2 μg/ml), 4OH-Tamoxifene 
(Sigma; 25 μM), Triamcinolone acetonide, TA (Sigma; 1 μM), and thymidine (Sigma; 2.5 mM).
Fluorescence-activated cell sorting (FACS) analysis. For quantification of GFP-positive cell popula-
tions, cells were trypsinized and re-suspended in complete media. Samples were run on a FACS-accuri (Beckton 
Dickinson) and data analysed with the BD accuri software. Briefly single cells were gated, first on their size (FLH) 
and their granularity (SSC) to exclude debris, and then on the linearity between FLH-H and FLH-A signal to 
exclude doublets. GFP-positive cells were quantified on the signal read on FL1 detector (GFP) vs FL3 (empty 
channel).
For cell-cycle analysis, cells were fixed with cold ethanol 70%, washed with PBS and re-suspended in PBS con-
taining propidium iodide (PI, Sigma, 5 ug/ml) and RNAse A (Sigma, 50 ug/ml) overnight at 4 °C. Samples were 
run and single cell gated as described above. PI signal (correlating with DNA content) was read on FL2 detector.
DSB-dependent deletion reporter system. The “U2OS RE-Sites TetR GFP” cell lines were seeded at 70% 
confluency and transfected with I-SceI-GR-LBD plasmid, as described above. DMEM media phenol-free (Gibco) 
with charcoal-stripped serum (Gibco) was used to prevent premature nuclear-localisation of I-SceI-GR-LBD. 
Two days after transfection, cells were treated with the drug triamcinolone acetonide (TA) (Sigma, 1 μM) for 2 to 
4 hours. After TA induction, cell were kept in culture, collected at different days (Day 4 and 7), and GFP-positive 
cells quantified by FACS, as described above. For the analysis of the GFP-positive subpopulation, data can be 
represented either by the raw percentage of GFP-positive cells, or by the fold increase of the GFP subpopulation 
normalised to undamaged cells =( )Fold increase of GFP sampleaverage of GFP untreated condition[% ][ % ] , or by percentage of 
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GFP-positive cells with subtraction of background levels (mock), normalised to a reference condition, 
− − + = .− −
− −
⁎( )I SceI dependent increase in GFP cells 100([% of GFP I SceI sample] [% of GFPMock sample] )(average of [[% of GFP I SceI reference] [% of GFPMock reference]])
siRNA depletion in DSB-induced deletion reporter system: cells were first transfected with siRNA overnight 
(as described above), the day after, cells were washed and transfected with I-SceI-GR-LBD, 48 h later TA induc-
tion was as described above. The quantification of a GFP-positive subpopulation was as described above.
Kinase inhibition (ATM, ATR, DNA-PK): 48 h after I-SceI transfection, cells were pre-treated for 1 h with the 
chemical inhibitor (as described above), then I-SceI nuclear localisation was induced (as described above) in the 
presence of the inhibitor and the inhibitor was maintained for 24 h after I-SceI nuclear localisation induction 
(TA). The GFP-positive subpopulation was analysed as described above.
CPT: 48 h after I-SceI transfection, cells were pre-treated for 1 h with the drug (as described above), then 
I-SceI nuclear-localisation was induced (as described above) in the presence of the inhibitor. After induction of 
I-SceI nuclear localisation, cells were washed and inhibitor removed. The GFP-positive subpopulation was ana-
lysed as described above.
Replication assay: 24 h after I-SceI transfection, thymidine was added (2.5 mM) for 18 h, and I-SceI nuclear 
localisation was induced (as described above) in the presence of thymidine. Then cells were washed 3 time with 
PBS and released. The GFP-positive subpopulation was analysed as described above. Cell cycle arrest and release 
were monitored by FACS as described above.
Immunoblot analysis. Proteins were resolved by Mini Gel SDS-PAGE (Bio-Rad system) and transferred 
to nitrocellulose membrane (GE Healthcare) as previously described30. All the blocking and antibody incuba-
tions were done in TBS −0.2% Tween-20 5% BSA (Fisher). The following primary antibodies were used: anti-
53BP1 (1:1000, Millipore), anti-ATM (1:1000, Abcam), anti-Chk1-phS317 (1:1000, Cell Signalling Technology), 
anti-GFP (1:1000), anti-HA (1:1000, Sigma), anti-H2AX-P (1:1000, Abcam), anti-p53 (1:1000, DO-1, SantaCruz), 
anti-p53-phS15 (1:1000, NEB), anti-RNaseH1 (1:1000, Abcam), anti-TetR (1:1000, TETO2, MoBiTec), 
anti-tubulin (1:5000, Abcam), and appropriate HRP-conjugated secondary antibodies were used: anti-mouse 
(1:10000, Cell Signalling Technology), anti-rabbit (1:10000, Cell Signalling Technology) and anti-rat (1:10000, 
Abcam). Immuno-reactive bands were detected by chemoluminescence induced by Supersignal reagent and 
detected with the ImageQuant LAS 4000 machine (GE Healthcare). Quantification was performed using ImageJ.
DNA extraction, RNA extraction, qPCR and RT qPCR. Total genomic DNA was isolated using the 
DNeasy kit (Qiagen). Total RNA was extracted using the RNeasy kit (Qiagen). Reverse transcription was per-
formed by using the Super Script III reverse transcriptase (Invitrogen) and random hexamers (Invitrogen).
The list of primers used for qPCR are available in Supp. Table 2. Quantitative PCR was performed with goTaq 
qPCR master mix (Promega) and Mx3005-P qPCR machine (Stratagene). The data was analysed with MX-Pro 
software (Stratagene).
Immunofluorescence microscopy. Images of GFP-positive live cells were acquired with the AMG-Evos 
inverted microscope. Immunofluorescence microscopy was performed as described30, with antibody dilutions: 
HA (1/500, Sigma), γH2AX (1/500, Millipore), GFP (1/500, Roche). Samples were examined either with a micro-
scope (Zeiss) equipped with a 10X, a 40X dry objective and a 100X oil immersion objective and a Hamamatsu 
Orca ER camera, or a confocal microscope (Olympus IX71) equipped with a 40X, 60X and 100X oil immersion 
objective and a CoolSNAP HQ2 camera. Pictures were analysed with ImageJ software.
Clonogenicity assay. Two days after I-SceI induction, cells were counted and plated in 6 well plates (200 000 
per well). One day after plating GFP+/PuroR clones were selected through puromycin treatment (2.5 µg/ml) for 
one week. Then the cells were fixed with formaldehyde 3% (FISHER) and stained with Brilliant blue 0.5% (Sigma) 
in PBS overnight. After PBS washing, drying and scanning, the clones were counted by ImageJ.
DNA:RNA hybrid Immunoprecipitation (DRIP-qPCR). After treatment as indicated, cells were col-
lected, and lysed with the lysis buffer (200 mM NaCl, 10 mM Tris pH7.5, 2 mM EDTA, 0.2% SDS and protein-
ase K 20 µg/ml (Sigma P2308) at 56 °C for 3 h. Then, DNA and associated RNA are precipitated by addition of 
one volume of isopropanol, washed with ethanol 70%, and resuspended in TE buffer (Tris-HCl pH 7.5, 0.5 mM 
EDTA). After sonication to obtain DNA fragments less than 800 bp, 50 µg of DNA was treated with recombinant 
RNaseH (NEB) and used as a negative control. 50 µg of digested DNA was immuno-precipitated with 3 µg of S9.6 
antibody12 (Kerafast) coupled to IgG magnetic beads (Invitrogen). Washing utilised five buffers (W1: Tris pH8 
10 mM, KCl 150 mM, NP40, 0.5%, EDTA 1 mM; W2: Tris pH8 10 mM, NaCl 100 mM, NaDoc 0.1%, TritonX100 
0.5%; W3: Tris pH8 10 mM, NaCl 400 mM, NaDoc 0.1%, TritonX100 0.5%; W3b: Tris pH8 10 mM, NaCl 500 mM, 
NaDoc 0.1%, TritonX100 0.5%; W4: Tris pH8 10 mM, LiCl 250 mM, NaDoc 0.5%, NP40 0.5%, EDTA 1 mM; W5: 
Tris pH8 10 mM, EDTA 1 mM). After washing, DNA:RNA hybrid associated structures are eluted with SDS buffer 
and the DNA purified with a Nucleospin Extract II kit (MACHEREY NAGEL). qPCR analyses of DRIP DNAs 
were performed as described above. The amount of DNA in DRIP samples was extrapolated from analysis of 
DNA before immunoprecipitation (input) and values were represented as fold increase compared to the positive 
control.
DNA break efficiency assay. The U2OS I-SceI TetR GFP cell line was transfected with I-SceI GR-LBD plas-
mid and its nuclear localisation was induced as described above. Two hours after induction, total genomic DNA 
was isolated, as described above. For quantification of I-SceI induced cutting efficiency, qPCR was performed (as 
described above), with amplification across the I-SceI sites. The data was normalised to an unconnected genomic 
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control locus (Genomic control #2), and then expressed as a ratio relative to the undamaged sample. Primer 
sequences available in Supp. Table 2.
Statistics. All p-values are from two-tailed, paired T-tests. All error bars represent the standard error of the 
mean, unless stated otherwise.
Data availability. All datasets generated during and/or analysed during the current study are available from 
the corresponding author on reasonable request.
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